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Obesity, and to a lesser extent also overweight, is characterized as an excessive 
accumulation of energy in the form of body fat. Overweight and obesity have 
reached epidemic proportions globally and the most recent estimate indicates that 
more than 1 billion adults worldwide are overweight, of whom at least 300 million 
are obese.1 This poses a serious health problem because overweight and obesity lead 
to adverse metabolic effects on blood pressure, blood lipids, and insulin resistance, 
consequently increasing the risk of chronic diseases such as type 2 diabetes, 
cardiovascular disease (CVD), hypertension, stroke, and certain forms of cancer. 
According to the World Health Report 2002, approximately 58% of diabetes, 21% of 
ischemic heart disease and 8-42% of certain cancers are attributable to a BMI above 
21 kg/m2.1 
The most commonly used quantitative measurement of adiposity is the body 
mass index (BMI), defined as the weight in kilograms divided by the square of the 
height in meters (kg/m2). Currently, a BMI ≥ 25 kg/m2 is defined as overweight, and a 
BMI ≥ 30 kg/m2 as obese. Waist circumference is also widely used to measure obesity, 
especially abdominal obesity. A waist circumference ≥ 102 cm in men or ≥ 88 cm in 
women is defined as abdominal obesity or central obesity.2  
 
Risk Factors for Weight Gain 
One of the few non-controversial facts about obesity is that weight is only gained 
when energy intake exceeds energy expenditure for a prolonged time period. Our 
current environment is characterized by an essentially cheap and unlimited supply 
of convenient, high palatable, energy-dense foods, coupled with a lifestyle 
prohibiting a sufficient level of physical activity, due to the invention of cars, 
washing machines, televisions, internet, etc. Such environment promotes a positive 
energy balance. In addition, with human evolution, our human being has developed 
excellent physiological defenses against the energy deficiency and has become very 
efficient in preventing weight loss. However, we are still relatively ineffective in 
preventing excessive weight gain in an environment where food is abundant.  
 
 
General introduction 
 
 1
Chapter 1 
 - 8 - 
Dietary factors 
A high total energy intake is the main driver of higher body weights in modern 
populations.3 Many dietary composition factors and dietary behaviors are associated 
with energy intake, and thereby with weight gain and obesity.4, 5 In 2003, the joint 
WHO/FAO expert consultation report on diet, nutrition and the prevention of chronic 
diseases summarized the strength of evidence of factors influencing weight gain and 
obesity.6 The diet-related factors are listed in Table 1-1 and are briefly discussed 
hereafter.  
 
Table 1-1. Summary of strength of evidence on factors that might promote or protect against weight 
gain and obesity* (adapted from WHO/FAO report6). 
Evidence Decreased risk No relationship Increased risk 
Convincing High dietary intake of 
dietary fiber† 
 High intake of energy-dense 
micronutrient-poor foods‡ 
Probable Breastfeeding  High intake of sugar-sweetened soft 
drinks and fruit juices 
Possible Low glycemic index foods Protein content 
of the diet 
• Large portion sizes 
• High proportion of food prepared 
outside the home (developed 
countries) 
• “Rigid restraint/periodic 
disinhibition” eating patterns 
Insufficient Increased eating frequency  Alcohol 
* Strength of evidence: the totality of the evidence was taken into account. The World Cancer Research Fund 
scheme was taken as the starting point but was modified in the following manner: randomized controlled trials 
were given prominence as the highest ranking study design (randomized controlled trials were not a major 
source of cancer evidence); associated evidence and expert opinion was also taken into account in relation to 
environmental determinants (direct trials were usually not available). 
† Specific amounts will depend on the analytical methodologies used to measure fiber. 
‡ Energy-dense and micronutrient-poor foods tend to be processed foods that are high in fat and/or sugars. Low 
energy-dense (or energy-dilute) foods, such as fruit, legumes, vegetables and whole grain cereals, are high in 
dietary fiber and water. 
 
Dietary fiber 
Dietary fiber is defined as the edible parts of plant foods that are resistant to 
digestion and absorption in the human small intestine with complete or partial 
fermentation in the large intestine. It can facilitate body weight control through 
different physiological mechanisms.7 Firstly, fiber rich foods tend to be more 
satiating due to their relatively low energy density and palatability as compared to 
low fiber foods. Secondly, dietary fiber, especially soluble fiber, could increase the 
viscosity of diets and slow down the gastric emptying and digestion, thus 
stimulating the release of gut hormones and promote satiety. In addition, dietary 
fiber could provide a mechanical barrier to the enzymatic digestion of other 
macronutrients such as fat and starch in the small intestine. Moreover, the slower 
digestion and absorption rate of carbohydrates in high fiber foods would lead to a 
reduced postprandial blood glucose response, which increase satiety and, over a 
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long term, could improve insulin sensitivity and influence fuel partitioning to favor 
fat oxidation.7 Although not completely consistent, findings in general support the 
beneficial role of dietary fiber in the regulation of body weight.8-10 Therefore, the 
WHO ranked the evidence for a beneficial role of dietary fiber in obesity control as 
“convincing” (Table 1-1). 
 
Energy density (ED) 
Energy density (ED) is defined as the amount of available energy per unit weight 
of foods or meals (kJ/g or kcal/g).11 Experimental data convincingly show that people 
tend to eat a similar volume of food to feel satiated, and, accordingly, consuming 
energy-dense foods could cause passive over-eating in terms of energy.12 
Furthermore, energy-dense foods, usually high in fat and low in fiber, tend to be 
highly palatable and stimulate over-eating.13 It is believed that the general accepted 
harmful impact of high fat diets on fat mass accumulation is primarily mediated by 
dietary ED. Several intervention studies among overweight and obese subjects 
consistently demonstrate that ED reduction is associated with weight loss.14-16 
Therefore, the evidence of a positive relationship between high intake of energy-
dense foods and weight gain and obesity was classified as “convincing” (Table 1-1).  
 
Breast-feeding 
The protective effect of breast-feeding against childhood obesity has been 
reported by several observational studies.17-19 The main explanations include infants 
fed with breast-milk consume lower amounts of total energy and protein as 
compared to infants fed with formula milk; bioactive substances in breast-milk could 
inhibit adipocyte differentiation; infants fed with breast-milk develop the ability of 
regulating food intake early;20 and the early exposure of breast-milk flavor could 
enhance the infants’ enjoyment of a wide variety of flavor in later life.21 On the other 
hand, formula-fed infants are often forced to finish the bottle, leading to an excessive 
consumption of energy and protein. Also, the higher protein content of formulas 
could stimulate the secretion of insulin therefore stimulating fat deposition and 
leading to the early development of adipocytes.22 However, results from the first 
published large randomized trial did not provide evidence about the protective role 
of breast-feeding.23, 24 Therefore, the evidence on the protective role of breastfeeding 
in obesity prevention was viewed as “probable” (Table 1-1).  
 
Sugar-sweetened beverages 
Sugar-sweetened beverages generally contain a large amount of liquid energy, 
which is poorly compensated and may result in excess energy intake.25 In addition, 
added sugars in the sugar-sweetened beverages are absorbed rapidly, which may 
promote visceral fat accumulation due to the insulin resistance and increased de novo 
hepatic fatty acid synthesis caused by the added sugars.26, 27 Increased consumption 
of sugar-sweetened beverages, mainly soft drinks and fruit juices, are considered as a 
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main driving force for weight gain and obesity, especially among children and 
adolescents.28 Although large high-quality clinical trials are lacking, the evidence in 
general support that consumption of sugar-sweetened beverages is a “probable” risk 
factor for obesity.29  
 
Glycemic index and glycemic load  
The glycemic index (GI) is a quantitative measure of carbohydrate quality based 
on the blood glucose response after consumption.30 Glycemic load (GL) measures the 
entire blood glucose-raising potential of dietary carbohydrates and is calculated as 
the product of GI and total carbohydrates.31 It has been suggested that low GI or GL 
diets can help to prevent body weight gain and stimulate weight loss.32 This is 
because the mild blood glucose and insulin response following a low GI or GL diet 
consumption could stimulate a higher satiation and satiety, thus leading to a 
decrease in energy intake,33 regulate energy partitioning resulting a reduced fat 
storage,34 and limit the decrease of resting metabolic rate under energy restriction.35, 
36 However, findings in the literature are inconsistent. For example, a Cochrane 
review37 of six randomized controlled trials (RCTs) has concluded that low GI and 
low GL diets are more effective in promoting body fat loss (~1 kg more) than 
comparison diets, but studies published thereafter have not been able to consistently 
confirm this finding.38-41 Findings from large prospective cohort studies are 
inconsistent as well. For example, in the SEASONS study, GI, but not GL, has been 
positively associated with a change in body mass index (BMI)42. In the Danish arm of 
the MONICA project, low GI diets have been associated with a lower weight and 
waist circumference gain in women but not in men.43 The evidence for GI was rated 
as “possible” in the WHO/FAO expert consultation report and more studies are 
needed to establish the association with certainty. 
 
Protein intake 
Protein has a higher satiety value than iso-energetic quantities of other 
macronutrients, and therefore higher protein intake could decrease total energy 
intake.44 Also, protein has a greater thermogenic effect and may therefore result in an 
increased energy expenditure.45 However, data from the USA show that the 
consumption of protein, both at absolute level and as percentage of total energy 
intake, has remained relatively stable during the past decades, while the obesity 
prevalence has increased dramatically. This secular trend data do not support the 
hypothesis that protein plays an important role of in the development of obesity.46, 47 
Most of the earlier observational studies even suggested a positive relationship 
between protein intake and adiposity among adults.48, 49 Also, high protein intake 
early in life is associated with an increased risk of childhood obesity.50 Therefore, the 
WHO/FAO expert consultation reckoned that protein content of diet “possibly” has 
no independent role in obesity. More recently, some researchers proposed the 
protein leverage hypothesis,51 which means that the body must be supplied with a 
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certain level of dietary protein. When a protein-rich diet is consumed, this demand 
can be easily reached with a lower level of fat and carbohydrate thus total energy 
intake, otherwise a higher amount of total energy must be consumed to obtain 
enough protein. Furthermore, several recent studies have observed an inverse 
association between protein intake and obesity.52, 53 
 
Portion size 
Larger portion size is often accompanied by a higher total energy content, and 
thus could contribute to weight gain.54-56 Large portion sizes served at restaurants 
and produced by manufactures have been commonly blamed as one of the important 
factors in the rising prevalence of obesity.57 However, the influence of portion size on 
food intake may vary by age58 and weight status, and may also depend on the energy 
density of the foods, because it is “possible” that consumption of a larger portion of 
lower energy dense foods, such as fruits and vegetables, is protective against weight 
gain.56  
 
Eating outside home 
Foods prepared at restaurants, especially fast food restaurants, are often of lower 
nutritional quality and have higher fat and energy contents than foods eaten at 
home.59 Individuals who eat more fast foods tend to have higher intake of energy, fat, 
and soft drinks, and lower intake of dietary fiber, fruits and vegetables.60 In addition, 
portion sizes served at restaurants are often larger and the palatability and variety of 
restaurant-prepared foods are often increased.57 These factors may contribute to an 
increased energy intake subsequently leading to obesity.57, 61 Due to the limited 
number of studies have been conducted on this topic, the WHO categorized the 
evidence for a positive association between eating out of home and obesity as 
“possible”. 
 
Rigid restraint and habitual disinhibition 
Restraint is the conscious restriction of food intake to control body weight. 
Disinhibition is the tendency to overeat in response to external stimuli, such as when 
a palatable food is available or under emotional distress. Rigid restraint and habitual 
disinhibition are the most important cognitive behaviors predicting weight gain and 
obesity in adults.62-64 Although data from intervention studies are lacking, it is 
“possible” that these psychological parameters of eating habits are positively related 
to weight gain and obesity.  
 
Eating frequency  
In comparison to eating infrequently (gorging), eating frequently (nibbling) is 
associated with metabolic advantages including reduced serum levels of total 
cholesterol, LDL cholesterol, and insulin.65 Eating frequently may increase food 
induced thermogenesis and decrease the efficiency of energy utilization. Frequent 
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meals may also suppress hunger and reduce overeating. However, evidence 
suggesting a beneficial role of increasing meal frequency on preventing obesity is 
“insufficient”.66, 67 Standardized definitions, e.g. how to define an eating occasion or a 
meal, are needed, not only for improving the quality of findings in this field but also 
for providing public recommendations.  
 
Alcohol intake 
Alcohol is a form of liquid energy and research revealed that dietary 
compensation for liquid energy is less precise. Therefore, over-consumption of total 
energy might follow after alcohol intake.25 In addition, alcohol cannot be stored in 
the human body therefore it must be preferentially oxidized and thereby results a 
suppressed oxidation of other macronutrients especially fat. Observational studies 
have demonstrated mixed associations between alcohol intake and weight gain or 
obesity status,62, 68-70 and the observed associations might be secondary to the 
associations between obesity and other risk factors, such as poor eating behavior, 
physical inactivity, and low dietary quality.62, 69 Currently there is “insufficient” 
evidence suggesting that alcohol consumption is a risk factor for obesity. 
 
Other dietary factors 
Many other dietary factors have been suggested to play a role in regulating 
energy intake and body weight, such as the intake of whole-grain,71 fruits and 
vegetables,72 and calcium,41 total and different types of fat,73 and a “prudent” type of 
dietary patterns.74 These factors have been hypothesized to reduce obesity, but 
evidence is inconclusive and they may also work through the factors indicated above.  
 
Physical activity 
As mentioned earlier, overweight and obesity can only result from a positive 
energy balance, where energy intake exceeds energy expenditure for a prolonged 
period of time. Although basal metabolic rate accounts for the majority of total 
energy expenditure, differences in energy expenditure between individuals are 
largely determined by the differences in physical activity.75 Several large studies 
have shown that the risk of weight gain is greater among individuals with a 
sedentary lifestyle as compared to those engaged in regular physical exercises. For 
example, in a cohort study of over 15,000 US adults, physical activity over 10 years 
has been inversely associated with weight gain.75 In a recent cross-sectional analysis 
of data from about 400,000 European adults, physical activity has been inversely 
associated with BMI status.76 Evidence from randomized controlled trials also 
indicate that participating physical activity programs during a dietary-induced 
weight loss could enhance the likelihood that the weight loss will be maintained.77 
 
Other newly detected determinants of obesity 
Early life programming 
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Over the past decade, the detrimental effects of poor fetal growth on the 
development of obesity in later life has become clear.78 These effects could be further 
increased by accelerated postnatal growth.79 Accumulating evidence suggests early 
life programming plays an important role in long term metabolic health. For example, 
data from Dutch Hunger Winter Families Study indicate that maternal malnutrition 
in early pregnancy may predict later obesity in both men and women.80, 81 One 
plausible mechanism for this effect relates to changes in the expressions of genes 
which are involved in the regulation of energy balance. In addition, epigenetic 
mechanisms may contribute to these changes in gene expression.82  
 
Quantity and quality of sleeping 
Chronic sleep deprivation is increasingly common in modern societies. 
Interestingly, this has been developing over the same period as the recent epidemic 
of metabolic conditions including obesity and diabetes. A number of epidemiological 
studies have been published relating short sleeping duration with more weight gain 
and obesity.62, 83, 84 In experimental studies, sleep restriction impaired glucose 
tolerance and insulin sensitivity, decreased leptin levels and increased levels of the 
appetite-stimulating hormone ghrelin.85 Recently, marked alterations in glucose 
metabolism and insulin sensitivity were also observed after experimental induction 
of a high degree of sleep fragmentation and low amounts of slow wave sleep, 
without changes in sleep duration.86 This result indicates that reduced sleep quality 
per se may also play a role in the pathophysiology of obesity-related risk factors.  
 
Environmental temperature 
The importance of the brown adipose tissue in adaptive thermogenesis, due to 
the expression of uncoupling protein-1 in the mitochondria, and the regulation of 
body weight have been proven in animal studies.87 However, it was generally 
thought that brown adipose tissue is only present in infants and has negligible 
physiologic relevance in adult humans. Recently, several studies have observed that 
functionally active brown adipose tissue is presented in adult humans, cold exposure 
can stimulate brown adipose tissue activity, and the amount and activity of brown 
adipose tissue is inversely correlated with BMI.88, 89 These findings imply that a 
slightly lower environmental temperature, or stimulated brown adipose tissue 
activity, could increase adaptive thermogenesis, thus facilitating body weight 
control.90 
 
Gene-environment interaction 
Because the genetic background of humans is relatively constant over several 
generations, it seems unlikely that the recent rise in the prevalence of obesity has 
been triggered by changes in our genome. However, the susceptibility to obesity is 
largely determined by our genes. Within any given environment, an individual’s 
becoming obese is not a certainty, but an event that occurs with a certain probability. 
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In other words, an individual’s body weight and body composition are determined 
by interactions between the environment and genetics.91 For example, the Pima 
Indians living in Arizona have a much higher incidence of obesity than the rest of the 
US population and their genetic kindred in the Sierra Madre mountains of Northern 
Mexico.92 Twins, adoptees and migrants have also provided good experimental 
settings for testing these interactive relationships. The results of these studies 
emphasize the importance of both environmental and genetic factors in the 
pathogenesis of obesity. Similar interactions between genes and environments have 
been suggested by observational studies in other populations also. For example, a 
study among Japanese men has demonstrated an interaction between a missense 
variant in the interleukin 6 receptor gene and dietary energy intake influencing 
abdominal obesity.93 In the Danish population-based Inter99 study, a low physical 
activity has been associated with an attenuated effect of a single nucleotide 
polymorphism (SNP) of the fat mass and obesity-associated (FTO) gene on body fat 
accumulation.94 The interaction between dietary fat and the Pro12Ala polymorphism 
in the peroxisome proliferator-activated receptor gamma (PPARγ) gene affecting BMI 
and insulin sensitivity has been observed in several studies.95-97  
These gene-environment interactions might explain the heterogeneity in studies 
associating dietary factors and obesity, and may also contribute to the lack of 
replication of genetic associations. Despite the identification of many obesity genes,98 
relatively few studies have been conducted investigating the effects of gene-
environment interactions on obesity development, which is a very important issue 
for better targeting the obesity prevention and programs.  
 
Physiological Regulation of Food Intake  
Physiological regulation of food intake can be divided into two phases: satiation 
and satiety. Satiation develops during a meal, ends eating, and determines the meal 
sizes. Satiety develops after foods have been ingested, delays the onset of the next 
meal and controls the inter-meal intervals. The regulation of satiation and satiety, 
thereby energy intake, is conducted by the hypothalamic signaling network.99 This 
network involves three main sets of signals.  
The first set comprises of gut hormones such as cholecystokinin (CCK), 
glucagon-like peptide-1 (GLP-1) and ghrelin. CCK and GLP-1 are released from the 
gut following food consumption to terminate meals (satiation) and their effects 
depend on gastric distention.100 Therefore, inhibiting the gastric emptying rate could 
lead to a higher satiation which might be the underlying mechanism for the satiating 
effects of diets high in fiber and low in glycemic index.7, 101 Ghrelin is the only gut 
hormone stimulating meal initiation (reducing satiety). In addition, metabolites in 
blood after absorption could influence people’s feeling of fullness (satiety). For 
example, the transient and dynamic declines in blood glucose concentrations could 
also promote eating (glucostatic hypothesis).100 This may also explain the low 
satiating effects of high GI foods because, as compared to low GI foods, high GI 
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foods cause high blood glucose levels immediately after consumption, followed by a 
low level of blood glucose and free fatty acids at middle postprandial stage. This 
low-fuel state could stimulate meal initiation.101, 102 It has been noted that 
macronutrients exert hierarchical effects on satiety in the order of protein > 
carbohydrate > fat. In addition, many short-term intake studies show that the weight 
or volume, rather than the energy content, of foods is one of the most important 
determinants of meal size.100 Energy dense foods are usually high in fat and low in 
water and fiber, and are consequently less satiating.103 
Adiposity signals, including leptin and insulin, are the second set of signals. 
They monitor the nutritional status of the body, mediate the effects of gut hormones 
on the hypothalamus, and influence the sensitivity of the hypothalamus to satiety 
hormones such as CCK. For example, leptin deficiency induced by fasting limits the 
satiating effect of CCK, which, in turn, leads to an increased food intake during a 
meal, thereby restoring energy balance.104  
Signals released by the central nerve system, especially the hypothalamus, are 
the third set of signals and include alpa-melanocyte-stimulating hormone (α-MSH) 
and its precursor pro-opiomelanocortin (POMC) (inhibits food intake) and 
neuropeptide Y (NPY) (increases food intake).99 A simplistic overview of the 
physiological regulation of energy intake is depicted in Figure 1-1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-1. Schematic overview of energy intake regulation. 
 
Rational and Outline of the Thesis  
Obesity is a preventable condition and the prevention is easier, less expensive 
and more effective as compared to the treatment. However, there is little data 
available on the impacts of dietary factors in the prevention of weight or adiposity 
gain. On the other hand, quite a large number of studies have been conducted 
POMC ↑  NPY ↓ 
Hypothalamic signals  
Energy intake: 
Fat, protein, carbohydrates & alcohol  
Gastrointestinal tract 
 
CCK, GLP-1 & PYY↑ 
Ghrelin ↓  
Adipose tissue 
Adiposity signals 
e.g. leptin, insulin 
Energy expenditure: BMR, 
thermogenesis, physical activity 
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investigating the effects of dietary factors in treating obesity and any low calorie diet 
seems to work.105 But, dietary factors which could induce a quick weight loss among 
obese subjects may not be appropriate for a long-term use in order to prevent weight 
gain, such as the well-known very-low-carbohydrate diet.106-108 In addition, they may 
not equally effective in obesity prevention. For example, in the Women’s Health 
Initiative, one of the longer-term intervention studies on weight loss, the low-fat 
group initially lost weight but then gained weight at least as fast as the control 
group.109  
Investigating the effects of dietary factors on the prevention of subsequent 
weight gain in the general population is of important public health relevance. The 
DiOGenes project was set up with the primary goal as to determine the efficacy of 
dietary macronutrient components for the prevention of weight gain and regain, due 
to the difficulties of conducting large intervention studies on primary weight gain.110 
Within the research line of the DiOGenes population-based cohort study, this thesis 
was initiated to investigate the associations of dietary factors having impacts on 
satiation or satiety, including dietary GI, GL, ED, and fiber intake, and the genetic 
variants involved in energy intake regulation with subsequent weight and waist 
circumference change. For this purpose, we analyzed data of 89,432 participants 
from five European countries that are involved in the existing EPIC study (European 
Prospective Investigation into Cancer and Nutrition). First, to better understand the 
GI concept, a narrative review about the physiological mechanisms underlying the 
potential associations between GI and chronic diseases including diabetes, 
cardiovascular diseases, obesity and certain cancers was conducted and this part of 
work is presented in Chapter 2. Given that the food frequency questionnaires (FFQs) 
used in this study are not specially designed to assess GI and GL and the validities of 
the measurements were unknown, two studies were conducted to obtain insights 
into the relative validities of GI and GL measured by the FFQ used in the Dutch part 
of the EPIC study. Chapter 3 describes the cross-sectional associations between GI, 
GL and food intake as well as metabolic risk factors including blood glucose, insulin, 
lipids and the inflammatory marker C-reactive protein. In Chapter 4, the 
reproducibility and relative validity of GI and GL, as compared to the measurements 
from multiple 24-hour recalls, is described. Chapter 5, 6 and 7 present the 
associations of GI and GL, dietary energy density, and the intake of fiber (in total 
and from different food sources) with subsequent changes of weight and waist 
circumference respectively. Given the critical role of the hypothalamic signaling 
network in regulating energy intake hence body weight, the effects of SNPs in or 
near genes involved in this network have been investigated. The interactions of these 
SNPs with dietary GI were also investigated (Chapter 8). This thesis ends with 
Chapter 9, in which the research findings are discussed in a broader context and 
implications for future research and developments are explored.  
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Introduction  
Carbohydrates (CHOs) are the most important energy source in human diets 
and are often classified by their molecular size as sugar, oligosaccharides, 
polysaccharides, and polyols (hydrogenated CHOs).1 However, the relevance of this 
structural classification has been questioned and interest in an alternative property 
of CHOs has grown.2 The glycemic index (GI) is a contribution of Jenkins and co-
workers in 1981 to classify CHO containing foods according to their impacts on 
body’s postprandial glycemic response.3 GI is defined as “The incremental area 
under the 2-hour blood glucose response curve of a test food containing 50g of 
glycemic (available) CHOs expressed as the percentage of the response to the same 
amount of glycemic CHOs from a standard food (either white bread or glucose) 
taken by the same subject”.4 Although white bread and glucose both give valid 
values, glucose may be the preferred control because of its stable composition. When, 
for any reason, white bread is used as reference, the obtained GI value needs to be 
divided by 1.4 to get the GI value contrast to glucose.  
Over the past decades, the concept of GI has attracted attention from various 
sectors such as the general public, commercial sectors, and health care professionals. 
The Food and Agriculture Organization (FAO) and World Health Organization 
(WHO) Joint Expert Consultation report has recommended the use of GI for 
categorizing dietary CHOs and to guide people’s food choices.4 But in addition to the 
appraisal, criticism on the utility and validity of GI is also present in scientific 
journals. This review will cover the physiological mechanisms of GI as well as the 
evidence gathered thus far about the health impacts of low GI diets on morbidity 
and mortality from chronic diseases such as diabetes, obesity, cardiovascular disease 
and cancer.  
 
Methods 
A PubMed (MEDLINE) search using the search strategy “glycemic index OR 
glycaemic index” located a total of 675 English publications (till mid December, 2005). 
Among them, articles related to physiological mechanisms and effects on the risk 
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and treatment of diabetes, obesity, cardiovascular disease and cancer were carefully 
studied. In addition, reference lists of these articles were hand searched for other 
relevant publications and current healthy eating guidelines from different nations 
were gone through. 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 2-1. Glycemic indices of several foods and food categories (adapted from Bornet5 ). 
 
Results 
Carbohydrate physiology and glycemic index 
The digestion, absorption and metabolism of CHOs are complex processes in 
which disaccharides and polysaccharides need to be broken down to 
monosaccharides prior to absorption. Digestion of CHOs starts in mouth although its 
predominant site is the small intestine where maltose (from starch) is broken down 
into two molecules of glucose; lactose into one glucose and one galactose and sucrose 
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into one glucose and one fructose by enzyme maltase, lactase and sucrase, 
respectively. Subsequently, these monosaccharides are transported across the 
intestinal wall to the hepatic portal vein and then to liver parenchymal cells and 
other tissues via distinct mechanisms. For example glucose and galactose are taken 
into the enterocytes by secondary active transport, whereas fructose is absorbed into 
the cells passively down a concentration gradient.4 Furthermore, the metabolic fates 
of these three monosaccharides are quite different as well: glucose can be catabolized 
to produce ATP, stored as glycogen when energy supply is sufficient or converted 
into fatty acids once muscle and liver glycogen stores are saturated. As for fructose 
and galactose, they are not direct energy source and need to be converted to glucose 
in the liver before they can supply ATP. All of the above mentioned aspects account 
for the fact that sucrose, lactose and fructose have lower GI values than glucose 
(Figure 2-1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-2. Postprandial blood glucose responses from foods with different GI values 
( www.glycemicindex.com). 
 
As shown in Figure 2-1, CHO containing foods, even though they belong to the 
same food category, cover a wide range of GI values. Generally, they are arbitrarily 
categorized as low, medium or high GI foods if their GI values are ≤ 55, 55 < GI < 70, 
or ≥ 70 (vs. glucose = 100), respectively. Low GI foods have slow digestion and 
absorption rates, and hence cause a small and gradual rise in postprandial blood 
glucose levels. In contrast, high GI foods are characterized by fast CHO digestion 
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and absorption, and hence cause a large and rapid increase in postprandial blood 
glucose (Figure 2-2). Some researchers believe that this response is independent of 
the amount of CHOs,6, 7 whereas others claim that it is the quantity of CHOs that is 
more important.8 To eliminate concerns about the influence of CHO quantity on 
postprandial glucose response, researchers at Harvard University developed the 
concept of glycemic load (GL) in 1990s.9 It combines both the quality (GI) and 
quantity of CHOs in a food or meal and is defined by a food or meal’s GI (in 
percentage) multiplied by its available CHO content in grams (GL = GI/100 × the 
amount of available CHOs). Foods with similar GI values may have completely 
different GL levels, and vice versa. For example, carrots and basmati rice may have 
similar GI values, but one serving of rice has a much higher GL than one serving of 
carrots due to the larger CHO content of  rice.10 Changing the GL of meals can be 
achieved by adjusting either the overall GI or total CHO intake. However, replacing 
high GI foods by low GI equivalents (thereby reducing the diets’ overall GI level) is 
more meaningful and applicable than cutting down CHO consumption (the other 
approach to reduce overall GL). This is because CHOs are important components of 
a balanced diet and very low CHO diets are unavoidably high in fat which in turn 
will increase the risk of cardiovascular disease. Besides, CHO containing foods are 
important sources of many nutrients, such as vitamins, minerals and fiber. Given the 
above, low CHO diets are not recommended11 (according to the USDA, CHOs 
should provide 55% of total energy intake12) and high CHO low GI diets should be 
advocated.  
The physiological responses after the ingestion of a high GI food compared with 
a low GI food are clearly explained by Ludwig.2 In summary, high GI food 
consumption is often followed by a rapid increase in blood glucose, which will 
stimulate the beta-cells of the pancreas to increase insulin secretion to a larger extent. 
Fat oxidation is inhibited by this hyperglycemic status and blood free fatty acid level 
is low. At the middle postprandial stage, the marked rise in blood insulin level leads 
to a rapid downward regulation of blood glucose (often to below fasting level). Fat 
oxidation remains suppressed and blood free fatty acid concentration maintains a 
low level. At the late postprandial stage, hypoglycemia stimulates the release of 
counter-regulatory hormones to restore euglycemia and the activation of fat 
oxidation to meet body’s energy needs. A marked increase in free fatty acid 
concentration thus follows. In contrast, a low GI food consumption results in lower 
but more sustained increases in blood glucose, thus less demand on pancreatic beta-
cells and mild changes in blood free fatty acid levels.  
Despite the popular success of the GI, also in the lay press, there is still no 
agreement reached on the utility of the GI concept in clinical as well as public health 
settings. Generally speaking, criticism on the GI can be summarized as follows: 
Firstly, many intrinsic and extrinsic factors affecting food digestibility, 
gastrointestinal motility or insulin secretion have impacts on the GI value of a 
specific food.13-15 These not only include the nature of the CHOs, but also other 
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factors such as the physical form of a food, its ripeness, the methods of cooking and 
processing, etc. (Table 2-1).1, 16-18 This is why different varieties of the same food may 
differ widely in their GI values. For instance, eight potato varieties that are 
commercially available on the UK market have GI values ranging from 56 to 94.19 
Some researchers are even claiming that the glycemic response to a mixed meal 
cannot be predicted from the published GI values of the composite foods.20-22 Under 
these circumstances, GI has been criticized as not being applicable and useless in 
daily life. However, there is also evidence on the usefulness of the GI in the context 
of mixed meals.23, 24 Although additional fat, protein or other components in a meal 
might influence the glycemic response, the rank order of the glycemic response to 
different CHO containing meals can still be predicted with reasonable accuracy from 
the GI values of constituent foods if standard procedures are followed.2, 25 
 
Table 2-1. Factors which have an influence on the glycemic index (GI) of foods. 
Factors Impacts 
Monosaccharide 
components 
Glucose has a higher GI value than fructose and galactose. So, the 
higher the relative content of glucose, the higher the GI value. 
Amylose vs. 
amylopectin 
Starch rich in amylose has a more compact structure and is more 
resistant to absorption and digestion than starch rich in 
amylopectin. So the higher the relative content of amylose vs. 
amylopectin, the lower the GI. 
Particle size and 
physical barriers 
Foods that are smaller in particle size and lack physical barriers 
(e.g. seed coats) are more easily digested and are inclined to have 
higher GI values. For example, refined and highly processed 
foods normally have higher GI values than whole grains and 
legumes. 
CHO structure 
Starch 
gelatinization 
The more gelatinization, the more easily digested and hence the 
higher the GI value. For instance cooked and riper foods. 
Fiber Diets rich in soluble fiber (e.g. guar gum, pectin and sugar beet 
fibers) can form gelatinous gels within the stomach which inhibit 
CHO absorption and digestion. So, fiber is thought to be able to 
decrease GI. 
Sugars and 
polyols  
Water binding sugars and polyols could restrict the amount of 
water for starch gelatinization, which may decrease GI. 
Acidity Increased acidity slows down the speed of gastric emptying and 
CHO digestion thereby reduces the GI value. For example, 
vinegar could decrease GI and sourdough bread has a lower GI 
than common bread. 
Accompanying 
food 
Fat and protein Co-ingestion of fat and protein slows the rate of gastric emptying, 
hence decreases the GI value. In addition, fat and protein could 
also stimulate the insulin response and increase insulin 
sensitivity.  
CHO: Carbohydrate      GI: Glycemic index  
 
Secondly, the rate at which different people digest CHOs varies substantially, 
and complicating things even more, a person's glycemic response may vary from 
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time to time and different people may have different insulin responses even though 
they have identical glycemic responses. These factors cause that the GI of a food 
varies from person to person and from day to day. However, these variations in GI 
are random variations and do not detract the utility of GI (Wolever, personal 
communication). 
And last, but not least, inter-laboratory differences in GI measurements are also 
of great concern. Many methodological variables markedly affect GI values, such as 
the amount of available CHOs tested, the choice of standard food, the number of 
standard tests and the frame of blood sampling (frequency and length). However, 
these variances could be reduced substantially by adopting standard measurement 
procedures.26, 27 There are several laboratories around the world that claim to control 
the variation in GI values to an acceptable level using strict and specific protocols 
(see for example http://www.glycemicindextesting.com). 
 
Glycemic index and diabetes 
Diabetes is a metabolic disorder resulting from an imbalance between insulin 
availability and insulin need. This can be caused by absolute insulin deficiency or 
impaired insulin function. A person with uncontrolled diabetes is unable to 
transport glucose into fat and muscle cells; as a result, blood glucose is elevated, the 
body cells are starved and the breakdown of fat and protein is increased. It is well 
known that diabetes is associated with an increased risk of numerous serious, 
sometimes life-threatening complications, such as cardiovascular disease, diabetic 
ketoacidosis, neuropathy, retinopathy and a reduced quality of life.28  
Besides drug therapy, dietary management is still the cornerstone of diabetes 
management where the general goal is reducing body mass index (BMI) to the 
normal range, controlling blood glucose levels close to normal, preventing acute (e.g. 
hypoglycemia) and long term (e.g. cardiovascular) complications etc. In addition to 
the benefits on weight control, which will be explained later, low GI diets could also 
help to achieve the other aspects of the diabetes management goal. 
 
Controlling blood glucose level close to normal 
Considerable research, including two important meta-analyses, have revealed 
that low GI food consumption could induce improved glycemic control.29-34 In the 
meta-analysis conducted by Brand-Miller et al, it was found that low GI diets 
reduced HbA1C by 0.43% points over and above that produced by high GI diets 
among 356 subjects from 14 randomized controlled trials in about 10 weeks. Taking 
both HbA1C and fructosamine data together and adjusting for baseline differences, 
level of glycated proteins was reduced 7.4% more on the low GI diet than on the high 
GI diet.33 More recently, Opperman et al combined the results from 16 randomized 
controlled trials and found that low GI diets significantly reduced fructosamine by 
0.1 mmol/L, HbA1C by 0.27% points, total cholesterol by 0.33 mmol/L and non-
significantly reduced low density lipoprotein cholesterol (LDL) in type 2 diabetic 
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subjects by 0.15 mmol/L compared with high-GI diets.34 Furthermore, a number of 
studies have demonstrated the benefit of fructose administration, which has a low GI, 
in diabetic control.35-38  
  
Table 2-2. Summary of the effects of low GI diets on the management of diabetes* 
Publication Study design Subjects Duration Summary of the outcomes 
Studies supporting the beneficial effects of low GI diets 
Opperman, et al34  
Br J Nutr, 2004 
Meta-analysis† 396 subjects 
from 16 
RCTs 
12 days 
to 6 mths
Compared to high GI diets, low GI 
diets reduced fructosamine by 0.1 
mmol/L, HbA1C by 0.27%, TC by 0.33 
mmol/L and LDL by 0.15 mmol/L. 
Brand-Miller, et 
al33 Diabetes Care, 
2003 
Meta-analysis† 
 
356 subjects 
from 14 
RCTs 
10 wks Compared with high GI diets, low GI 
diets decreased HbA1C by 0.43% in 
about 10 wks and fructosamine by 0.2 
mmol/L in about 4 wks. 
Rizkalla, et al39  
Diabetes Care, 
2004 
RCT (cross-
over design) 
12 T2DM 
men 
4 wks Low GI diet improved fasting glucose, 
HbA1C, whole-body glucose 
utilization, PAI-1 activity as well as 
TC, LDL cholesterol, FFAs and apo B 
concentrations. 
Jimenez-Cruz, et 
al40 Diabetes Care, 
2003 
RCT (cross-
over design) 
14 subjects 
with T2DM
6 wks Compared to the high GI diet, the low 
GI diet resulted in more reduction in 
fasting glucose and HbA1C.   
Jarvi, et al41 
Diabetes Care, 
1999 
RCT (cross-
over design) 
20 T2DM 
patients 
24 days In contrast to the high GI diet, the low 
GI diet induced more favorable 
changes in blood insulin, glucose, C-
peptide, cholesterol, apoB, apoA-1, 
and PAI-1 activity. 
Fontvielle, et al29  
Diabetic Med, 
1992 
RCT (cross-
over design) 
18 diabetic 
patients 
5 wks Compared to the high GI diet, the low 
GI diet led to improved glycemic 
control and TG levels 
Qi, et al42 
Diabetes Care, 
2005 
Cross-
sectional 
study 
780 diabetic 
patients 
- Dietary GI was inversely associated 
with adiponectin concentration. 
Buyken, et al43  
Am J Clin Nutr, 
2001 
Cross-
sectional 
study 
2810 people 
with T1DM 
- Dietary GI was positively related to 
HbA1C concentration and inversely 
related to HDL cholesterol 
concentration. 
Studies that failed to show beneficial effects of low GI diets 
Calle-Pascual, et 
al44 Diabet Metab, 
1988 
RCT (cross-
over design) 
24 diabetic 
patients 
4 wks No difference was found in insulin 
dose, weight change and  HbA1C 
levels 
* Ordered by study design and publication year (most recent first)    
† Meta-analysis, the results of single studies on glycemic control are not presented in this table.  
apoA: Apolipoprotein A, apoB: Apolipoprotein B, FFA: Free fatty acids, GI: Glycemic index, HbA1C: Glycated 
haemoglobin, HDL: High density lipoprotein cholesterol, LDL: Low density lipoprotein cholesterol,  PAI-1: 
Plasminogen activator inhibitor 1, RCT: Randomized controlled trial, TC: Total cholesterol, T1DM: Type 1 
diabetes, T2DM: Type 2 diabetes, TG: Triglycerides.  
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Preventing acute complications such as hypoglycemia  
As shown in Figure 2-1, low GI foods cause lower peaks and less fluctuation in 
postprandial blood glucose levels than foods with high GI values. Therefore, low or 
medium GI foods are often recommended to diabetes patients for the prevention of 
hypoglycemia.2, 3  
 
Preventing long term complications such as cardiovascular disease 
It has been acknowledged that insulin resistance, postprandial hyperglycemia 
and dislipidemia are strong risk factors for cardiovascular disease in diabetes 
patients.45 Several studies, including a meta-analysis,34 several randomized 
controlled trials29, 39, 41 and observational studies,42, 43 have related the consumption of 
low GI diets to an improved cardiovascular risk profile in patients with diabetes, 
reflecting favorable levels of high density lipoprotein cholesterol (HDL), triglycerides 
(TG), LDL, C-reactive protein (CRP) and adiponectin. These findings stress the 
importance of low GI diets, along with other lifestyle adaptations, in reducing the 
risk of macrovascular complications of diabetes.46 
In Table 2-2, results from published clinical trials and epidemiological studies 
relating dietary GI to the management of diabetes are listed. In summary, two meta-
analyses,33, 34 four additional randomized controlled trials that were not included in 
the meta-analyses,29, 39-41 two large-scale cross-sectional studies support the beneficial 
effects of low GI diets on diabetic control.42, 43 However, there is also one randomized 
controlled trial that did not find favorable impacts of low GI diets on insulin dose, 
weight change and HbA1C level.44  
 
Table 2-3. Summary of the effects of low GI diets on type 2 diabetes risk factors* 
Publication Study design Subjects Duration Summary of the outcomes 
Studies supporting the beneficial effects of low GI diets 
Laaksonen, 
et al47 
Am J Clin 
Nutr, 2005 
RCT (parallel 
design) 
72 adults with the 
metabolic 
syndrome 
12 wks The insulinogenic index increased 
more in the rye bread and pasta 
group than in the oat and wheat 
bread and potato group. 
Brynes, et al48  
Br J Nutr, 
2003 
RCT (cross-
over design) 
17 men with cardiac 
risk factors 
24 days The low GI diet led to more 
favorable postprandial glucose and 
insulin levels than the high GI diet. 
Wolever, et 
al49 Am J Clin 
Nutr, 2003 
RCT (parallel 
design) 
35 subjects with IGT 4 mths Compared to the high GI 
counterpart, the low GI diet induced 
more postprandial glucose decreases. 
Seewi, et al50 
Eur J Nutr, 
1999 
RCT (cross-
over design) 
26 healthy subjects 6 hrs  Low GI pea starch elicited less 
hyperglycemia, hyperinsulinemia 
and C-peptide secretion as compared 
to corn starch. 
Slabber, et 
al51  
Am J Clin 
Nutr, 1994 
RCT (parallel 
& cross-over) 
30 obese women 
with hyper-
insulinemia 
12 wks Fasting and postprandial insulin 
decreased and insulin: C-peptide 
ratio increased more after a low GI 
diet compared with a high GI diet. 
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Schulze, et 
al52 Am J Clin 
Nutr, 2004 
Prospective 
cohort study  
91249 US female 
nurses  
8 yrs  Dietary GI was positively associated 
with the risk of T2DM (RR of the 
highest quintile =1.59) 
Hodge, et al53 
Diabetes 
Care, 2004 
Prospective 
cohort study 
31641 non-diabetic 
Australian adults 
4 yrs Dietary GI was positively associated 
with the risk of T2DM (OR per 10 
units GI =1.32)  
Salmeron, et 
al9  
JAMA, 1997 
Prospective 
cohort study 
 
65173 US female 
nurses  
6 yrs  Dietary GI was positively associated 
with risk of T2DM (RR of the highest 
quintile =1.37) 
Salmeron, et 
al54 Diabetes 
Care, 1997 
Prospective 
cohort study 
 
42759 US male 
health professionals 
6 yrs  Dietary GI was positively associated 
with risk of T2DM (RR of the highest 
quintile =1.37) 
McKeown, et 
al55 
Diabetes 
Care, 2004 
Cross-
sectional 
study 
2834 US subjects - Dietary GI was positively associated 
with insulin resistance and the 
prevalence of the metabolic 
syndrome (OR of highest quintile = 
1.41).  
Studies that failed to show beneficial effects of low GI diets 
Stevens, et 
al56 Diabetes 
Care, 2002 
Prospective 
cohort study 
12251 African-
American and 
white adults 
9 yrs  No statistically significant 
association between dietary GI and 
the incidence of diabetes was found 
Meyer, et al57 
Am J Clin 
Nutr, 2000 
Prospective 
cohort study 
35988 US women  6 yrs  Failed to find a predictive impact of 
dietary GI on the incidence of 
diabetes 
van Dam, et 
al58 Eur J 
Clin Nutr, 
2000 
Prospective 
cohort study 
646 Dutch men 10 yrs  GI was not appreciably associated 
with (fasting or post-load) insulin 
and glucose levels. 
Liese, et al59 
Diabetes 
Care, 2005 
Cross-
sectional 
study 
970 adults  - No association was found between 
GI / GL and insulin sensitivity and 
insulin secretion. 
Lau, et al60 
Diabetes 
Care, 2005 
Cross-
sectional 
study 
5675 non-diabetic 
Danish adults 
- Dietary GI and CHO intake were not 
associated with insulin resistance. 
*Ordered by study design and publication year (most recent first)  
CHO: Carbohydrate, GI: Glycemic index, GL: Glycemic load, HbA1C: Glycated hemoglobin, HOMA-IR: Insulin 
resistance from homeostasis model assessment, IGT: Impaired glucose tolerance, OR: Odds ratio, RCT: 
Randomized controlled trial, RR: Relative risk, T2DM: Type 2 diabetes. 
 
Moreover, low GI foods may also play an important role in preventing type 2 
diabetes. This is supported by the results from animal studies,61-63  randomized 
controlled trials48, 49 and large-scale long-term cohort studies.9, 54 As listed in Table 2-3, 
five randomized controlled trials 47-51 and four prospective cohort studies9, 52-54 and 
one cross-sectional study55 found a beneficial impact of low GI foods on the risk 
factors of developing type 2 diabetes, but no consensus has been reached. Three 
prospective cohort studies56-58 and two large cross-sectional studies59, 60 failed to find 
significant beneficial effect of low GI diet on the incidence of type 2 diabetes as well 
as insulin sensitivity level. The authors of one of these papers, however, 
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acknowledge that the failure to detect an association might be due to using a limited 
66-item semi-quantitative food-frequency questionnaire to assess diets.56 
Given the aforementioned evidence supporting the benefits of low GI diets on 
diabetes prevention and management, the use of GI concept has now been endorsed 
by the British Dietetic Association,64 Diabetes UK,65 the European Association for the 
Study of Diabetes,66 the Canadian Diabetes Association67 and the World Health 
Organisation.4 
 
Table 2-4. Summary of the effects of low GI diets on weight or body composition change* 
Publication Study design Subjects Duration Summary of the outcomes 
Studies supporting the beneficial effects of low GI diets 
Brynes, et al48  
Br J Nutr, 
2003 
RCT (cross 
over design) 
17 middle-aged 
men with one or 
more cardiac risk 
factors 
24 days The low GI diet group had lowest 
daily energy intake and more 
favorable weight change compared 
to high fat, high sucrose and high 
GI groups. 
Jimenez-
Cruz, et al40 
Diabetes 
Care, 2003 
RCT (cross-
over design) 
14 Mexican 
overweight or 
obese subjects with 
T2DM 
6 wks Compared to the high GI diet, the 
low GI diet induced more reduction 
in BMI (0.6 vs. 0 kg/m2) and body 
weight (1.5 vs. 0.6 kg).   
Bouche, et al7 
Diabetes 
Care, 2002 
RCT(cross-
over design) 
11 healthy men 5 wks The low GI diet induced a ~700 g fat 
mass reduction and an improved 
lipid profile. 
Slabber, et 
al51  
Am J Clin 
Nutr, 1994 
RCT(parallel 
study;  
16 of 30 also 
cross-over) 
30 obese females 
with 
hyperinsulinemia 
12 wks The low GI energy-restricted diet 
led to more weight loss and greater 
reduction in BMI compared to the 
high GI counter diet. 
Spieth, et al68 
Arch Pediat 
Adol Med, 
2000. 
Non-random 
parallel study 
107 obese children 4 mths The low GI diet induced greater 
reduction in BMI and body weight 
compared with the conventional 
reduced-fat diet. 
Bahadori, et 
al69 Diabetes 
Obes Meta, 
2005 
Uncontrolled 
intervention 
study 
109 obese patients 
from obesity 
outpatient clinics 
6 mths  The low fat low GI diet led to a 
significant reduction of fat mass. 
Toeller, et al70 
Int J Obes 
Relat Meta 
Disord, 2001 
Cross-
sectional 
study 
2868 patients with 
T1DM 
- Dietary GI was positively correlated 
with body waist-to-hip ratio and 
waist circumference. 
Studies that failed to show beneficial effects of low GI diets 
Raatz, et al71 
J. Nutr. 2005 
RCT (parallel  
design) 
29 obese subjects 36wks The low GI diet group experienced 
a slightly greater but not statistically 
significant reduction in weight, BMI 
and fat mass than high GI and high 
fat groups. 
Carels, et al72 
Eat Behav, 
2005  
RCT (parallel  
design) 
53 obese adults 20 wks 
treatment 
and 1 year 
Low GI diets achieved via GI 
education had no significant impact 
on weight loss treatment outcomes 
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follow up at post treatment or 1-year follow-
up. 
Sloth, et al73  
Am J Clin 
Nutr, 2004 
RCT (parallel  
design) 
45 healthy 
overweight 
women 
10 wks Low GI diet induced only slightly, 
but not significantly greater 
reduction in energy intake, body 
weight, fat mass than did high GI 
diet. 
Rizkalla, et 
al39 Diabetes 
Care, 2004 
RCT (cross-
over design) 
12 T2DM patients 4 wks No difference in body weight, BMI, 
fat and lean body mass was found. 
Wolever74 
Diabetes 
Care, 1992 
RCT (cross-
over design) 
6 T2DM patients 6 wks A small and similar amount of 
weight was lost on both diets. 
Jenkins, et 
al75 Am J Clin 
Nutr, 1988 
RCT (cross-
over design) 
8 patients with 
T2DM 
2 wks Both high and low GI diets induced 
weight loss but the reduction in low 
GI group was smaller.  
Liese, et al59 
Diabetes 
Care, 2005 
Cross-
sectional 
study 
970 adults with 
normal or 
impaired glucose 
- No association was found between 
GI / GL and adiposity (BMI and 
waist circumference). 
*Ordered by study design and publication year (most recent first)  
BMI: Body mass index, GI: Glycemic index, RCT: Randomized controlled trial, T2DM: Type 2 diabetes. 
 
Glycemic index and obesity 
The prevalence of obesity (BMI ≥ 30 kg/m2) and overweight (BMI ≥ 25 kg/m2) is 
rapidly increasing worldwide. It has been found that obesity, and to a lesser extent 
overweight, is associated with an increased risk of mortality and morbidity from 
metabolic syndrome, type 2 diabetes, cardiovascular disease, gastrointestinal 
disorders and several malignancies.76  
Because a low GI diet could promote satiety and fat oxidation, it is believed to 
benefit weight control. According to Brand-Miller et al, low GI diets, characterized by 
slow digestion and absorption rates, could persistently stimulate the nutrient 
receptors in the gastrointestinal tract, so could result in a prolonged feedback, via 
satiety signals such as cholecystokinin (CCK) and glucagon-like peptide-1 (GLP-1), 
to the satiety centre in the hypothalamus.77 In addition, at middle postprandial stage, 
the low levels of blood glucose and free fatty acids, which is often following the high 
GI consumption, often cause hunger and stimulate food intake.2, 77 Many published 
studies support the effects of low GI foods as compared to high GI foods, on a 
delayed return of hunger, decreased subsequent food intake, and increased satiety.13, 
78-82 However, others are unable to demonstrate these effects. For example, in one 
randomized controlled trial,22 no significant differences in plasma glucose or insulin 
responses, appetitive ratings, or food intake between low and high GI  groups were 
observed. 
With regard to the effects of low GI foods on weight change and obesity, 
evidence from animal studies shows that high GI feeding is associated with higher 
fat mass,61 more visceral fat61, 83 and increased adipocyte size.6, 84 As summarized in 
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Table 2-4, results from six prospective studies (including intervention and cohort 
studies)7, 40, 48, 51, 68, 69 suggest that low GI diets result in more weight or fat loss than 
high GI diets. This is supported by the cross-sectional analysis from the EURODIAB 
Complications Study in which low GI diets are independently correlated with a 
smaller waist-to-hip ratio and waist circumference in men.70 Unsurprisingly, there 
are also several studies that did not report beneficial effects of low GI diets on weight 
change.39, 59, 71-75 However, in some of these studies, low GI diets actually induce 
slightly more weight reduction compared to the high GI control and the failure to 
reach statistical significance in these studies might be due to a small sample size, 
hence a low statistical power.71, 73 In one study, it was found that patients on low GI 
diets lost less weight than those on high GI diets.75 The fact that low GI group was 
given meals containing greater amount of total energy than high GI group should be 
taken into account. Large-scale long-term randomized controlled trials as well as 
prospective cohort studies investigating the effects of low GI diets on the prevention 
and treatment of obesity, such as the Diogenes study, are currently underway 
(http://www.diogenes-eu.org). 
 
Glycemic index and cardiovascular disease 
Cardiovascular disease, primarily heart disease and stroke, is one of the leading 
causes of death in both men and women around the world. Reducing fat intake 
hence decreasing blood lipid levels has been recognized as the key dietary strategy 
to prevent the incidence and progression of cardiovascular disease. However, it has 
been found that increasing CHO intake, which is often the case when fat should be 
constrained, but without considering the quality of CHO might not be a good choice 
to reduce cardiovascular disease incidences.85 Postprandial hyperglycemia caused by 
habitual high CHO high GI diets has been acknowledged as a significant risk factor 
of cardiovascular disease.25, 86, 87 The biological mechanisms behind this association 
might be through increased oxidative stress induced by high levels of blood glucose. 
Several lines of evidence have shown that high blood glucose levels could increase 
reactive oxygen species (ROS), which may in turn lead to the oxidation of membrane 
lipids, proteins, lipoproteins and DNA, damage endothelial function and activate 
inflammation.2, 88 Hyperinsulinemia may also be involved in the development of 
cardiovascular disease through hypertension because high insulin levels and insulin 
resistance could induce arterial stiffness and augmented generation, availability and 
subsequent application of ROS.89-92 In addition, hypoglycemia, which often occurs in 
the middle postprandial stage following a high GI meal, was also believed to be one 
of the most important risk factors of cardiovascular disease. That is because 
hypoglycemia could stimulate the release of counter-regulatory hormones and cause 
a marked increase in free fatty acids at the late postprandial stage, which could 
promote the incidence and progress of cardiovascular disease.93  
Many groups around the world have investigated the relationship between 
dietary GI and the risk factors of cardiovascular disease in animals and humans. 
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They observed that low GI diets, as compared to high GI diets, induce lower levels of 
triglycerides7, 61 and LDL cholesterol,94, 95 higher levels of HDL cholesterol96 and 
adiponectin42, 61 and favorable changes in other cardiovascular risk factors like the 
haemostatic factor Plasminogen Activator Inhibitor-1 (PAI-1) and C-reactive protein 
(CRP).41, 97 However, as shown in Table 2-5, the findings are far from consistent. The 
most important underlying reason for these opposite findings might be the 
methodology used to assign GI values to different food items. As already mentioned 
 
Table 2-5. Summary of the benefits of low GI diets on the risk factors and the progress of 
cardiovascular disease* 
Publication Design Subjects Duration Summary of the outcomes 
Studies supporting the beneficial effects of low GI diets 
Ebbeling, et al98 
Am J Clin Nutr, 
2005 
RCT (parallel 
design), Pilot 
study  
23 obese young 
adults 
12 mths Compared to the low fat group, the 
low GL/GI group showed a 
significantly greater decline in 
plasma level of TG and PAI-1. 
Pereira, et al97 
JAMA, 2004 
RCT (parallel 
design) 
39 overweight or 
obese young 
adults 
~2 mths 
(10% 
weight 
loss) 
Compared to low fat diet, energy 
restricted low GL/GI diet induced 
favorable changes (%) in resting 
energy expenditure, self-reported 
hunger, serum TG, HOMA-IR, CRP 
and blood pressure.  
Sloth, et al73  
Am J Clin Nutr, 
2004 
RCT (parallel 
design) 
45 healthy 
overweight 
women 
10 wks Compared with the high GI group, 
the low GI diet induced a larger 
reduction in LDL and TC. 
Harbis, et al99 
Am J Clin Nutr, 
2004 
RCT (parallel 
design) 
9 subjects with 
central obesity 
and insulin 
resistance  
6 hrs 
after 
meal 
Mixed meals containing slowly 
digestible (low GI) CHO induced 
low glycemic and insulinemic 
responses, plasma TG, apoB-48 and 
apoB-100. 
Patel, et al100 
J Hum Nutr Diet. 
2004 
RCT (parallel 
design) 
35 adult subjects 
with CHD 
awaiting bypass
4 wks  Patients in the low GI group had 
improved glucose tolerance and 
significantly greater in vitro 
adipocyte insulin sensitivity at the 
time of surgery and shorter hospital 
stay compared with those in high 
GI group.  
Brynes, et al48  
Br J Nutr, 2003 
RCT (cross 
over design) 
17 middle-aged 
men with one or 
more cardiac 
risk factors 
24 days Compared with macronutrient-
matched high GI diet, low GI diet 
induced greater reduction in 
postprandial HOMA-IR. 
Dumesnil, et al101  
Br J Nutr, 2001 
RCT (cross-
over design) 
12 overweight 
men 
6 days Waist and hip circumferences, 
plasma TG level, LDL particle size 
and fasting insulin concentrations 
changed favorably by low GI diets. 
Frost, et al102  
Metabolism, 1998 
RCT (parallel 
design) 
61 women 3 wks Compared to the high GI diet, the 
low GI counterpart improved 
insulin sensitivity.  
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Sciarrone, et al103 
J Hypertens,1993 
RCT (parallel 
design) 
20 healthy male 
volunteers 
6 wks Low GI was associated with lower 
ambulatory blood pressure and 
lower heart rate. 
Brynes, et al104 
Br J Nutr, 2005 
Uncontrolled 
intervention 
study 
9 healthy 
subjects 
1 wk The low GI diet induced a 
significantly improved 24 hour 
glucose profile, including fasting 
glucose, mean glucose, area under 
24h glucose curve and area under 
8h glucose curve. 
Liu, et al86  
Am J Clin Nutr, 
2000 
Prospective 
cohort study 
75521 US female 
nurses 
10 yrs  GI was associated with the risk of 
CHD in a multivariate model (RR of 
the highest quintile =1.31).  
McKeown, et al55 
Diabetes Care, 
2004 
Cross-
sectional 
study 
2834 US subjects - GI was positively associated with 
HOMA-IR and the prevalence of 
the metabolic syndrome.  
Ford, et al105  
Arch Intern Med, 
2001 
Cross-
sectional 
study 
13907 US adults - GI was inversely correlated with 
HDL. 
Frost, et al96  
Lancet, 1999 
Cross-
sectional 
study 
1420 British 
adults 
- Dietary GI was the only dietary 
factor significantly related to serum 
HDL. 
Studies that failed to show beneficial effects of low GI diets 
Frost, et al106 
Eur J Clin Nutr, 
2004 
RCT (parallel 
design) 
55 patients with 
CHD 
12 wks Lowering dietary GI did not cause 
any significant improvement in 
fasting glucose, insulin, TC, HDL, 
VLDL, LDL and TG. 
Oh, et al85  
AM J Epidemiol, 
2005 
Prospective 
cohort study 
78779 US female 
nurses 
18 yrs Neither GL nor GI was significantly 
associated with the incidence of 
total stroke or specific subtypes of 
stoke. 
van Dam, et al58  
Eur J Clin Nutr, 
2000 
Prospective 
cohort study 
646 Dutch men 10 yrs  GI was not appreciably associated 
with CHD incidence (RR = 1.11) and 
TC, HDL, TG, insulin and glucose 
levels. 
Tavani, et al107 
Heart, 2003 
Case-control 
Study 
433 MI cases  
and 448 controls 
in Italy 
GI was not statistically significantly 
associated with MI (OR = 1.38).   
* Ordered by study design and publication year (most recent first)  
apoB: Apolipoprotein B, CHD: Coronary heart disease, CHO: Carbohydrate, CRP: C-reactive protein, GI: 
Glycemic index, GL: Glycemic load,  HDL: High density lipoprotein cholesterol, HOMA-IR: Insulin resistance 
from homeostasis model assessment, LDL: Low density lipoprotein cholesterol, MI: Myocardial infarction, OR: 
Odds ratio, PAI-1: Plasminogen activator inhibitor 1, RCT: Randomized controlled trial, RR: Relative risk, TC: 
Total cholesterol, TG: Triglycerides, VLDL: Very low density lipoprotein cholesterol.  
 
by Dickinson et al., the low quality of the GI database used in these kinds of 
observational studies is the most important contributor of the errors and biases 
towards the null hypothesis.25 The preliminary results of an ongoing study on the 
inter-method variation in GI values calculated by different persons shows that the 
outcome general GI values vary dramatically even though the same international 
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table of glycemic index and glycemic load was used.10 In addition to this, we have 
some concern about the plausibility of basing the interpretation of findings merely 
on p-values. For example, in a study conducted by Tavani et al., the authors 
concluded that “high glycemic load and glycaemic index were not strongly 
associated with acute myocardial infarction risk” but in fact the Odds Ratios (OR) are 
1.35 (95% confidence interval: 0.93, 1.98) and 1.38 (95% CI: 0.95, 2.00), respectively for 
the middle and highest tertiles compared to the lowest tertile of GI,107 which might 
be clinically relevant.  
 
Glycemic index and cancer 
Cancer is now an increasingly important factor in the global burden of disease 
and, according to the WHO, dietary factors are estimated to account for 
approximately 30% of cancers in the western world. In recent years, a substantial 
amount of studies have been conducted to link dietary GI to the risks of several types 
of cancer, including breast, colorectal, ovarian, endometrial, prostate, pancreatic, and 
gastric cancer.108-115 Although the underlying mechanisms are slightly different for 
different types of cancer, the insulin-like growth factor (IGF) system has been 
recognized as the mediator of the association between dietary GI and cancer risks.116 
In both animal and human studies, insulin has been found to down regulate the 
levels of IGF binding proteins, thereby increase the bioactivity of IGF-1. A growing 
body of epidemiological data suggest that a high level of circulating IGF-1 is a risk 
factor for breast, prostate, colorectal and other types of cancer.117 However, results on 
the effects of foods with diverse GI levels on cancer risks are not in a complete 
agreement. For example, in one prospective study, the consumption of high GI was 
found to be associated with an increased risk of breast cancer among 
postmenopausal women (hazard ratio (HR) = 1.87, 95%CI: 1.18, 2.97).118 This 
association, however,  was not so marked in other studies.108, 119, 120 Therefore, further 
studies in this area are needed to clarify this issue. 
 
Glycemic index and disease-specific mortality 
So far, there are no data showing a reduction in mortality resulting from habitual 
low GI diets. However, it has been reported that hyperglycemia is a risk factor for 
subsequent cardiovascular disease mortality in diabetics and non-diabetics.25, 121, 122 
This implies that focusing on the reduction of dietary GI may be relevant to decrease 
mortality, particularly mortality from cardiovascular disease, given the impacts of 
dietary GI on postprandial glycemic levels. Indirectly, similar conclusions could be 
drawn from the comparison of mortality rates in different countries. For example, 
according to the WHO, the age-standardized death rates from diabetes, 
cardiovascular disease and malignant neoplasms are much lower in Japan compared 
to those in the UK and USA (see http://www.who.int/healthinfo/en/). Besides other 
potential factors, such as genetic susceptibility, which may have undeniable impacts 
on disease-specific mortality, habitual low GI eating patterns might also have a role 
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in this. This hypothesis is based on the observation that the general GI levels of 
Japanese and Chinese diets may be lower than typical western meals because east 
Asian diets are rice based (which has a relatively lower GI than potatoes) and rich in 
vegetables and legumes.123, 124 Additionally, plenty of evidence indicates that the 
Mediterranean diet represents a healthy eating pattern associated with lower all-
cause mortality and mortality from coronary heart disease and cancer.125, 126 Although 
not exactly the same, the Mediterranean diet is essentially a low GI diet because it is 
pasta, instead of potato or bread, based and rich in grains (especially whole grains), 
fruits, nuts and vegetables.43, 127  
 
Conclusions 
Despite the lack of consensus, the use of the GI has grown over the years and 
appears to have withstood the test of time. GI might be a complex term from a food 
science perspective but its public health application can be simple. For example, in 
Australia, people are instructed to: 1) replace higher GI foods with lower GI foods, 
choosing porridge or muesli instead of corn flakes, wholegrain bread instead of 
whole-meal or white bread and basmati or doongara rice instead of jasmine rice; 2) 
consume at least one serve of a lower GI CHO food at each meal; 3) look for foods 
with the GI symbol when selecting CHO foods at the supermarket. Meanwhile, 
promoting the consumption of low GI foods in clinical and public settings at least 
does not seem to have any foreseen adverse effects on human health. Choosing a 
high CHO low GI diet may help to “fine-tune” the glycemic control. This is also 
acknowledged by GI opponents.128 
However, we must bear in mind that low GI foods are not necessarily healthier. 
Foods high in fat or sugar may have lower GI values than some healthy foods. 
Fructose has a low GI value but over- consumption of added fructose may elevate 
blood triglycerides level and contribute to insulin resistance. So, it may be imprudent 
to base food choices solely on GI values. Our recommendations are that the 
application of the GI should be in the context of the overall nutrient composition of 
the diet, focusing on the quality of starchy foods in particular while other dietary 
factors, such as energy density and contents of fiber and antioxidant should also be 
taken into account. 
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Abstract  
Background: Previous studies on the glycemic index (GI) and glycemic load (GL) 
have shown inconsistent findings on their association with metabolic risk factors. 
This may be partly due to differences in underlying dietary patterns. 
Objective: To examine the association of GI and GL with food and nutrient intake, 
and metabolic risk factors including blood glucose, insulin, lipids and high 
sensitivity C-reactive protein (CRP).  
Design: Cross-sectional analyses of data from two joint observational studies, the 
CoDAM study and the Hoorn study. 
Results: In total 974 subjects aged 42 - 87 yrs were included in this study. Mean (SD) 
GI was 57 (4) and mean GL was 130 (39). Dairy products, potatoes and other tubers, 
cereal products, and fruits were the main predictive food groups for GI. GL was 
closely correlated with intake of total carbohydrates (rs = 0.97), which explained more 
than 95% of the variation in GL. After adjusting for potential confounders, GI was 
significantly inversely associated with HDL-C and positively associated with fasting 
insulin, HOMA-index of insulin resistance, total to HDL-C cholesterol ratio and CRP. 
No association was observed between GL and any of the metabolic risk factors, 
except for a borderline significant positive association with CRP.  
Conclusions: In this population, a low GI diet, which is high in dairy and fruits but 
low in potatoes and cereals, is associated with improved insulin sensitivity and lipid 
metabolism and reduced chronic inflammation. GL is highly correlated with 
carbohydrate intake and is not clearly associated with the investigated metabolic risk 
factors. 
Key words:  Glycemic index (GI); Glycemic load (GL); Metabolic risk factor; 
Glycemic control; Insulin Resistance; Lipid metabolism; Systematic chronic 
inflammation. 
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Introduction 
The glycemic index (GI), an indicator ranking carbohydrates according to their 
impacts on body’s postprandial glycemic response,  was introduced more than two 
decades ago to facilitate glycemic control in patients with diabetes.1 It was described 
as the percentage of incremental area under the 2-hour blood glucose response curve 
of a test food divided by the corresponding area of a reference food containing same 
amount of available carbohydrates. The glycemic load (GL) was introduced more 
recently, as a product of GI with the amount of total available carbohydrates.2 Since 
then, research has been extended to the role of GI and GL in the prevention and 
management of overweight and obesity,3 cardiovascular diseases (CVD),4 cancer,5 
and many other health problems such as age-related macular degeneration.6 
However, findings are not always consistent and consensus regarding the 
incorporation of the GI and GL concepts in dietary guidelines has not yet been 
reached.7, 8 
Liu et al. observed that GI and GL are inversely associated with the 
concentration of high-density lipoprotein cholesterol (HDL-C) and positively 
associated with triacylglycerol (TG) and high sensitivity C-reactive protein (CRP) 
concentrations in US women.9, 10 Frost et al. showed that GI is associated with serum 
HDL-C concentration in middle aged British men and women.11 These associations, 
however, were not detected by van Dam et al. in Dutch elderly men.12 In a Danish 
prospective study, Oxlund et al. found only weak associations between GI, GL and 
changes in serum lipids.13 
Although GI and GL are based on the different influences of carbohydrates on 
glucose and insulin responses, findings from epidemiological studies on their 
associations with markers of glycemic control and insulin sensitivity are conflicting.14 
For example, a positive association between GI and insulin resistance index was 
found in the Framingham Offspring Cohort,15 but not in the Insulin Resistance 
Atherosclerosis study.16 Evidence from observational studies and clinical trials 
supports the positive association between GI and HbA1C  in diabetic patients,17-19 but 
findings in general populations are contradictory.20, 21  
One of the practical concerns about whether a low GI diet should be 
recommended is that low GI or GL diets may limit food choices and increase fat 
intake.22 Therefore, understanding the relationship of GI and GL with food and 
nutrient intake is important. This may also provide further insight into the 
underlying reasons for the diverse findings in the associations between GI and GL 
and health-related outcomes.  
Under the joint efforts of the EPIC (European Prospective Investigation into 
Cancer and Nutrition) and the DiOGenes study, an extensive GI database has 
recently been developed to be used to investigate the association of GI and GL with 
cancer, obesity and other health indicators.23 For European studies this incorporates 
the best knowledge in the field so far. Using this database, we conducted the current 
study to investigate the relationship of GI and GL with food and nutrient intake, and 
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to explore their association with metabolic risk factors, including markers of 
glycemic control, insulin sensitivity, lipid metabolism and systematic chronic 
inflammation, in a combined population consisting of subjects from two ongoing 
observational studies in The Netherlands.  
 
Subjects and Methods 
Subjects 
The study population included participants of the CoDAM study (Cohort study 
Diabetes and Atherosclerosis Maastricht) 24 and subjects taking part in the follow-up 
examination of the Hoorn study.25 Supported by a common grant, both studies were 
carried out jointly and followed a same research protocol to investigate the 
behavioral and genetics associates of obesity, diabetes and atherosclerosis.  
The CoDAM study started in 1999-2000 and is a population based cohort study 
designed to investigate the effects of glucose metabolism, blood lipids, lifestyle and 
genetic factors on CVD morbidity and mortality.24 Subjects were invited after a 
screening oral glucose tolerance test in a high-risk population based on the following 
inclusion criteria: Caucasian, 40 to 70 years old, not using medication that affects 
glucose metabolism, and either BMI > 25 kg/m², a family history of type 2 diabetes 
mellitus (T2DM), a history of gestational diabetes, use of antihypertensive 
medication, a postprandial blood glucose > 6.0 mmol/l, or glucosuria. In total 574 
subjects were recruited. The study protocol was approved by the Medical Ethical 
Review Committee of Maastricht University and written informed consent was 
obtained from all participants before the start of the study.  
The Hoorn study, which started in 1989, is a population based cohort study 
investigating the glucose tolerance status and cardiovascular risk factors among a 
sample of the general population in Hoorn, the Netherlands.25 In 2000-2001, a follow-
up examination was conducted in a selected group of 903 subjects consisting of all 
subjects with T2DM and a random sample of the survival cohort with normal or 
impaired glucose metabolism. Details of the study population have been described 
previously.26 The Ethical Review Committee of the VU University Medical Center 
Amsterdam approved the study and written informed consent was obtained from all 
participants prior to participation.  
We excluded a priori subjects to whom any of the following applied: more than 
10% missing items in the food-frequency questionnaire (FFQ), ratio of total energy 
intake over predicted resting energy expenditure in the top and bottom 1%, 
implausible energy intake (< 800 or > 4200 kcal/day for men and < 500 or > 3500 
kcal/day for women), self-reported diabetes, following a specific diet (i.e. weight-loss 
or cholesterol-lowering diet), and using cholesterol-lowering medication. The 
current study population consisted of 974 subjects, 517 men and 457 women, of 
whom 321 originated from the CoDAM study and 653 from the Hoorn study. 
 
Dietary assessments 
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Both studies used the same validated FFQ to assess subjects’ habitual dietary 
intake. This FFQ was developed for Dutch cohorts of the EPIC study and details of 
the FFQ have been described previously.27, 28 In brief, it is a self-administered 
quantitative FFQ. Its relative validity against multiple 24-hour recalls in terms of 
total energy, carbohydrates, fiber, breads, cereals and pasta, potatoes, fruits, dairy 
products, sugar and sweet products was relatively high (Spearman correlation 
coefficients (rs) 0.51 - 0.79). Food items from the FFQ were collapsed into seventeen 
food groups following the same classification method applied by the EPIC study.29 
Intakes of energy and nutrients were calculated according to the extended version of 
the Dutch food composition table (NEVO) 1996.30 Dietary GI and GL were calculated 
according to the formulas below: 
 
GI =     (GIi × CHOi ) /      CHOi                    GL =      (GIi × CHOi )/100  
 
 
GIi is the GI value of food i from the GI database. The source of the GI values used to 
compile this GI database has been described before.23 In brief, published GI values31-33 
derived from 50-gram glucose as the reference food and 2-hour testing periods. For 
generic items in the FFQ, the 24-hour dietary recall values were used to weigh the 
mean GI values based on the frequency of consumption. CHOi is the amount of 
available carbohydrates from food i calculated by the amount of food consumed 
(g/day) multiplied by the carbohydrate content from NEVO (g/g), and n is the 
number of foods eaten per day. In the current analysis, foods involved in calculating 
the GI and GL provided approximately 98% of the total available carbohydrate 
intake. 
 
Biochemical measurements  
During the first visit of subjects to the research units, venous blood samples were 
drawn from all participants after overnight (> 12h) fasting. Serum and plasma were 
immediately separated after centrifugation (3000 rpm for 15 min at 4 °C) and stored 
at -70 °C until the assays were performed.  
A standard 75g oral glucose tolerance test (OGTT) was performed. Fasting and 2-
hour postprandial plasma glucose concentrations were measured using enzymatic 
methods (G6PDase method, ABX Diagnostics Glucose HK 125, Montpellier, France 
for the CoDAM study; hexokinase method, Roche Diagnostics GmbH, Mannheim, 
Germany for the Hoorn study). Glucose metabolic status was evaluated according to 
the WHO 1999 criteria.34 HbA1C was analyzed using ion-exchange high performance 
liquid chromatography (HPLC, Bio-Rad, Veenendaal, The Netherlands). Insulin was 
measured using a paired monoclonal antibody-based two-site immunoradiometric 
assay (Medgenix Diagnostics, Fleurus, Belgium). HOMA-IR (insulin resistance index 
of homeostatic model assessment) was calculated using a Microsoft Excel® based 
HOMA 2 calculator.35 Total cholesterol (TC), HDL-C and TG were measured using 
i=1 
∑ ∑∑ 
i=1 i=1 
  n   n   n 
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enzymatic techniques (Roche Diagnostics, Mannheim, Germany) and low-density 
lipoprotein cholesterol (LDL-C) was calculated using the Friedewald formula.36 High 
sensitivity CRP was measured in serum samples using a Hitachi-912 auto-analyzer 
(Roche Diagnostics, Mannheim, Germany) in the CoDAM study, and in EDTA-
plasma samples using a high sensitive in-house sandwich enzyme immunoassay 
(Dako, Copenhagen, Denmark and Sigma Chemical Co., St. Louis, USA) in the 
Hoorn study. All measurements have inter- and intra- assay coefficients of variation 
(CVs) lower than 8 %. 
 
Anthropometric and other measurements  
A self-administered questionnaire was used to collect information on 
demographic characteristics, lifestyle habits and health and disease status. The 
validated SQUASH (Short QUestionnaire to ASsess Health-enhancing physical 
activity) questionnaire was used to measure physical activity levels.37  
At the time of research unit visit, body weight, height and waist circumference 
were measured without shoes and in light clothing to the nearest 100 gram and 1 cm 
respectively. Body mass index (BMI, kg/m2) was calculated as weight divided by 
height squared.  
 
Statistical methods 
Stepwise regression analyses were carried out to investigate the contribution of 
food groups to the inter-individual variation in GI and GL.  For those food groups 
contributing at least 1% variation, multiple linear regression analyses were 
performed with only those predictive food groups plus total energy as explanatory 
variables, and GI or GL as the response variable. Associations of energy, 
macronutrients and their components with GI and GL were investigated through 
Spearman correlation analyses with and without the adjustment for total energy 
intake.  
Metabolic risk factors were log-transformed to improve their distribution 
towards normal. Multiple linear regression analyses were performed to explore the 
associations of GI and GL with the metabolic risk factors. These analyses were 
adjusted for potential confounders including age, gender, current smoking status 
(yes or no), physical activity (inactive, moderately active, highly active and 
unknown), cohort (CoDAM or Hoorn) and the intake of total energy, alcohol, fiber, 
cholesterol, animal- and plant-based protein and saturated fatty acids (SFA). For GI, 
we additionally adjusted for monounsaturated fatty acids (MUFA), polyunsaturated 
fatty acids (PUFA), polysaccharides and mono- and disaccharides. Total energy 
intake was adjusted for by using the residual method.38  
Interaction of GI and GL with age, gender, smoking, physical activity and cohort 
was explored by adding interaction terms to the models. In none of the analyses the 
interaction term with cohort reached statistical significance, indicating that pooling 
of the data was justified. All analyses were performed using the SAS statistical 
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software package (version 9.1; SAS Institute Inc, Cary, NC, USA). P < 0.05 was 
considered significant.  
 
Table 3-1. Population characteristics by study (n = 974). 
 Total 
(n = 974) 
CoDAM  
(n = 321) 
Hoorn 
(n = 653) 
 
P value* 
Age†, years 65 ± 9 58 ± 7 68 ± 7 < 0.0001 
Gender, n (%) of men 517 (53) 192 (60) 325 (50) 0.003 
Glycemic index†, ‡ 57 ± 4 59 ± 3 56 ± 3 < 0.0001 
Glycemic load†, ‡ 130 ± 39 143 ± 41 123 ± 36 < 0.0001 
Smoking, n (%) of current smokers 166 (17) 56 (17) 110 (17) 0.9 
BMI†, kg/m2 27.8 ± 4.2 28.0 ± 4.1 27.6 ± 4.3 0.05 
Physical activity†, hrs/day 4.0 ± 3.0 5.3 ± 3.3 3.4 ± 2.6 < 0.0001 
Glucose metabolic status 
Normal, n (%) 
IHG,  n (%) 
Newly diagnosed T2DM, n (%) 
 
456 (47) 
218 (23) 
288 (30) 
 
212 (66) 
72 (22) 
37 (12) 
 
244 (38) 
146 (23) 
251 (39) 
 
 
< 0.0001 
Fasting glucose§, mmol/L 5.8 (5.3–6.6) 5.4 (5.1–5.9) 6.0 (5.5–7.0) < 0.0001 
2h glucose§, mmol/L 6.5 (5.2–8.3) 6.4 (5.1–8.1) 6.6 (5.4–8.3) 0.3 
HbA1C§, % 5.8 (5.5–6.2) 5.7 (5.4–6.0) 5.9 (5.6–6.4) < 0.0001 
Fasting insulin§, pmol/L 56 (42 – 82) 54 (43 – 74) 57 (41 – 84) 0.3 
HOMA-IR§ 1.1 (0.8–1.6) 1.0 (0.8–1.4) 1.1 (0.8–1.7) 0.1 
Total cholesterol§, mmol/L 5.6 (4.9–6.3) 5.2 (4.7–5.8) 5.8 (5.1–6.4) < 0.0001 
HDL-C§, mmol/L 1.3 (1.1–1.6) 1.2 (1.0–1.4) 1.3 (1.1–1.6) < 0.0001 
TC/HDL-C ratio§ 4.3 (3.5–5.4) 4.4 (3.6–5.9) 4.3 (3.5–5.3) 0.2 
LDL-C§, mmol/L 3.6 (3.0–4.2) 3.3 (2.8–3.9) 3.7 (3.1–4.2) < 0.0001 
Triacylglycerol§, mmol/L 1.4 (1.0–1.9) 1.4 (1.0–1.9) 1.4 (1.0–1.9) 0.5 
CRP§, ║, mg/L 2.0 (1.2–3.6) 2.2 (1.3–3.5) 2.0 (1.1–3.6) 0.6 
Total energy intake†, Mj/day 8.6 ± 2.3 9.4 ± 2.5 8.2 ± 2.1 < 0.0001 
Carbohydrate intake†, % energy 45.5 ± 6.6 44.5 ± 6.1 46.0 ± 6.8 0.002 
Protein intake†, % energy 15.4 ± 2.3 15.2 ± 2.0 15.5 ± 2.4 0.1 
Fat intake†, % energy 34.8 ± 5.2 35.8 ± 4.8 34.3 ± 5.4 < 0.0001 
Fiber intake†, g/MJ 2.9 ± 0.7 2.9 ± 0.6 2.9 ± 0.7 0.6 
BMI: Body mass index; IHG: Intermediate hyperglycemia; T2DM: Type 2 diabetes mellitus; HbA1C: Glycated 
hemoglobin A1C; HOMA-IR: Homeostasis model assessment insulin resistance index; HDL-C: High density 
lipoprotein cholesterol; TC/HDL-C ratio: Total cholesterol to high density lipoprotein cholesterol ratio; LDL-C: 
Low density lipoprotein cholesterol; CRP: High sensitivity C-reactive protein. 
* Comparison between the two studies was conducted by Wilcoxon rank sum test for continuous variable or 
chi-square test for categorical variables. † x  ± SD. ‡ Based on GI of glucose = 100 scale. § Median (inter-quartile 
range). ║ Those with CRP > 10 mg/L were excluded from the calculation. 
 
Results 
The study population consisted of 517 men and 457 women; 30% of them had 
newly diagnosed T2DM and 23% had intermediate hyperglycemia (IHG, including 
impaired glucose tolerance and impaired fasting glycemia) (Table 3-1). The subjects 
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were on average 65 ± 9 (mean ± SD) yrs old (range: 42-87 yrs), with a mean GI of 57 ± 
4 and a mean GL of 130 ± 39. Compared to the subjects from the CoDAM study, the 
Hoorn population was on average older (58 vs. 68 yrs), included slightly less men 
(50% vs. 60%) and more newly diagnosed T2DM patients (39% vs. 12%), and were 
less physically active (3.4 vs. 5.3 hrs/d).  
The dairy products group was inversely associated with GI and it contributed 
most (30%) to the inter-individual variation in GI. The group of fruits was also 
inversely associated with GI and predicted 6% of the variation in GI. The group of 
potatoes and other tubers and the group of cereals and cereal products were 
positively associated with GI and they respectively accounted for 17% and 7% of the 
variation in GI (Table 3-2). In total, these four groups accounted for 61% of the GI 
variation. GL was positively associated with all 17 food groups except vegetables. Six 
carbohydrate-rich food groups explained in total 85% of the variation in GL. The 
most predictive food group was cereal products, which explained 43% of the 
variation, followed by sugar and confectionery (23%). 
 
Table 3-2. Food groups contributing to the inter-individual variation of GI and GL (n = 974). 
Food groups * ß (SE)† Partial R2 Model R2 
GI 
Dairy products  -0.66 (0.03) 0.30 0.30 
Potatoes and other tubers  1.84 (0.11) 0.17 0.48 
Cereals and cereal products  1.43 (0.11) 0.07 0.55 
Fruits -0.69 (0.06) 0.06 0.61 
GL 
Cereals and cereal products  19.96 (0.70) 0.43 0.43 
Sugars and confectionery 42.04 (1.71) 0.23 0.66 
Potatoes and other tubers  13.04 (0.64) 0.09 0.75 
Cakes 27.12 (1.74) 0.07 0.81 
Fruits 4.13 (0.33) 0.03 0.84 
Dairy products 0.72 (0.18) 0.01 0.85 
* Stepwise regression analysis with 17 food groups as explanatory variables and GI or GL as response variable; 
only those food groups that contributed at least 1% of the variation are listed. 
† Models with listed variables and total energy as the explanatory variables and GI or GL as the response 
variable; regression coefficients mean the change of GI or GL with a 100 gram increase of each food group. 
 
Both GI and GL were positively associated with total energy intake (rs = 0.17 and 
0.82 respectively) (Table 3-3). In crude analyses, GI was positively associated with 
most of the nutrients but inversely associated with the intake of mono- and 
disaccharides, animal protein and alcohol; GL was positively associated with all 
nutrients under investigation. After the adjustment for total energy intake by using 
partial regression analysis, GI was strongly and positively associated with 
polysaccharides (rs = 0.61), plant protein (rs = 0.32), total fat (rs = 0.17), PUFA (rs = 0.20) 
and MUFA (rs = 0.15) but inversely associated with mono-and disaccharides (rs = -
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0.38), animal protein (rs = -0.26), alcohol (rs = -0.18) and total protein (rs = -0.16). Total 
carbohydrates and fiber were only weakly associated with GI and the association of 
GI with saturated fat and cholesterol were not statistically significant. GL was 
positively associated with the intake of total carbohydrates (rs = 0.92), 
polysaccharides (rs = 0.63), mono- and disaccharides (rs = 0.49), plant protein (rs = 0.43) 
and fiber (rs = 0.38), but inversely associated with the other nutrients (Table 3-3). 
 
Table 3-3. Correlation of nutrient intake with GI and GL* (n = 974). 
Nutrients† GI GL 
 rs rs_adj rs rs_adj 
Total energy, Mj/d 0.17** - 0.82** - 
Total carbohydrate, g/d 0.18** 0.06** 0.97** 0.92** 
Total fat, g/d 0.23** 0.17** 0.62** -0.42** 
Total protein, g/d 0.05 -0.16** 0.59** -0.29** 
Polysaccharides, g/d 0.51** 0.61** 0.86** 0.63** 
Mono- and disaccharides, g/d -0.21** -0.38** 0.70** 0.49** 
Saturated fat, g/d 0.18** 0.06 0.60** -0.31** 
Polyunsaturated fat, g/d 0.26** 0.20** 0.56** -0.10** 
Monounsaturated fat, g/d 0.22** 0.15** 0.57** -0.47** 
Animal protein, g/d -0.09** -0.26** 0.32** -0.41** 
Plant protein, g/d 0.33** 0.32** 0.80** 0.43** 
Fiber intake, g/d 0.17** 0.08** 0.69** 0.38** 
Cholesterol, mg/day 0.12** 0.02 0.36** -0.37** 
Alcohol, g/d -0.10** -0.18** 0.05 -0.49** 
* rs: Spearman correlation coefficient; rs_adj: Partial spearman correlation coefficient (adjusted for total energy 
intake). ** P < 0.05  
 
GI was positively associated with insulin resistance indicated by both the 
concentration of fasting insulin and HOMA-IR level (Table 3-4). A 10-unit GI 
increment, which corresponds to the difference between the lowest and highest 
quintile, was significantly associated with a 23% increase in markers of insulin 
resistance. The association of GI with HDL-C (inverse) and CRP (positive) 
concentration and TC/HDL-C ratio (positive) was also statistically significant. A 10-
unit increase in GI was associated with 7% decrease in HDL-C concentration, 10% 
increase in TC/HDL-C ratio and 29% increase in CRP concentration. In addition, this 
amount of GI increase was also associated with 10% increase in TG concentration, 
although this association was not statistically significant. In contrast, GL was not 
significantly associated with any of the metabolic risk factors, except for a borderline 
positive association with CRP. 
Neither GI nor GL was significantly associated with BMI and waist 
circumference after the adjustment for age, gender and physical activity level (data 
not shown). The only significant interaction was between GI and smoking in the 
association with fasting glucose (P = 0.02), fasting insulin (P = 0.04) and HOMA-IR (P 
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= 0.04). Additional stratified analyses showed that the positive associations between 
GI and these metabolic factors were confined to non-smokers, and absent in current 
smokers (data not shown).  
 
Table 3-4. Associations of GI and GL and metabolic risk factors (n = 974)*. 
GI (10 units) GL (50 units) Metabolic factors 
ß (SE) P ß (SE) P 
Fasting glucose, mmol/L 0.02 (0.01) 0.09 0.004 (0.009) 0.7 
2h- glucose, mmol/L 0.02 (0.02) 0.4 -0.01 (0.02) 0.6 
HbA1C, % 0.004 (0.008) 0.6 -0.001 (0.006) 0.8 
Fasting insulin, pmol/L 0.09 (0.03) 0.005 0.03 (0.03) 0.2 
HOMA-IR 0.09 (0.03) 0.004 0.03 (0.03) 0.3 
Total cholesterol, mmol/L 0.006 (0.01) 0.6 0.004 (0.009) 0.7 
HDL-C, mmol/L -0.03 (0.02) 0.04 0.0001 (0.01) 1.0 
TC/HDL-C ratio 0.04 (0.02) 0.04 0.004 (0.02) 0.8 
LDL-C, mmol/L 0.01 (0.02) 0.4 -0.003 (0.01) 0.8 
Triacylglycerol, mmol/L 0.04 (0.03) 0.1 0.002 (0.02) 0.9 
CRP†, mg/L 0.11 (0.06) 0.05 0.08 (0.05) 0.09 
ß: Regression coefficient; SE: Standard error of ß; HbA1C: Glycated hemoglobin A1C; HOMA-IR: Insulin 
resistance index from homeostasis model assessment; HDL-C: High density lipoprotein cholesterol; TC/HDL-
C ratio: Total cholesterol to high density lipoprotein cholesterol ratio; LDL-C: Low density lipoprotein 
cholesterol, CRP: high sensitivity C-reactive protein. 
* Multiple linear regression analysis was used with log-transformed metabolic risk factor as response variable 
and GI or GL as main exposure variable. Adjustment was made for age, gender, smoking, physical activity, 
cohort, and the intake of total energy, alcohol, fiber, cholesterol, animal protein, plant protein and saturated 
fatty acids (SFA). For GI, also adjusted for monounsaturated fatty acids (MUFA), polyunsaturated fatty acids 
(PUFA), polysaccharides and mono- and disaccharides. Total energy intake was adjusted for via using 
residual method. † Analyses confined to those with CRP <= 10mg/L. 
 
Discussion 
In this study population, a low GI diet was characterized by a high dairy and 
fruit and a low potato and cereal intake. GI was inversely associated with HDL-C 
and positively associated with fasting insulin, HOMA-IR, TC/HDL-C ratio and CRP. 
In non-smokers, it was also associated with fasting glucose. In contrast, GL was not 
clearly associated with any of these risk factors. 
Previous studies on GI/GL and metabolic risk factors showed inconsistencies.9, 12 
We used a newly developed GI database which for European studies incorporates 
the best knowledge in the field so far.23 This enabled us to study the association with 
metabolic risk factors in a more optimal way. We acknowledge the difficulties and 
inaccuracy in assessing GI and GL using FFQs.39 However, the validity in terms of 
estimating carbohydrate intake of our FFQ is comparable to that used in the Nurses’ 
Health study 40 and is for example higher than the FFQ used in the Insulin Resistance 
Atherosclerosis Study.16 Moreover, GI values were assigned to foods providing 98% 
of the total available carbohydrate consumption, which was slightly higher than in 
previous reports.13, 41, 42  
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We analyzed the pooled data of two Dutch cohort studies to increase the 
statistical power. Although baseline characteristics differed mainly due to the age 
and sex-differences between the two studies, pooling the data was justified as 
statistical analyses of interaction term in regression models showed no evidence of 
effect modification. In addition, in both studies, a common examination protocol was 
used, general questionnaires and FFQ were the same, and biochemical 
measurements were mostly done in the same laboratory, which ensures the lack of 
bias. Analyses of metabolic factors were adjusted for an extended set of potential 
confounders including age, gender, smoking, physical activity, cohort, total energy, 
dietary fiber, alcohol and cholesterol intake. For GI, additional adjustment was made 
for fatty acids, plant- and animal-based protein, polysaccharides and mono- and 
disaccharides. Therefore, the observed associations are not likely to be explained by a 
different dietary composition. For GL, additional adjustment was made for animal- 
and plant-based protein and SFA, but not MUFA and PUFA. Thus, the observed 
associations represented substituting unsaturated fatty acids (PUFA and MUFA) 
with GL. In a post hoc analysis, models substituting either animal protein or plant 
protein with GL yielded essentially the same results. Thus in this population a low 
GL diet is not different from a high unsaturated fat or high protein diet in its 
associations with metabolic risk factors.  
The concern that low GI diets may limit food choices and increase fat intake 22 
was not supported by our findings. Actually, we found a moderate positive 
association between GI and fat intake, both unadjusted and adjusted for total energy. 
At the food level, GI was positively associated with the intake of meats, and fats and 
oils, but inversely associated with the intake of vegetables, legumes, fruits, and fish. 
These findings imply that a low GI diet may be a marker of healthy eating habits. 
The positive association between GI and foods containing negligible amounts of 
carbohydrates, including meats and fats and oils, was also found in a previously 
published US study.43 An explanation may be that these foods are usually consumed 
in combination with high GI foods such as potatoes and cereals. 
The association between GI and dairy products was consistent with previous 
findings among Dutch elderly men 12 and US population.43 Unexpectedly, GI and GL 
in our study were positively, not inversely, associated with total dietary fiber intake. 
This supports the notion that low GI and GL diets are not necessarily high in fiber, 
and attributing the health effects of low GI and GL diets to higher fiber content may 
be imprudent. Separating soluble and insoluble fiber may shed more light on this 
issue, but was currently not possible due to lack of information in the Dutch food 
composition table.  
Regarding alcohol, some found an inverse association with GI,40, 44 while others 
found the opposite.43 In this study, we found a modest inverse association between 
GI and GL and alcohol intake. Different approaches used to assign GI values to 
alcoholic beverages might be, at least partly, the explanation for these dissimilar 
findings. In our study, the GI values of most alcoholic drinks, except for beer, 
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liqueurs and cocktails (GI = 61 vs. glucose), were 0, while Schulz et al. assigned an 
estimated GI value of 95 to beer and a value of 61 to wine and other alcoholic 
beverages.43 More information on the GI values of alcoholic beverages in different 
countries may be needed. 
GL was strongly associated with intake of total carbohydrates (rs = 0.97) but only 
moderately associated with GI (rs = 0.41). Over 95% of the variation in GL was 
explained by total carbohydrates, and only about 4% by GI. Compared with what 
has been demonstrated by Brand-Miller et al,45 GL in our study depended more 
heavily (95% vs. 68%) on carbohydrate intake. This might be secondary to the 
smaller variation in GI than in carbohydrate intake. Previous epidemiological studies 
showing similar variation of GI did however not report the relationship of GL with 
carbohydrates.10, 16, 42 
Mechanisms involved in the association of GI and GL with blood glucose, 
insulin and lipid concentrations have been reviewed before.14 In addition to the 
significant inverse association between GI and HDL-C, we also observed a positive 
association between GI and the TC/HDL-C ratio. The TC/HDL-C ratio is considered 
the best predictor of ischemic heart diseases as it takes into account both the cardio-
protective effect of HDL-C and the atherogenic effect of LDL-C and very low density 
lipoprotein cholesterol (VLDL-C).46 Although small, the significant association of GI 
with HDL-C and TC/HDL-C ratio suggests a protective role of low GI diets on lipid 
metabolism disorders and CVD.  
Potential mechanisms underlying the association between GI, GL and chronic 
systematic inflammation have recently been summarized in detail.47 Hyperglycemia, 
dyslipidemia, insulin resistance and weight change may all be involved in this 
pathway. A positive relationship between GI, GL and CRP was found previously in 
two US studies.10, 48 Although the association was only of borderline significance for 
GL, a 29% decrease in CRP by 10 unit GI decrease seems promising for decreasing 
the risk of metabolic syndrome and CVD.49 
Low GI diets showed significant benefits on fasting glucose and insulin 
sensitivity among non-smokers. None of the previous studies on GI and GL has 
reported this effect modification. It may be that the independent adverse effects of 
cigarette smoking on glucose and insulin metabolism leaves little room for the main 
exposure variables, as in a study on beta-carotene,50 although this is rather unlikely 
in comparison with stronger determinants of glucose metabolism, such as BMI and 
waist. Further investigation on the potential impacts of smoking on nutrient 
(carbohydrates) partitioning may be needed.  
It should also be noted that the current findings resulted from analyses that 
included both polysaccharides and mono- and disaccharides as covariates. This was 
due to the fact that GI in our study, also in a US study,43 was positively associated 
with polysaccharides but inversely associated with mono- and disaccharides. When 
we adjusted for total carbohydrate instead, GI was not significantly associated with 
fasting insulin and HOMA-IR, whereas the association with lipids and CRP 
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remained essentially the same. This suggests that low GI diets may benefit insulin 
sensitivity via replacing high GI polysaccharides with low GI polysaccharides but 
not replacing polysaccharides with mono- and disaccharides.  
In this study, GI and GL were not associated with HbA1C, a marker of long term 
glycemic control. Although more than half of the subjects had T2DM or IHG, HbA1C 
was on average in the low diabetic and normal range. Subgroup analyses among 
T2DM patients (n = 288), subjects with either T2DM or IHG (n = 506) and subjects 
with a high HbA1C level (7%, n = 78) also failed to detect any statistically significant 
association.  
In conclusion, in this Dutch population, a low GI diet is high in dairy products 
and fruits but low in potatoes and cereals. Even though cross-sectional studies do not 
prove a causal relationship, the findings of this current study support a beneficial 
role of low GI diets in optimizing insulin sensitivity, lipid metabolism, chronic 
inflammation and, in non-smokers, fasting glucose. GL was highly correlated with 
total carbohydrates and marginally associated with CRP but not other metabolic risk 
factors under investigation. Large prospective cohort studies and clinical trials are 
warranted to ascertain the beneficial effects cast on low GI diets. 
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Abstract 
Limited information is available on the reproducibility and validity of dietary 
glycemic index (GI) and glycemic load (GL) estimated by habitual diet assessment 
methods such as food-frequency questionnaires (FFQs), including the FFQ used in 
the Dutch cohorts of the European Prospective Investigation into Cancer and 
Nutrition (EPIC) study. To examine the reproducibility and relative validity of GI 
and GL, we used data from 121 Dutch men and women aged 23-72 years. They 
completed the FFQ three times at intervals of 6 months and twelve 24-hour dietary 
recalls (24HDRs) monthly during 1991-1992. GI and GL were calculated using 
published values. Intra-class correlation coefficients of the three repeated FFQs were 
0.78 for GI and 0.74 for GL. Pearson correlation coefficients between the first FFQ 
and the weighted average of the 24HDRs were 0.63 for both GI and GL. Weighted 
kappa values between the first FFQ and the average of the 24HDRs (in quintiles) 
were 0.40 for GI and 0.41 for GL. Bland-Altman plots showed a proportional bias in 
GI (β = 0.46) but not in GL (β = 0.06). In conclusion, this FFQ can be used in 
epidemiological studies to investigate the relationship of GI and GL with disease 
risks but the proportional bias should be taken into account when using this FFQ to 
assess the absolute GI values.  
Key words 
Glycemic index; Glycemic load; Reproducibility; Validity; Food frequency 
questionnaire 
 
Introduction 
The food-frequency questionnaire (FFQ) is the most frequently used method to 
assess habitual diets in large scale epidemiological studies given that it is relatively 
inexpensive and less labor demanding as compared to for example food diaries or 24 
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hour dietary recalls (24HDRs). Dietary glycemic index (GI) and glycemic load (GL) 
have recently been considered as potential risk factors of chronic diseases such as 
type 2 diabetes, heart diseases and certain types of cancer.1 Several epidemiological 
studies have been conducted investigating the potential role of dietary GI and GL on 
disease risks.2-5 However, none of the FFQs used in these studies are specifically 
designed for measuring dietary GI and GL and the reproducibility and validity of GI 
and GL assessed by these FFQs are mostly unknown.  
The FFQ used in the Dutch cohorts of the European Prospective Investigation 
into Cancer and Nutrition (EPIC) study was designed to capture the habitual intake 
of nutrients and major food items of the Dutch adult population. It is a self-
administered semi-quantitative FFQ, contains 178 food items, and has also been used 
by other Dutch studies apart from EPIC.3 The reproducibility and validity of energy, 
food and nutrient intake have been investigated before.6, 7 The current study was 
conducted, using previously collected data, to examine the reproducibility and 
relative validity of GI and GL estimated by this FFQ.  
 
Methods 
Subjects, study design and dietary assessment 
A detailed description of the subject recruitment, FFQ, reference method, data 
collection and data processing has been published previously.6 In brief, the subjects 
were recruited from the study populations of the Dutch part of the EPIC study from 
4 towns in The Netherlands. Of the 960 people invited by mail, 240 (25%) responded 
positively, 288 (30%) refused to participate, and 432 (45%) did not respond. Out of 
the 240 who responded positively, we selected 134 subjects equally distributed 
across the four towns, in 20-year age groups and of both genders. In total 121 
subjects, 63 men and 58 women, completed the study. They were between 23 and 72 
years old and had a mean body mass index (BMI) of 25.2 kg/m2. During 1991-1992, 
the FFQ was administered three times with intervals of 6 months by mailing to the 
participants at home. 24HDRs (one for each weekend day, and two for each weekday) 
were administered monthly throughout a year either face to face or by telephone 
interview. Nutrient intake was calculated according to the 1993 version of the Dutch 
food composition table (Nederlands Voedingsstoffenbestand table, NEVO table).8 
Weighted average of 24HDRs was calculated with weight of 1 for weekdays and 2 
for weekend days. 
 
GI and GL calculation 
In order to calculate dietary GI and GL, GI values were assigned to every 
carbohydrate-containing food item included in the FFQ and 24HDRs. The GI-
database developed in the EPIC study was used as the main source of information. 
Methodologies used to compile this GI-database have been briefly explained before2, 
3 and a full descriptive paper is going to be published elsewhere.9 In brief, this GI 
table was compiled from different published sources, 10-12 including 415 values from 
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the international table of GI and GL values from Foster-Powell et al,10 31 published 
values for British foods,11 9 foods from the official website of the Glycemic Index and 
GI Database from the Sydney University,12 and 20 communicated values for food 
(groups) with no equivalent in above mentioned sources (Thomas Wolever and 
Jennie Brand-Miller, personal communication). For the Foster-Powell table, a few 
adaptations were made according to a prioritized selection list of criteria developed 
by the FAO/WHO expert consultation. For example, items that were not measured 
under standard conditions were excluded if items analyzed under standard 
conditions were already available in the table (standard conditions include: 50 g or, 
in case of low carbohydrate containing foods, 25 g of available carbohydrate, 
measurement time for healthy and diabetic subjects of 2 and 3 hours respectively, 
and at least 6 participants).9 All food items in the FFQ could be linked to a GI value 
in this GI-database. For about 30% (258 out of 764) of the items in the 24HDRs, no 
direct link was possible. So a GI value from other sources had to be assigned. For this, 
the same sources of information and criteria as used in the compilation of the EPIC 
GI-database were applied. Dietary GI and GL were calculated as the weighted mean 
of GI and GL from all foods consumed daily using the commonly used formulas.3  
 
Statistical method 
To assess reproducibility, intra-class correlation coefficients (ICCs) were 
calculated. 
To assess relative validity, Pearson correlation coefficients and weighted kappa 
statistics were calculated for the first FFQ and the average of the 24HDRs. Absolute 
agreement between two measurements was determined using the Bland-Altman 
method, in which the difference was plotted against the mean of the two dietary 
assessment methods. Linear regression analysis was performed to investigate 
whether the bias was proportional to the levels of GI and GL. Residual method was 
used to adjust for energy intake.13  
Statistical analyses were performed using SAS version 9.1 (SAS Institute, Cary, 
NC) and SPSS 15.0 for Windows (SPSS Inc, Chicago, IL, USA). 
 
Table 4-1. Mean GI and GL measured by the FFQ used in the Dutch cohorts of the EPIC study and 24-h 
dietary recalls (24HDRs; n = 121). 
GI GL  
Mean SD Mean SD 
FFQ1 56.8 4.0 143.7 57.5 
FFQ2 57.0 4.1 138.2 49.1 
FFQ3 57.1 3.9 132.6 46.3 
Weighted average of 24HDRs 58.9 2.8 146.7 48.6 
GI: Glycemic index; GL: Glycemic load; SD: Standard deviation; FFQ1: The 1st food frequency 
questionnaire. FFQ2: The 2nd food frequency questionnaire;   FFQ3: The 3rd food frequency questionnaire; 
24HDRs: 24-hour dietary recalls. 
 
Chapter 4 
 - 62 - 
Results 
Mean and standard deviation (SD) of GI and GL as assessed by the FFQs and 
24HDRs are shown in Table 4-1. Both GI and GL were roughly normally distributed 
(data not shown). No gender differences were observed. Therefore analyses were 
performed in combined population of men and women. Crude ICCs between three 
repeated FFQs were 0.82 for GI and 0.86 for GL (Table 4-2). Adjusting for energy 
intake slightly attenuated the correlation coefficients to 0.78 for GI and 0.74 for GL.  
 
Table 4-2. Reproducibility and relative validity of GI and GL measured by the FFQ used in the Dutch 
cohorts of the EPIC study (n = 121). 
GI GL 
Reproducibility and validity Crude  
(95% CI) 
Adjusted 
 (95% CI)* 
Crude  
(95% CI) 
Adjusted 
 (95% CI)* 
ICC of repeated FFQs 0.82 (0.77, 0.86) 0.78 (0.71, 0.83) 0.86 (0.82, 0.90) 0.74 (0.67, 0.80) 
Pearson correlation† 0.69 (0.58, 0.77) 0.63 (0.51, 0.73) 0.79 (0.71, 0.85) 0.63 (0.51, 0.73) 
Spearman correlation† 0.67 (0.56, 0.76) 0.62 (0.49, 0.72) 0.83 (0.76, 0.88) 0.60 (0.48, 0.71) 
Weighted kappa†, ‡ 0.42 (0.31, 0.53) 0.40 (0.29, 0.51) 0.53 (0.43, 0.63) 0.41 (0.30, 0.52) 
GI: Glycemic index; GL: Glycemic load;  CI: Confidence interval; ICC: Intra-class correlation coefficient 
* Adjusted for energy intake.  † FFQ1 was compared with the average of 24HDRs.   
‡ Agreement between quintiles of FFQ1 and the average of the 24HDRs. 
 
Pearson correlation coefficients between the first FFQ measurement and the 
average of 24HDRs were 0.69 for GI and 0.79 for GL before adjusting for energy 
intake, and 0.63 for both GI and GL after the adjustment for total energy intake. 
Weighted kappa values between the first FFQ and the average of 24HDRs (in 
quintiles) were 0.42 for GI and 0.53 for GL. After the adjustment for energy intake, 
these values changed to 0.40 and 0.41 respectively. 
 
 
 
 
 
 
 
 
 
 
Figure 4-1. Bland–Altman plot of GI from the first FFQ and weighted average of 12 24HDRs (n = 121). 
Lower limit of agreement
Upper limit of agreement
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There was a systematic underreporting in the FFQ for both GI (mean difference 
2.2) and GL (mean difference 3.0) as compared to the average of 24HDRs (Table 4-1). 
A positive association was found between the difference and the mean of GI (β = 0.46, 
95% confidence interval (CI): 0.28, 0.63) (Figure 4-1), suggesting the presence of 
proportional bias in the FFQ: underreporting at lower GI level and over-reporting at 
higher GI level. No such association was found for GL (β = 0.06, 95% CI: -0.11, 0.24) 
(Figure 4-2), although fairly wide limits of agreement were observed (-43.7 to 37.7). 
Logarithmic transformation, as proposed by Bland and Altman,14 did not remove the 
proportional bias in GI (data not shown).  
 
 
 
 
 
 
 
 
 
Figure 4-2. Bland–Altman plot of GL from the first FFQ and weighted average of 12 24HDRs (n = 121). 
 
Discussion  
We found good reproducibility and relative validity of GI and GL assessed by 
the FFQ used in the Dutch EPIC cohorts.  
To our knowledge, only three dietary questionnaires have been evaluated for 
their validity of GI and GL measurements,15-17 of which the Swedish FFQ16 and the 
Japanese dietary history questionnaire17 have also been evaluated for their 
reproducibility. The reproducibility of the current FFQ was higher than those found 
in these two studies. Reproducibility of questionnaires could be influenced by the 
time interval between administrations. Too long, real change in eating habits may 
occur which may underestimate the reproducibility. On the other hand, if the 
interval is too short, participants may remember the previous questionnaire and 
therefore respond with the same answers, thus overestimate the reproducibility. 
Compared with the two previous studies, the time interval of the current study (6 
months) is shorter than the study from Levitan et al (1 year)16 but longer than the 
administration time of Japanese dietary history questionnaire (3 months).17 Therefore, 
Upper limit of agreement
Lower limit of agreement
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most likely the time interval is not the reason for the higher reproducibility observed 
in the present study. 
The validity of dietary assessment methods can be tested with different statistical 
tools depending on the intended use. The Bland-Altman method has been suggested 
as the best method for assessing the agreement between two measurement 
methods.18 In our case, the plots indicate a systematic underestimation of GL by the 
FFQ, whereas for GI there is an underestimation at the lower GI level and an 
overestimation at the higher GI level. However, given that FFQs are most of the time 
used in association studies to rank individuals according to their intake level rather 
than for measuring the absolute level of intake, calculating correlation coefficients 
and weighted kappa statistics are more appropriate.19 The validity of GI and GL in 
this study, as indicated by Pearson correlation coefficients, was similar as the results 
from three previous studies.15-17 Only one of these three studies used weighted kappa 
values to assess the agreement between the modified Willett FFQ and three 4-day 
weighted food records.15 Values from our current study were higher for GL (0.41 vs. 
0.30) but lower for GI (0.40 vs. 0.53) as compared with their findings.  It has been 
suggested that correlation coefficients of 0.5 or higher indicate that the FFQ has 
sufficient ability to rank individuals according to their nutrient intake as continuous 
variable, while for categorical variables, weighted kappa values are recommended to 
be above 0.4 in order to draw valid conclusions.19  
In conclusion, the findings of the current study support the use of this FFQ in 
epidemiological studies in which associations of GI and GL, either as continuous or 
categorical variables, with disease risks are under investigation. However, the 
proportional bias should be taken into account when using this FFQ to assess 
absolute GI values.  
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Abstract 
Objectives: To investigate whether dietary glycemic index (GI) and glycemic load 
(GL) were associated with subsequent weight and waist circumference change. 
Design: Population-based prospective cohort study. 
Setting:  Five European countries, which are Denmark, Germany, Italy, The 
Netherlands, and the UK.  
Participants: 89,432 participants, aged 20-78 years (mean = 53 years) at baseline and 
followed for 1.9-12.5 years (mean = 6.5 years). All participants were free of self-
reported cancer, cardiovascular diseases and diabetes at baseline.  
Methods: GI and GL were calculated based on dietary intake assessed by food 
frequency questionnaires and by using a GI table developed for this study with 
published GI values as the main sources. Anthropometric data were collected both at 
baseline and at the end of follow-up. Multiple linear regression analyses were 
conducted in each centre and random-effect meta-analyses were used to combine the 
effects. Adjustment was made for baseline anthropometrics, demographic and 
lifestyle factors, follow-up duration, and other dietary factors. 
Results: Mean GI and GL were 57 and 134 respectively. Associations of GI and GL 
with subsequent changes of weight and waist circumference were heterogeneous 
across centers. Overall, per 10-unit GI higher, weight increased by 34 g/year [95% 
confidence interval (CI): -47, 115] and waist circumference increased by 0.19 cm/year 
[95% CI: 0.11, 0.27]. Per 50-unit GL higher, weight increased by 10 g/year [-65, 85], 
waist circumference increased by 0.06 cm/year [-0.01, 0.13]. 
Dietary glycemic index, 
glycemic load and subsequent 
changes of weight and waist 
circumference in European 
men and women 
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Conclusions: Our findings do not support an effect of GI or GL on weight change. 
The positively significant association between GI, not GL, and subsequent gain in 
waist circumference may imply a beneficial role of lower GI diets in the prevention 
of abdominal obesity. However, further studies are needed to confirm this finding 
given the small effect observed in this study. 
Keywords: glycemic index, glycemic load, weight change, waist circumference 
change, cohort. 
 
Introduction 
With the increase of overweight and obesity worldwide and the growing burden 
of obesity-related chronic diseases, there is an increasing interest in identifying 
modifiable determinants of body weight gain. Glycemic index (GI) has received 
considerable attention in this respect. The concept of GI, developed in the early 1980s 
by Jenkins and co-workers, is a quantitative measure of carbohydrate quality based 
on the blood glucose response after consumption.1 Glycemic load (GL) was defined 
later to capture the entire blood glucose-raising potential of dietary carbohydrates 
and it is calculated as the product of GI and total available carbohydrates.2 It has 
been suggested that low GI or GL diets can help to prevent body weight gain and 
stimulate weight loss.3 This is because the mild blood glucose and insulin response 
following a low GI or GL diet consumption could stimulate a higher satiation and 
satiety, thus leading to a decrease in energy intake;4 regulate fuel partitioning in the 
way of reducing fat storage;5 and limit the decrease of resting metabolic rate under 
energy restriction.6, 7 
A recent Cochrane Review of six randomized controlled trials (RCTs) has 
concluded that over the intervention period of five weeks to six months, low GI and 
low GL diets are more effective in promoting body fat loss (~1 kg more) than the 
comparison diets.8 However, this conclusion has not been consistently confirmed by 
RCTs published thereafter.9-12 Short duration, difficulties in adhering to the 
prescribed diets, and a high drop-out rate are well known drawbacks of clinical 
intervention studies. Furthermore, dietary factors promoting weight loss among 
obese individuals may not be appropriate to prevent weight gain in a long term.13 
Given that weight gain usually develops slowly over many years, it is difficult, if not 
impossible, to conduct RCTs investigating the effects of dietary factors on preventing 
weight or waist circumference gain. Therefore, large prospective cohort studies are 
important in exploring dietary determinants of longterm weight and waist 
circumference gain.14 In the analysis of data from the SEASONS study in the US, GI, 
but not GL, has been positively associated with change in body mass index (BMI).15  
In the Danish arm of the Monitoring Trends and Determinants in Cardiovascular 
Disease study, low GI diets have been associated with a lower weight and waist 
circumference gain in women but not in men. During the 6 year follow-up, women 
who had 10-unit higher GI have gained 1.3 kg more weight and 2 cm more waist 
circumference than those with lower GI.16  
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This prospective cohort study was conducted with the objective of examining the 
association of dietary GI and GL with subsequent changes of weight and waist 
circumference. With data from five European countries, this study also provided a 
good opportunity to test the robustness of findings across populations. 
 
Methods 
Participants 
This study is a part of the DiOGenes project (acronym for “Diet, Obesity and 
Genes”) which is a pan-European program targeting on obesity. Participants came 
from eight cities or counties within five European countries, which are Florence 
(Italy), Norfolk (UK), Amsterdam, Maastricht and Doetinchem (The Netherlands), 
Potsdam (Germany), Copenhagen and Aarhus (Denmark), participating in the 
European Prospective Investigation into Cancer and Nutrition (EPIC) study. 
Detailed information on the study population and data collection has been described 
elsewhere.17 Of the 146,543 men and women who took part in the baseline 
examination of EPIC during 1992-1998, 102,346 (69.8%) participated in the follow-up 
examination of DiOGenes during 1998-2005. The exclusion criteria for the current 
study were: pregnancy at baseline or follow-up (n = 133), missing information on 
diet, anthropometric data or follow-up duration (n = 2,135), the ratio of energy intake 
to estimated basal metabolic rate (EI:BMR) within the top or bottom 1% of the total 
EPIC population (n = 1,803), unrealistic anthropometric measurements (n = 331) and 
self-reported chronic diseases including cancer, cardiovascular diseases (CVD) and 
diabetes at baseline (n = 8,512). In total, 89,432 participants, 37,125 (42%) men and 
52,307 (58%) women, were included in the data analyses. 
 
Dietary assessment 
Country-specific food frequency questionnaires (FFQs) were self-administered at 
baseline. All FFQs are validated for total energy, total carbohydrate intake, dietary 
fiber, and main carbohydrate containing foods.18-24 Energy and nutrient intakes were 
calculated using country-specific food composition tables.17 Since GI values of foods 
were largely absent in food composition tables, a GI-database was specially 
developed, using mainly published information, under the joint efforts of the EPIC 
and the DiOGenes projects.25 Dietary GI was calculated as the weighted average of 
GI values (GI of glucose = 100) of foods consumed per day and GL was calculated as 
the product of GI multiplied with total available carbohydrates intake (g/day), 
divided by 100.26 GI and GL measured by the Dutch FFQ have been validated against 
multiple 24-hour recalls (r = 0.63).27 To improve the comparability of dietary data 
collected using different FFQs and to adjust for measurement errors, a linear 
calibration was performed using a single 24-hour dietary recall from a stratified 
random sample of the entire EPIC study populations as reference method.28, 29 
Among the 89,432 participants included in the current study, 6,790 participants also 
had 24-hour dietary recall data available. These 24-hour dietary recall data were 
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collected using a software program (EPIC-SOFT, IARC, Lyon, France) specifically 
designed to standardize the dietary measurements across European populations.30 
Nutrient intake in the 24-hour recall data were standardized based on the 
standardized nutrient database developed within the EPIC study (ENDB).31 Gender- 
and centre-specific calibration models were built with 24-hour dietary recall 
measurements as dependent variables and FFQ measurements as independent 
variables. Age, body weight, height, and season in which the FFQ was administered 
were adjusted for. Energy density was calculated as energy (kcal) from foods divided 
by the weights (g) of these foods. Drinks were not included in the calculation.32 
Under-reporting of energy intake was defined as EI: BMR < 1.1.33 BMR was estimated 
using the Harris-Benedict equation.34 
 
Anthropometric measurements 
Weight and waist circumference were collected at baseline and at the end of 
follow-up. At baseline, all participants were measured for weight, height and waist 
circumference. Methods used have been described in detail previously.35 In brief, 
body weight and height were measured when participants wear light clothes and no 
shoes. Waist circumference was measured either at the midway between the lowest 
rib and the iliac crest (NL-AmMa, NL-Doe, and GER-Pot) or the narrowest torso 
circumference (the other centers). At follow-up, participants in Norfolk (UK) and 
Doetinchem (NL) were measured by trained technicians using the same protocols as 
baseline, while others provided self-reported data. For the latter, guidance was 
provided to measure waist circumference as at baseline, except for DK-CopAa where 
participants were guided to measure their waist circumference at the umbilicus (the 
reason of changing the site of measurement was to simplify the measurement 
instructions for participants). Annual change in weight (g/year) and waist 
circumference (cm/year) were calculated as follow-up values minus baseline values 
and divided by follow-up duration in years. Due to the differences in methods used 
to collect anthropometric data at follow-up and the length of follow-up, participants 
from Doetinchem (NL) were treated separately from those from Amsterdam and 
Maastricht (NL), while participants from Copenhagen and Aarhus (DK) were 
combined because no such differences between these two groups existed. Thus, six 
study centers were identified, namely Florence (IT-Flo, 2,041 men and 7,256 women), 
Norfolk (UK-Nor, 5,594 men and 7,214 women), Amsterdam-Maastricht (NL-AmMa, 
2,996 men and 3,915 women), Doetinchem (NL-Doe, 2,009 men and 2,191 women), 
Potsdam (GER-Pot, 6,214 men and 10,093 women) and Copenhagen-Aarhus (DK-
CopAa, 18,271 men and 21,638 women). 
 
Other covariates  
Information on lifestyle was collected via self-administered questionnaires. 
Questions covered age, gender, physical activity, education level, smoking, 
menopausal status, and use of hormone replace therapy (HRT). Information on 
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health status (cancer, CVD, and diabetes) was collected using either questionnaires 
or disease registries. Physical activity level was indexed into five categories (inactive, 
moderately inactive, moderately active, active, or unknown) based on occupational 
and recreational activities.17 Education level was inquired as the highest level of 
school achieved and participants were classified into either primary school and less, 
technical-professional school, secondary school, university degree, or unknown. 
Smoking information was also available at follow-up. With baseline smoking 
information together, it classified participants into one of the following five 
categories: stable smoking, start smoking, quit smoking, not smoking, or unknown. 
 
Statistical methods 
Characteristics of study participants are given for each quintile of dietary GI, 
using means (with overall SDs) or frequencies where appropriate. A linear trend for 
characteristics across quintiles was tested by linear regression (continuous variables) 
or by the Cochrane-Armitage trend test (categorical variables). 
The association of GI and GL with annual change in weight and waist 
circumference was investigated using multiple linear regression analyses. Centre-
stratified analyses were performed first, and random-effect meta-analyses were used 
to evaluate heterogeneity (I2) across study centers and to obtain pooled estimates of 
the associations. Analyses were adjusted for baseline age (years), gender, weight (kg), 
height (cm) and waist circumference (cm, for waist circumference change analyses 
only), smoking, physical activity, education, follow-up duration (years), and alcohol 
intake (non-drinker, 0.1-4.9g/day, 4.9-15 g/day, 15-30 g/day, 30-60 g/day, > 60 g/day). 
In women, analyses were also adjusted for menopausal status (postmenopausal 
yes/no) and HRT use (yes/no, or unknown). The analyses for GI were additionally 
adjusted for the intake of dietary fiber, fat, protein and total available carbohydrates 
and the analyses for GL were additionally adjusted for the intake of total energy, 
fiber and protein. All dietary variables included in the analyses were calibrated and 
were adjusted for total energy intake using the residual method.36 To investigate 
whether the effects of GI and GL are independent of the chemical composition of 
dietary carbohydrates, analyses were run with and without adjustment for simple to 
complex carbohydrate ratio. 
Interactions of GI and GL with baseline age, gender, baseline BMI, follow-up 
duration, baseline waist circumference (for waist circumference change analyses 
only), smoking, and EI:BMR were investigated by introducing product terms into the 
models. A two-sided P < 0.05 was considered statistically significant in the analyses 
of main effects, whereas P < 0.01 in at least three of the six study centers was 
considered relevant when testing for interaction.  
Several sensitivity analyses were performed for the main analyses, including 
using un-calibrated dietary variables; using anthropometric variables corrected for 
clothing differences and self-reporting using methods previously developed in the 
EPIC study35; excluding those participants who self-reported onset of cancer, type 2  
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Table 5-1. Characteristics of study participants across quintiles of glycemic index (GI). 
Characteristics*,† Overall Q1 Q2 Q3 Q4 Q5 
Glycemic index (GI) 57 ± 2.6 53 56 57 58 60 
Baseline age, yrs  53 ± 8.6 51 54 54 55 53 
Gender, % men 42 22 32 37 48 68 
Follow-up length, yrs  6.5 ± 2.2 7.9 6.7 6.1 5.6 6.0 
Baseline weight, kg  73.4 ± 13.5 71.3 72.1 72.6 74.4 76.6 
Baseline BMI, kg/m2  25.7 ± 3.8 25.7 25.6 25.7 25.8 25.9 
Overweight, % 41 38 40 41 42 43 
Obesity, %  12 13 12 12 12 12 
Baseline waist circumference, cm  86.2 ± 12.3 83.2 84.5 85.5 87.6 90.1 
Total energy intake, kcal/day 2,200 ± 460 2,047 2,123 2,156 2,249 2,426 
Energy density, kcal/g 1.73 ± 0.27 1.55 1.63 1.70 1.81 1.96 
Fat, En %  35.6 ± 3.6 36.7 34.9 34.5 35.4 36.6 
Protein, En %  15.1 ± 1.4 14.5 15.5 15.6 15.2 14.8 
Carbohydrates, En %  43.1 ± 4.4 43.8 43.7 43.9 43.0 40.9 
Polysaccharides, En % 21.8 ± 3.9 19.5 22.2 22.9 22.2 22.0 
Mono-disaccharides, En % 19.9 ± 4.1 22.9 20.1 19.7 19.4 17.5 
Glycemic load 134 ± 29 119 128 134 140 149 
Fiber, g/day 22.8 ± 5.2 21.8 22.4 22.6 23.1 24.2 
Smoking status‡,§, %        
Stable smoking 19 14 16 17 20 29 
Start smoking 2 2 2 2 2 2 
Quit smoking 7 6 6 6 6 9 
Not smoking 72 79 76 75 72 60 
Education‡,║, %        
Primary school or lower 27 19 27 30 29 32 
Technical/professional school 36 37 32 34 39 39 
Secondary school 13 11 16 16 13 11 
University degree or higher 23 33 25 21 20 19 
Physical activity‡,¶, %       
Inactive 16 18 18 17 16 13 
Moderately inactive 33 37 35 33 31 28 
Moderately active 24 24 23 24 23 24 
Active 27 20 24 27 29 35 
Post-menopausal women, %  57 46 59 62 63 62 
Hormone-use women $, % 22 24 20 21 22 23 
* Values presented are mean (±SD) or percentages. 
† A linear trend for characteristics across quintiles was tested by linear regression (continuous variables) or by 
the Cochrane-Armitage trend test (categorical variables). P for trend <0.001 for all characteristics except for 
obesity (P = 0.11) and hormone user (P=0.08). 
‡  Percentages are based on those participants with available data on that variable and may not sum to 100% due 
to rounding. § 1,440 participants with missing values. ║ 1,579 participants with missing values. 
¶ 3,319 participants with missing values. $ 1,273 participants with missing values.
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diabetes or CVD during follow-up. Except for the random-effect meta-analyses, 
which were conducted using STATA 8.2 (StataCorp, Texas, USA), all statistical 
analyses were performed using SAS 9.1 (SAS, Institute, Cary, NC).  
 
Results 
Mean age at baseline was 53 years (range: 20-78 years) and participants were 
followed for a mean of 6.5 years (range: 1.9-12.5 years). At baseline, 51% of men and 
34% of women were overweight (30 kg/m2 > BMI ≥ 25 kg/m2). Furthermore, 12% of 
the participants were obese (BMI ≥ 30 kg/m2) and 21% had abdominal obesity (waist 
circumference ≥ 102 cm for men or ≥ 88 cm for women).  
Mean (SD) GI was 58 (2.5) in men and 56 (2.4) in women; mean GL was 156 (26) 
in men and 118 (19) in women. Characteristics of study participants along quintiles 
of GI are presented in Table 5-1. Participants with higher GI were more often men, 
overweight and smokers, had a lower education level and were more physically 
active than those with lower GI. From the lowest to the highest GI quintile, the intake 
of total energy and dietary fiber and dietary energy density increased and the intake 
of mono-and disaccharides decreased. Participants in the higher GL quintile groups 
were more often men and smokers, had a higher education level and were more 
physically active. The intake of total energy, dietary fiber, fat and polysaccharides 
and dietary energy density increased with increasing levels of GL (Table 5-2). The 
characteristics of participants by study centre are presented in a supplementary table 
(S-Table 5-1). 
GI was inversely associated with weight change in UK-Nor and NL-Doe, while 
positively in all other centers. Overall, a 10-unit GI difference was associated with an 
annual weight change of 34 g/year [95% confidence interval (CI): -47, 115] (I2 = 83%, P 
for heterogeneity < 0.001) before adjusting for simple to complex carbohydrate ratio 
(Figure 5-1a). After adjusting, the overall effect of 10 unit GI on annual weight 
change was 84 g/year [95% CI: -5, 172] (I2 = 78%, P for heterogeneity < 0.001) (Figure 
5-1b). GI was positively associated with waist circumference change in all study 
centers. The overall effect of 10-unit GI on an annual waist circumference change was 
0.19 cm/year [95% CI: 0.11, 0.27] (I2 = 72%, P for heterogeneity = 0.003) (Figure 5-2a) 
and 0.26 cm/year [95% CI: 0.20, 0.33] (Figure 5-2b) respectively before and after 
adjusting for simple to complex carbohydrate ratio. In addition, heterogeneity 
became non-significant (I2 = 36%, P for heterogeneity = 0.17) when the simple to 
complex carbohydrate ratio was additionally adjusted for. 
The association of GL with both weight and waist circumference change was also 
heterogeneous across study centers (I2 = 83% and 86% respectively, P for 
heterogeneity < 0.001 for both). Overall, a 50-unit GL difference was associated with 
an annual weight change of 10 g/year [95% CI: -65, 85] (Figure 5-3) and an annual 
waist circumference change of 0.07 cm/year [95% CI: -0.04, 0.18] (Figure 5-4). These 
associations did not materially change after additionally adjusting for the simple to 
complex carbohydrate ratio (data not shown). 
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None of the potential effect modifiers under investigation fulfilled pre-defined 
criteria. Using un-calibrated dietary variables slightly attenuated the associations; 
using clothing- and self-report-corrected anthropometrics did not change the 
Table 5-2. Characteristics by gender and across quintiles of glycemic load (GL). 
Characteristics*,† Q1 Q2 Q3 Q4 Q5 
Glycemic load (GL) 99 116 130 147 179 
Baseline age, yrs  54 54 53 54 51 
Gender, %men 2 11 37 69 89 
Follow-up length, yrs  6.5 6.4 6.7 6.3 6.5 
Baseline weight, kg  69.5 68.7 72.2 76.8 79.7 
Baseline, kg/m2   26.6 25.4 25.4 25.7 25.6 
Overweight (25 kg/m2 ≤ BMI < 30kg/m2), %  42 36 38 44 44 
Obesity (BMI ≥ 30kg/m2), %  19 11 11 11 9 
Baseline waist circumference, cm 83.1 81.7 85.0 89.6 91.5 
Total energy intake, kcal/day 1,703 1,905 2,166 2,432 2,794 
Energy density, kcal/g 1.58 1.64 1.73 1.82 1.89 
Fat, En %  35.0 34.9 35.8 36.1 36.2 
Protein, En %  15.8 15.4 15.0 14.8 14.6 
Carbohydrates, En %  42.1 43.7 42.9 42.5 44.1 
Polysaccharides, En % 20.9 21.8 21.6 21.6 22.9 
Mono-disaccharides, En % 20.0 20.6 19.6 19.3 20.2 
Glycemic index 56 56 57 57 58 
Fiber, g/day 18.4 20.5 22.6 24.4 28.3 
Smoking status‡,§, %                              Stable smoking 19 17 19 20 21 
Start smoking 2 2 2 2 2 
Quit smoking 6 6 7 7 7 
Not smoking 74 75 72 71 69 
Education‡,║, %                       Primary school or lower 31 29 26 25 25 
Technical/professional school 41 37 35 34 33 
Secondary school 12 14 14 13 14 
University degree or higher 17 20 25 28 27 
Physical activity‡,¶, %                                         Inactive 21 18 16 15 10 
Moderately inactive 37 37 34 31 25 
Moderately active 23 23 24 25 25 
Active 20 22 26 29 39 
Post-menopausal women, %  62 59 54 50 42 
Hormone-use women$, % 24 22 20 20 16 
* Values presented are mean (± SD) or percentages. 
† A linear trend for characteristics across quintiles was tested by linear regression (continuous variables) or by the 
Cochrane-Armitage trend test (categorical variables). P for trend < 0.001 for all characteristics except for obesity (P = 0.11) 
and hormone user (P = 0.08). 
‡  Percentages are based on those participants with available data on that variable and may not sum to 100% due to 
rounding. § 1,440 participants with missing values. ║ 1,579 participants with missing values. 
¶ 3,319 participants with missing values. $ 1,273 participants with missing values.
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associations; excluding participants with self-reported onset of cancer, type 2 
diabetes or CVD during follow-up slightly strengthen the associations. However, 
none of the above mentioned sensitivity analyses essentially changed the results 
(data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5-1a.      I2 = 83%, P for heterogeneity < 0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5-1b.      I2 = 78%, P for heterogeneity < 0.001 
95% CI: 95% Confidence interval of regression coefficients. The overall estimate was based on random-effect 
model and indicates the weight change (g/year) for a 10-unit GI difference.  
5-1a. Analyses were adjusted for follow-up duration, gender, baseline age, height and weight, smoking, 
physical activity, education, alcohol intake, the intake of fiber, fat, protein and total available carbohydrates, 
and, for women, menopausal status and use of hormone replace therapy.  
5-1b. Analyses were additionally adjusted for simple to complex carbohydrate ratio. 
Figure 5-1. Association of glycemic index with annual weight change. 
 
Discussion 
-353 0 353
Study center Weight change (g/year) (95% CI)
IT-Flo 3 (-104, 109)
UK-Nor -200 (-353, -48)
NL-AmMa 69 (-1, 140)
NL-Doe -81 (-222, 59)
GER-Pot 183 (109, 258)
DK-CopAa 104 (66, 142)
Overall 34 (-47, 115)
-392 0 392
Study center Weight change (g/year) (95% CI)
IT-Flo 161 (36, 286)
UK-Nor -204 (-392, -15)
NL-AmMa 62 (-26, 150)
NL-Doe -48 (-230, 135)
GER-Pot 221 (130, 312)
DK-CopAa 146 (99, 194)
Overall 84 (-5, 172)
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In this prospective cohort study with participants from five European countries, 
GI was not associated with body weight change but was positively associated with 
waist change. GL was not associated with either weight or waist change.  
 
The main strengths of the current study include its large-scale and multi-centre 
prospective design, the availability of calibrated dietary variables based on 24-hour 
dietary recall data collected using a uniform system (EPIC-SOFT) 29 and related 
standardized nutrient databases,31 and the centrally standardized covariate variables. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5-2a.      I2 = 72%, P for heterogeneity = 0.003 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5-2b.      I2 = 36%, P for heterogeneity = 0.17 
95% CI: 95% Confidence interval of regression coefficients. The overall estimate was based on random-effect 
model and indicates the waist circumference change (cm/year) for a 10-unit GI difference.  
5-2a. Analyses were adjusted for follow-up duration, gender, baseline age, height, weight and waist 
circumference, smoking, physical activity, education, alcohol intake, the intake fiber, fat, protein and total 
available carbohydrates, and, for women, menopausal status and use of hormone replace therapy.  
5-2b. Analyses were additionally adjusted for simple to complex carbohydrate ratio. 
Figure 5-2. Association of glycemic index with annual change in waist circumference. 
-0.43 0 0.43
Study center Waist change (cm/year) (95% CI)
IT-Flo 0.10 (-0.04, 0.24)
UK-Nor 0.01 (-0.19, 0.22)
NL-AmMa 0.20 (0.12, 0.29)
NL-Doe 0.08 (-0.10, 0.26)
GER-Pot 0.35 (0.26, 0.43)
DK-CopAa 0.24 (0.18, 0.30)
Overall 0.19 (0.11, 0.27)
-0.54 0 0.54
Study center Waist change (cm/year) (95% CI)
IT-Flo 0.22 (0.05, 0.38)
UK-Nor 0.11 (-0.15, 0.36)
NL-AmMa 0.22 (0.11, 0.32)
NL-Doe 0.31 (0.08, 0.54)
GER-Pot 0.38 (0.28, 0.49)
DK-CopAa 0.25 (0.17, 0.32)
Overall 0.26 (0.20, 0.33)
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Furthermore, we used the GI-database specifically developed for this study, which 
incorporated the best available knowledge in the field, especially for European 
population studies.25 However, using data from FFQs, which are not specifically 
designed for measuring GI and GL, and published GI values to assess dietary GI and 
GL might be a limitation because information on some factors influencing GI values, 
such as the food matrix of total meals, are sometimes missing in FFQs.25 Weight and 
waist circumference were self-reported instead of measured in four out of six study 
centers, potentially causing heterogeneity. In additional analyses, we corrected 
anthropometrics for clothing differences and self-reporting using methods 
previously developed in the EPIC study,35 but the results did not appreciably change. 
To investigate the influence of the site differences for waist circumference 
measurements, we have applied the regression equations developed in a previous 
study37 to correct waist circumference at baseline and at follow-up. The associations 
between GI, GL and annual waist circumference change were essentially unchanged 
after the corrections. Another limitation is the residual confounding, which may flaw 
our results, although we have adjusted our analyses for a bunch of potential 
confounders. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
I2 = 83%, P for heterogeneity <0.001 
95% CI: 95% Confidence interval of regression coefficients 
The overall estimate was based on random-effect model and indicates the weight change (g/year) for a 50-unit GL 
difference.  
Analyses were adjusted for follow-up duration, gender, baseline age, height, and weight, smoking, physical 
activity, education, alcohol intake, the intake of total energy, fiber and protein, and, for women, menopausal 
status and use of hormone replace therapy.  
Figure 5-3. Association of glycemic load with annual weight change. 
 
The GI was introduced to replace the traditional classification of simple and 
complex carbohydrates as a marker of blood glucose increase after consumption. 
Compared with low GI foods, carbohydrates from high GI foods are absorbed more 
-253 0 253
Study center Weight change (g/year) (95% CI)
IT-Flo -74 (-144, -3)
UK-Nor -65 (-253, 123)
NL-AmMa -9 (-73, 56)
NL-Doe -32 (-140, 77)
GER-Pot 55 (-11, 121)
DK-CopAa 126 (80, 171)
Overall 10 (-64, 84)
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rapidly, cause higher postprandial glucose and insulin response and affect nutrient 
partitioning in a way that encourages body fat storage.5, 7 This is supported by the 
current findings because the potential benefits of low GI diets on weight and waist 
circumference change remained after adjusting for macronutrient composition and 
fiber intake. Notably, the effects of GI on weight and waist circumference change 
were not mediated by the simple to complex carbohydrate ratio and additional 
adjustment of this ratio even strengthened the associations (the association between 
GI and weight change tended to be borderline significant). This finding indicates that 
the GI is independent of the simple and complex carbohydrate composition and a 
low GI diet should not be achieved by replacing high GI starchy foods with low GI 
sugars. In other words, replace high GI starchy foods with low GI starchy food 
should be recommended. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
I2 = 86%, P for heterogeneity <0.001 
95% CI: 95% confidence interval of regression coefficients. 
The overall estimate was based on random-effect model and indicates the waist circumference change (cm/year) 
for a 50-unit GL difference.  
Analyses were adjusted for follow-up duration, gender, baseline age, height, weight, and waist circumference, 
smoking, physical activity, education, alcohol intake, the intake of total energy, fiber and protein, and, for 
women, menopausal status and use of hormone replace therapy.  
Figure 5-4. Association of glycemic load with annual waist circumference change. 
 
The role of dietary GI or GL on weight change is still an issue of debate. Whereas 
some clinical intervention studies observed a beneficial effect of reducing dietary GI 
and GL on weight loss,8, 12 others did not.9-11 Few long term cohort studies among 
free-living populations have been conducted to explore associations between GI or 
GL and weight change.15, 16 In these two cohort studies, a positive association 
between GI, but not GL, and weight change has been observed, at least in 
subgroups.16 Compared with our study, these studies were much smaller in sample 
size, were conducted among a more homogeneous population, and had measured 
weight data. In our study, however, weight was partly self-reported in four out of six 
-0.37 0 0.37
Study center Waist change (cm/year) (95% CI)
IT-Flo -0.01 (-0.10, 0.08)
UK-Nor 0.12 (-0.13, 0.37)
NL-AmMa -0.01 (-0.09, 0.06)
NL-Doe -0.09 (-0.23, 0.04)
GER-Pot 0.14 (0.06, 0.21)
DK-CopAa 0.25 (0.17, 0.32)
Overall 0.07 (-0.04, 0.17)
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of the study centers. However, when we look at the association in UK-Nor and NL-
Doe, where weight change was measured, GI was inversely, instead of positively, 
associated with weight change. This rules out the possibility that the different 
findings in our study compared to the previous ones were due to the self-reported 
weight change. 
The association of GI and GL with waist circumference change has been less 
investigated. In a Danish population, Hare-Bruun et al have observed a marginally 
positive association between GI and waist circumference change in women (a 10-unit 
GI difference was associated with 2 cm waist circumference enlargement in 6 years), 
but not in men.16 However, this association was not independent of weight change 
because GI was also positively and significantly associated with weight change. In 
the current study, a 10-unit GI difference was associated with a waist circumference 
change of 0.19 cm/year or 0.26 cm/year depending on the adjustment strategies 
applied. Although weaker as compared to previously observed,16 this association 
was independent of weight change because GI was not in an overall association with 
weight change. Increase in waist circumference independent of weight change 
indicates an accumulation of visceral fat, which has been found strongly associated 
with insulin resistance, and thus the risk of type 2 diabetes and CVD.38 The reason 
that GI was associated with waist circumference change but not weight change may 
be due to the characteristic of visceral fat that it is more vulnerable to the influence of 
high insulin responses stimulated by high GI foods as compared to subcutaneous fat. 
Therefore visceral fat may be a marker of a disturbed metabolic state, and eventually 
cause insulin resistance, metabolic syndrome and CVD.39 Another possibility might 
be simply due to the underreporting in dietary data. There is evidence that 
underreporting is less waist-related than weight-related,40 which may be due to the 
higher awareness of the importance of a healthy BMI than a healthy waist 
circumference.  
The exact reason of heterogeneity observed in the current study was unknown. 
However, the sources of study population in different centers may partly explain the 
phenomenon. For example, in IT-Flo, participants came from a sample of the general 
population and women participating in a breast cancer screening program. 
Participants in UK-Nor were recruited through general practitioners in the Norfolk 
region.41 In NL-Doe, only respondents from a pre-existing cardiovascular disease risk 
factor monitoring project were invited.42 Although in general there is no reason to 
assume a priori that these cohorts are different, subtle differences in underreporting 
of dietary intake and health consciousness among cohorts may exist.  
GL was introduced to capture the joint effects of carbohydrates quantity and 
quality on human health.2 It is thought to be superior to either GI or total 
carbohydrate intake alone. However, for mixed meals, low GL diets can be low in 
carbohydrates or low in GI or both. Both low fat high carbohydrate diets and low 
carbohydrate high fat diets have been found to be effective strategies for weight loss 
in intervention studies.43-46 In our study, when carbohydrate intake was analyzed in 
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the same regression models as used for GL, no association with weight and waist 
circumference change was observed. Also noteworthy, the correlation coefficient 
between GL and carbohydrates was 0.98, while it was only 0.36 between GL and GI 
(data not shown). Therefore, although GL reflects both GI and amount of 
carbohydrates, the measure in our study was more closely related to the latter. We 
might therefore have limited ability to evaluate potential effects of GL which extend 
beyond the effect from total carbohydrates itself.  
To conclude, in this large prospective multi-centre cohort study, although the 
association between GI and weight change was not statistically significant, a positive 
association between dietary GI and subsequent changes of waist circumference was 
observed. This finding may implicate that a higher dietary GI could accelerate waist 
circumference gain, in other words, consuming a low GI diet may protect against the 
long-term development of abdominal obesity. However, given that only a small 
effect was observed, further studies are needed to confirm this finding. 
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S-Table 5-1. Characteristics of study participants and associations of across study centre. 
Characteristics* 
IT-Flo 
 
UK-Nor
 
NL-
AmMa 
NL-Doe
 
GER-Pot 
 
DK-
CopAa 
N 9,297 12,808 6,911 4,200 16,307 39,909 
Glycemic index (GI) 56 ± 1.2 57 ± 1.4 58 ± 2.5 58 ± 2.2  54 ± 1.6 58 ± 2.3 
Baseline age, yrs                          51 ± 7.6  58 ± 8.9 42 ±10.6 46 ± 9.7  50 ± 8.8  56 ± 4.3 
Gender, % men 22 44 43 48 38 46 
Follow-up length, yrs         9.4±1.1 3.7 ± 0.7 10.0±1.4 5.0 ± 0.2 8.6 ± 0.8 5.4 ± 0.3 
Baseline weight, kg                67± 11.9 73± 12.6 73± 13.0 77± 12.9 73± 13.7 75± 13.6 
Baseline BMI, kg/m2     25.2±3.8 26.0±3.7 24.9±3.7 25.7±3.5    25.9±4.0 25.8±3.8 
Overweight, % 37 45 35 44 41 42 
Obesity, %  10 13 9 10 14 13 
Baseline waist, cm   80 ±10.9 87±12.0 84 ±11.8 90 ±11.0 85 ±12.5 88 ±12.3 
Total energy, kcal/d 2,009±426 1,971±354 2,366±566 2,385±556 2,156±456 2,288±419 
Energy density, kcal/g 1.51±0.17 1.67± 0.20 1.86± 0.29 1.68±0.23 1.62± 0.24 1.83± 0.26 
Fat, En %                                     32.3±2.4 32.2±2.8 36.1±3.8 35.1±2.9 38.1±2.7 36.4±3.0 
Protein, En %                              16.7±1.2 16.3±1.2 15.3±1.4 16.0±1.4 13.9±0.8 14.7±0.9 
Carbohydrates, En %                 47.5±2.7 46.2±2.3 43.1±3.8 44.3±4.6 43.3±4.1 40.8±4.0 
Polysaccharides, En % 30.0±3.3 22.8±1.1 21.9±2.6 21.5±2.6 19.2±2.2 20.5±2.6 
Mono-disaccharides, En % 17.5±2.1 23.4±3.0 21.1±3.4 22.8±4.0 22.4±4.4 17.9±3.1 
Glycemic load 135 ± 29 130 ± 25 148 ± 37 153 ± 40 124 ± 25 135 ± 27 
Fiber, g/d 22.1±4.5 18.6±2.9 22.7±5.8 23.9±6.3 22.1±3.8 24.6±5.3 
Smoking status†,‡, %        
Stable smoking 17 7 21 24 12 25 
Start smoking 1 1 2 2 2 2 
Quit smoking 9 2 13 5 5 7 
Not smoking 72 90 63 68 81 65 
Education†,§, %        
Primary school or lower 43 35 9 8 18 30 
Technical school 12 42 32 46 37 39 
Secondary school 26 9 27 25 7 11 
University or higher 18 14 32 21 39 20 
Physical activity†,║, %       
Inactive 25 35 9 3 21 9 
Moderately inactive 41 42 25 21 39 31 
Moderately active 19 9 27 29 24 25 
Active 15 14 39 46 16 35 
Post-menopausal women, %    52 68 17 24 42 73 
Hormone-use women¶, % 9 22 5 4 24 30 
* Values presented are mean (±SD) or percentages. 
†  Percentages are based on those participants with available data on that variable and may not sum to 100% due 
to rounding. ‡ 1,440 participants with missing values.   § 1,579 participants with missing values. 
║ 3,319 participants with missing values.   ¶1,273 participants with missing values. 
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Abstract 
Background: Experimental studies show that a reduction in dietary energy density 
(ED) is associated with reduced energy intake and body weight. However, few 
observational studies have investigated the role of ED on long-term weight and 
waist circumference change.  
Methods and Principal Findings: This population-based prospective cohort study 
included 89,432 participants from five European countries with mean age 53 years 
(range: 20-78 years) at baseline and were followed for an average of 6.5 years (range: 
1.9-12.5 years). Participants were free of cancer, cardiovascular diseases and diabetes 
at baseline. ED was calculated as the energy intake (kcal) from foods divided by the 
weight (g) of foods. Multiple linear regression analyses were performed to 
investigate the associations of ED with annual weight and waist circumference 
change.  
Mean ED was 1.7 kcal/g and differed across study centers. After adjusting for 
baseline anthropometrics, demographic and lifestyle factors, follow-up duration and 
energy from beverages, ED was not associated with weight change, but significantly 
associated with waist circumference change overall. For 1 kcal/g ED, the annual 
weight change was -42 g/year [95% confidence interval (CI): -112, 28] and annual 
waist circumference change was 0.09 cm/year [95% CI: 0.01, 0.18]. In participants 
with baseline BMI < 25 kg/m2, 1 kcal/g ED was associated with a waist circumference 
change of 0.17 cm/year [95% CI: 0.09, 0.25]. 
Conclusion: Our results suggest that lower ED diets do not prevent weight gain but 
have a weak yet potentially beneficial effect on the prevention of abdominal obesity 
as measured by waist circumference. 
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Introduction 
The global obesity epidemic triggers research investigating the dietary 
determinants of a positive energy balance. The energy density (ED) of foods or diets, 
defined as the amount of available energy per unit weight of foods or meals (kJ/g or 
kcal/g),1 has gained much attention in this respect.2 For example, the joint WHO / 
FAO expert consultation on diet, nutrition and the prevention of chronic diseases 
classifies the evidence of a positive relationship between high intake of energy-dense 
foods and weight gain and obesity as convincing.3 In addition, the Dietary 
Guidelines for Americans 2005 recommend eating foods that are low in calories for a 
given measure of food to reduce calorie intake.4  
Experimental data suggest that people tend to eat a similar volume of food to feel 
satiated, and, accordingly, consuming energy-dense foods could cause passive over-
eating in terms of energy.2 Furthermore, energy-dense foods high in fat and sugar 
tend to be highly palatable and stimulate over-eating5. Some cross-sectional studies 
show a positive association between ED and obesity but there are concerns about 
reverse causality.1, 6 Intervention studies among overweight and obese subjects 
consistently demonstrate that ED reduction is associated with weight loss.7-9 
However, these interventions were of relatively short period. Findings from 
observational studies, on the other hand, are less consistent. For instance, in two 
recently published studies among US women, higher ED has been found to predict 
higher weight gain.10, 11 However, no such significant relationship was observed in an 
earlier study among Danish adults.12 In a study among British children, higher ED at 
seven years of age, but not at 5 years of age, has been found to be a risk factor for 
excessive adiposity at the age of nine years.13  
The present study was conducted to examine the prospective relationship 
between dietary ED and long-term (1.9-12.5 years) changes in body weight and waist 
circumference within a large European study, which is a part of the DiOGenes 
project (acronym for “Diet, Obesity and Genes”).14  
 
Methods 
Participants 
The current study included participants from eight cities or counties in five 
different countries involved in the European Prospective Investigation into Cancer 
and Nutrition (EPIC) study, namely Florence (Italy), Norfolk (the UK), Amsterdam, 
Maastricht and Doetinchem (The Netherlands), Potsdam (Germany), Copenhagen 
and Aarhus (Denmark). EPIC study has been approved by local review board of all 
participating institutions. Written informed consent has been obtained from all 
participants before joining EPIC study. Detailed information on the study population 
and data collection of the EPIC study has been described elsewhere.15 Of the 146,543 
participants who took part in the baseline examination during 1992-1998, 102,346 
(69.8%) participated in the follow-up examination during 1998-2005. For the present 
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study, the following exclusion criteria were applied: pregnancy (n = 133), missing 
information on diet, anthropometrics or follow-up time (n = 2,135), the ratio of 
energy intake (EI) to estimated basal metabolic rate (BMR) (EI: BMR) being top or 
bottom 1% of the entire EPIC population (n = 1,803), unrealistic anthropometric 
measurements (n = 331) and those with history of cancer, diabetes or cardiovascular 
diseases (CVD) at baseline (n = 8,512). In total, 89,432 participants, 37,125 (42%) men 
and 52,307 (58%) women, were included in the analyses.  
 
Dietary assessment 
Country-specific food frequency questionnaires (FFQs) were self-administered at 
baseline. Energy and nutrient intakes were calculated using country-specific food 
composition tables.15 ED was calculated as energy (kcal) from foods (solid foods and 
semi-solid or liquid foods such as soups) divided by the weights (g) of these foods. 
Drinks (including water, tea, coffee, juice, soft drinks, alcoholic drinks and milk) 
were not included in the calculation.16 To improve comparability of dietary data 
collected using different FFQs, and to adjust for measurement errors, linear 
calibration was performed with single 24-hour dietary recall from a stratified 
random sample of the total EPIC study population as reference method.17, 18 Among 
the 89,432 participants included in the current study, 6,790 participants had also 24-
hour dietary recall data available. This 24-hour dietary recall was collected using a 
software program (EPIC-SOFT) specifically designed to standardize the dietary 
measurements across European populations.19 Nutrient intake in this 24-hour recall 
data were standardized based on the standardized nutrient database developed 
within the EPIC study (ENDB).20 Gender- and center-specific calibration models 
were built with 24-hour recall data as the dependent variable and FFQ data as the 
independent variable. Age, weight, height, and season in which the FFQ 
measurement was conducted were adjusted for. Under-reporting of EI was assessed 
by EI: BMR < 1.1,11 where BMR was estimated using Harris-Benedict equations.21  
 
Anthropometric measurements 
Weight and waist circumference were collected at baseline and at the end of 
follow-up. At baseline, all participants were measured by trained technicians for 
weight, height and waist circumference using standard study protocols as previously 
described.22 At follow-up, participants in Doetinchem (NL) and Norfolk (UK) were 
measured by trained technicians, while those in the other centers provided self-
reported weight and waist circumference. Annual changes in weight (g/year) and 
waist circumference (cm/year) were calculated as follow-up values minus baseline 
values and divided by the total years of follow-up. Due to differences in methods 
used to collect anthropometric information at follow-up and the length of follow-up 
time, participants from Doetinchem (NL) were treated separately from those from 
Amsterdam and Maastricht (NL), while participants from Copenhagen and Aarhus 
(DK) were combined because no such differences between these two groups existed. 
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Thus six study centers were formed, namely Florence (IT-Flo) (n = 9,297, 10%), 
Norfolk (UK-Nor) (n = 12,808, 14%), Amsterdam-Maastricht (NL-AmMa) (n = 6,911, 
8%), Doetinchem (NL-Doe) (n = 4,200, 5%), Potsdam (GER-Pot) (n = 16,307,18%) and 
Copenhagen-Aarhus (DK-CopAa) (n = 39,909, 45%). 
 
Other covariates  
Information on lifestyle was collected via self-administrated questionnaires. 
Questions covered age, gender, education level, physical activity, smoking, 
menopausal status, and use of hormone replacement therapy (HRT). Information on 
health status, including CVD, cancer and diabetes, was collected using either 
questionnaires or disease registries. Assessment of physical activity level was 
indexed into four categories based on their occupational and recreational activities. 
Education level was inquired as the highest level of school achieved. Based on the 
information of smoking status at baseline as well as at follow-up, participants were 
classified into one of the following four categories: stable smoking, start smoking, 
quit smoking, non- smoking or unknown. 
 
Statistical methods 
Characteristics of participants were given along quintiles of ED. Stepwise 
regression analyses were conducted to investigate the contribution of food groups 
and nutrients to the inter-individual variation in ED. Fifteen food group variables 
were entered into the regression model, including potatoes, vegetables, legumes, 
fruits, dairy products, cereals, meat, fish, eggs, fats, sugar and confectionery, cakes, 
condiments and sauces, soups and miscellaneous.23 As for nutrients, six 
macronutrient variables, including saturated fatty acids, monounsaturated fatty 
acids, polyunsaturated fatty acids, polysaccharides, mono-&disaccharides and 
protein were entered in the regression model. 
The association of ED with annual weight and waist circumference change was 
investigated using multiple linear regression analyses. Center-specific analyses were 
first performed and random-effect meta-analyses were used to evaluate 
heterogeneity (I2) and obtain pooled estimates of associations. Analyses were 
adjusted for a pre-decided set of potential confounders including baseline age (years), 
gender, height (cm), baseline weight (kg) and waist circumference (cm, only for 
waist circumference change analyses), smoking, physical activity (inactive, 
moderately inactive, moderately active, active or missing), education (primary 
school and less, technical-professional school, secondary school, university degree or 
missing), follow-up time (years), alcohol intake (non-drinker, 0.1-4.9g/day, 4.9-15 
g/day, 15-30 g/day, 30-60 g/day, >60 g/day), energy intake from beverages, and 
among women only, menopausal status (postmenopausal yes or no) and HRT use 
(yes, no, or missing).  
Interactions of ED with age, gender, baseline BMI, smoking, EI:BMR, follow-up 
duration, and baseline waist circumference (for waist circumference change analyses 
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only) were investigated by introducing product terms into the models. A two-sided 
P < 0.05 was considered statistically significant in the analyses of main effects, 
whereas P < 0.01 in at least three of the six study centers was considered relevant 
when testing of interaction.  
 
 
Table 6-1. Characteristics of study population across quintiles of dietary energy density (n = 89,432) 
Characteristics* Overall Q1 Q2 Q3 Q4 Q5 
Energy density, kcal/g 1.7 ± 0.27 1.4 1.6 1.7 1.9 2.1 
Baseline age, yrs  53 ± 8.6 54 54 54 53 52 
Gender, % of men 42 11 26 41 58 73 
Follow-up duration, yrs  6.5 ± 2.2 7.3 6.6 6.2 6.1 6.2 
Baseline weight, kg  73.4 ± 13.5 69.4 71.0 73.2 75.7 77.8 
Baseline BMI, kg/m2     25.7 ± 3.8 25.9 25.7 25.6 25.7 25.7 
Baseline waist circumference, cm  86 ± 12 82 84 86 88 90 
Total energy, kcal/day  2,200 ± 460 1,860 2,032 2,197 2,363 2,549 
Energy from beverages, kcal/day 350 ± 169 260 302 348 394 447 
Total gram of foods, g/day 1,308 ± 260 1,315 1,312 1,318 1,316 1,281 
Fiber†, g/day  22.8 ± 4.0 23.6 22.9 22.9 22.8 22.1 
Glycemic index† 57 ± 2.0 55 56 57 58 59 
Glycemic load† 134 ± 22 124 130 134 139 143 
Smoking status‡,§, %        
Stable smoking 19 12 14 17 22 31 
Start smoking 2 2 1 2 2 2 
Quit smoking 7 6 6 6 7 9 
Non-smoking 72 81 79 75 69 58 
Education‡,║, %         
Primary school or lower 27 30 28 25 25 28 
Technical/professional school 36 33 36 37 38 37 
Secondary school 13 15 14 13 12 11 
University degree or higher 23 22 22 24 26 24 
Physical activity‡,¶, %        
Inactive 16 19 18 16 14 13 
Moderately inactive 33 36 35 33 32 29 
Moderately active 24 23 23 25 25 24 
Active 27 22 24 26 29 34 
Post menopausal women, %  57 58 57 57 56 57 
Hormone-use women$, % 22 21 22 22 22 22 
* Expressed as means (or mean ± SD), otherwise indicated. Differences between quintile groups were tested using 
chi-square test (categorical variables) or ANOVA test (continuous variable). P < 0.0001 for all. † Energy-adjusted 
residuals of dietary variables. 
‡ Percentages are based on those participants with available data on that variable and may not sum to 100% due 
to rounding. § 1,440 participants with missing values. ║ 1,579 participants with missing values. ¶ 3,319 participants 
with missing values. $ 1,273 participants with missing values.
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We performed several sensitivity analyses, including use un-calibrated dietary 
variables; use corrected anthropometric variables based on the equations developed 
in EPIC study;24 exclude participants who developed type 2 diabetes, cancer, or CVD 
during follow-up; and additionally adjust for individual food or nutrient variables 
which potentially mediate the effects of ED on weight and waist circumference 
change, including total energy, fruits, vegetables, total fat, saturated fatty acids, 
dietary fiber, glycemic index and glycemic load. Except for the random-effect meta-
analyses, which were conducted using STATA 8.2 (StataCorp, Texas, USA), all other 
statistical analyses were performed using SAS 9.1 (SAS, Institute, Cary, NC).  
 
Results 
The mean baseline age was 53 years (range: 20-78 years) and mean follow-up 
duration was 6.5 years (range: 1.9-12.5 years). At baseline, 12% of participants were 
obese (BMI ≥ 30 kg/m2); a further 41% were overweight (30 kg/m2 > BMI ≥ 25 kg/m2); 
and 21% had abdominal obesity (waist circumference ≥ 102 cm for men and ≥ 88 cm 
for women) (data not shown). On average, participants in NL-AmMa were the 
youngest at baseline (42 years) and were followed for a longest period (10 years), 
while those from UK-Nor were the oldest at baseline (58 years) and with the shortest 
follow-up duration (3.7 years). Annual weight change was higher in NL-Doe (mean = 
440 g/year) and UK-Nor (374 g/year) compared to the weight change in the other 
centers with self-reported weight at follow-up (164 g/year, 164 g/year, 183 g/year and 
-51 g/year respectively for participants from IT-Flo, NL-AmMa, GER-Pot and DK-
CopAa). However, for waist circumference change, the highest value was observed 
in DK-CopAa (0.96 cm/year), followed by the waist circumference change in the IT-
Flo (0.84 cm/year), GER-Pot (0.76 cm/year), NL-AmMa (0.63 cm/year), and NL-Doe 
(0.58 cm/year), and the lowest in UK-Nor (0.22 cm/year). 
The overall mean ED was 1.7 kcal/g and higher in men (1.9 kcal/g) than in 
women (1.6 kcal/g). Participants in NL-AmMa had the highest ED (1.9 kcal/g), 
followed by those from DK-CopAa (1.8 kcal/g), UK-Nor (1.7 kcal/g), NL-Doe (1.7 
kcal/g), and GER-Pot (1.6 kcal/g), and the lowest was observed among those from IT-
Flo (1.5 kcal/g). Although consuming lower amount (total grams) of foods, 
participants with higher ED had greater intake of total energy and energy from 
beverages. They smoked more and were more physically active. Those in the higher 
ED quintile groups also had lower fiber intake and higher dietary glycemic index 
and glycemic load (Table 6-1).  
Among foods, fruits explained the most variation in ED (35%), followed by sugar 
and confectionery, fats, and vegetables (13%, 8% and 7% respectively) (Table 6-2). 
ED was inversely associated with the intake of fruits and vegetables but positively 
associated with the intake of fats and sugar and confectionery. Among nutrients, 
saturated fatty acids explained the most variation in ED (24%).  
After adjusting for the aforementioned covariates, there was no significant 
overall association between ED and annual weight change. The mean weight change 
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for each 1 kcal/g ED was -42 g/year [95% confidence interval (CI): -112, 28]. A 
significant degree of heterogeneity across study centers was observed (I2 = 86%, P for 
heterogeneity < 0.001). In IT-Flo, ED was inversely, but not significantly, associated 
with weight change. In NL-AmMa and DK-CopAa, the associations were toward a 
positive direction. The inverse associations in UK-Nor and NL-Doe and the positive 
association in GER-Pot were statistically significant (Figure 6-1). 
ED was positively and significantly associated with waist circumference change 
in IT-Flo, NL-AmMa, GER-Pot and DK-CopAa. In UK-Nor, ED was inversely but not 
significantly associated with waist circumference change. In NL-Doe, ED was 
inversely and significantly associated with waist circumference change. Overall, 1 
kcal/g ED was associated with a waist circumference change of 0.09 cm/year [95% CI: 
0.01, 0.18] (I2 = 84 %, P for heterogeneity < 0.001) (Figure 6-2). 
 
Table 6-2. Relationships of food groups and macronutrients with dietary energy density (kcal/g)  
(n = 89,432). 
Food groups β* Partial R2† Model R2 
Fruits  - 0.10 0.35 0.35 
Sugar and confectionery 0.32 0.13 0.48 
Fats 0.46 0.08 0.56 
Vegetables - 0.19 0.07 0.63 
Cereals and cereal products 0.07 0.06 0.69 
Soups and bouillon - 0.19 0.04 0.73 
Potatoes and other tubers - 0.10 0.02 0.75 
Cakes and cookies 0.20 0.01 0.76 
Meat and meat products 0.10 0.01 0.77 
Nutrients    
Macronutrients  β‡ Partial R2 Model R2 
Saturated fatty acids 0.04 0.24 0.24 
Mono- & disaccharides - 0.02 0.08 0.32 
Protein - 0.04 0.05 0.37 
* β regression coefficients refer to the energy density (kcal/g) difference explained by 100 g foods. 
† Only food or nutrient items had Partial R2 >0.01 were listed here. 
‡ β regression coefficients refer to the energy density (kcal/g) difference explained by 1% of energy contributed by 
individual nutrient. 
 
Only baseline BMI fulfilled the pre-decided criteria for being a significant effect 
modifier. Among participants with baseline BMI < 25 kg/m2, ED was in the direction 
of positively associated with weight change: 1 kcal/g ED was associated with a 
weight change of 29 g/year [95% CI: -19, 77] (Figure 6-3a). However, among those 
participants who were overweight or obese at baseline (BMI ≥ 25 kg/m2), ED was 
inversely associated with weight change: 1 kcal/g ED was associated with a weight 
change of -103 g/year [95% CI: -223, 18] (Figure 6-3b). In IT-Flo, ED was significantly 
and positively associated with weight change among those participants with BMI < 
25 kg/m2 but inversely among those BMI ≥ 25 kg/m2. In UK-Nor and NL-Doe, the 
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inverse association between ED and weight change was much weaker among 
participants who had a healthy BMI at baseline compared to the association in 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
I2 = 86%, P for heterogeneity < 0.001 
95% CI: 95% Confidence interval of regression coefficients. Regression coefficients represent the annual weight 
change (g/year) for 1 kcal/g ED. The overall estimate was based on random-effect model. 
* Adjusted for follow-up time and baseline age, height and weight, smoking, physical activity, education, alcohol 
intake, menopausal status, hormone replace therapy use, and energy intake from beverages.  
Figure 6-1. Association of energy density with annual weight change (n = 89,432)*. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
I2 = 84%, P for heterogeneity < 0.001 
95% CI: 95% Confidence interval of regression coefficients. Regression coefficients represent the annual waist 
circumference change (cm/year) for 1 kcal/g ED. The overall estimate was based on random-effect model. 
* Adjusted for follow-up time and baseline age, height, weight, and waist circumference, smoking, physical 
activity, education, alcohol intake, menopausal status, hormone replace therapy use, and energy intake from 
beverages.  
Figure 6-2. Association of energy density with annual waist circumference change (n = 89,432)*. 
 
those who were overweight or obese. The differences in the other study centers were 
less evident. For the associations with waist circumference change, the most evident 
-386 0 386
Study center Weight change (g/year) (95% CI)
IT-Flo -39 (-108, 30)
UK-Nor -272 (-386, -158)
NL-AmMa 28 (-27, 83)
NL-Doe -164 (-295, -33)
GER-Pot 53 (2, 104)
DK-CopAa 29 (-6, 64)
Overall -42 (-112, 28)
-0.32 0 0.32
Study center Waist change (cm/year) (95% CI)
IT-Flo 0.17 (0.07, 0.27)
UK-Nor -0.05 (-0.21, 0.11)
NL-AmMa 0.08 (0.02, 0.14)
NL-Doe -0.16 (-0.32, -0.00)
GER-Pot 0.16 (0.10, 0.22)
DK-CopAa 0.22 (0.16, 0.28)
Overall 0.09 (0.01, 0.18)
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differences were observed in IT-Flo and NL-Doe. The associations in participants 
with BMI < 25 kg/m2 were much stronger, in the positive direction, than the 
associations in those who were overweight or obese. Overall, 1 kcal/g ED was 
associated with a waist circumference change of 0.17 cm/year [95% CI: 0.09, 0.25] and 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6-3a.      I2 = 58%, P for heterogeneity = 0.04 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6-3b.   I2 = 88%, P for heterogeneity < 0.001 
6-3a: for participants with BMI < 25 kg/m2 (n = 41,914);  
6-3b: for participants with baseline BMI ≥ 25 kg/m2 (n = 47,518) 
95% CI: 95% confidence interval of regression coefficients. Regression coefficients represent the annual weight change 
(g/year) for 1 kcal/g ED. The overall estimate was based on random-effect model. 
* Adjusted for follow-up time and baseline age, height and weight, smoking, physical activity, education, alcohol intake, 
menopausal status, hormone replace therapy use, and energy intake from beverages.  
Figure 6-3. Association of energy density with annual weight change by baseline BMI*. 
 
0.04 cm/year [95% CI: -0.10, 0.18] respectively in participants with BMI < 25 kg/m2 
(Figure 6-4a) and those with BMI ≥ 25 kg/m2 (Figure 6-4b). 
-312 0 312
Study center Weight change (g/year) (95% CI)
IT-Flo 110 (34, 186)
UK-Nor -165 (-312, -18)
NL-AmMa 36 (-29, 101)
NL-Doe -4 (-169, 161)
GER-Pot 53 (-10, 116)
DK-CopAa 18 (-23, 59)
Overall 29 (-19, 77)
-518 0 518
Study center Weight change (g/year) (95% CI)
IT-Flo -217 (-335, -99)
UK-Nor -351 (-518, -184)
NL-AmMa 7 (-89, 103)
NL-Doe -284 (-482, -86)
GER-Pot 64 (-16, 144)
DK-CopAa 46 (-7, 99)
Overall -103 (-223, 18)
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Associations remained essentially similar in all sensitivity analyses performed, 
including use un-calibrated dietary variables; use corrected anthropometric variables; 
exclude participants who developed type 2 diabetes, cancer, or CVD during follow-
up; and additionally adjust for individual food or nutrient variables which 
potentially mediate the effects of ED on weight and waist circumference change 
(results not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6-4a.      I2 = 71%, P for heterogeneity = 0.005 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6-4b.      I2 = 85%, P for heterogeneity < 0.001 
6-4a: for participants with BMI < 25 kg/m2 (n = 41,914) 
6-4b: for participants with baseline BMI ≥ 25 kg/m2 (n = 47,518) 
95% CI: 95% confidence interval of regression coefficients. Regression coefficients represent the annual waist 
circumference change (cm/year) for 1 kcal/g ED. The overall estimate was based on random-effect model. 
* Adjusted for follow-up time and baseline age, height, weight, and waist circumference, smoking, physical 
activity, education, alcohol intake, menopausal status, hormone replace therapy use, and energy intake from 
beverages.  
Figure 6-4. Association of energy density with annual waist circumference change by baseline BMI*. 
 
-0.44 0 0.44
Study center Waist change (cm/year) (95% CI)
IT-Flo 0.32 (0.20, 0.44)
UK-Nor -0.07 (-0.29, 0.15)
NL-AmMa 0.10 (0.02, 0.18)
NL-Doe 0.15 (-0.09, 0.39)
GER-Pot 0.17 (0.09, 0.25)
DK-CopAa 0.24 (0.16, 0.32)
Overall 0.17 (0.09, 0.25)
-0.64 0 0.64
Study center Waist change (cm/year) (95% CI)
IT-Flo 0.02 (-0.14, 0.18)
UK-Nor -0.02 (-0.24, 0.20)
NL-AmMa 0.07 (-0.05, 0.19)
NL-Doe -0.40 (-0.64, -0.16)
GER-Pot 0.17 (0.07, 0.27)
DK-CopAa 0.25 (0.17, 0.33)
Overall 0.04 (-0.10, 0.18)
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Discussion 
In this large multi-center prospective cohort study, we observed that a diet with a 
lower ED was associated with a lower intake of sugar and fats and a higher intake of 
fruits and vegetables. Higher ED was not associated with weight change but was 
positively associated with waist circumference change.  
The main strengths of our study are the large sample size and variation in dietary 
intake based on participants from five European countries, and the availability of 
information on important confounding variables and predictors of weight or waist 
circumference change such as physical activity, education level, changes in smoking 
status, menopausal status and HRT use. Some differences in methodologies used to 
collect anthropometric data at follow-up (weight and waist circumference were self-
reported instead of measured in four out of six centers) might have affected the 
results. However, in additional analyses, we corrected anthropometrics for clothing 
differences and self-reporting using previously developed methods in the EPIC 
study,24 but the associations of ED with changes in weight and waist circumference 
remained unchanged. We therefore opted to use the original uncorrected data in our 
analyses. Using FFQs to assess ED might be another limitation of the current study 
because FFQs, based on self-report of habitual food intake, may have inherent 
measurement error as well as bias from conscious or sub-conscious under-reporting 
or possible over-reporting of some food items. We addressed this in two ways. First, 
we used standardized 24-hour recall data to calibrate the FFQ measurements, 
thereby reducing potential measurement error. In addition, we also compared ED 
measured by the FFQ used in the two Dutch centers (NL-AmMa and NL-Doe) and 
the ED derived from the weighted average of multiple 24-hour recalls in a 
preliminary study. Spearman correlation coefficient was 0.64 in men and 0.56 in 
women (unpublished data), which indicated a good validity of the ED values 
measured by this FFQ.25, 26 
No clear consensus has been reached yet on the calculation of ED. A previous 
review of the literature identified 13 different calculation methods which mostly 
differed in the inclusion or exclusion of drinks, including free water, alcoholic 
beverages, energy-containing beverages, juice and milk.12, 16, 27 In the present study, 
we a priori decided to use the calculation method based on foods only but not 
drinks.28 Beverages add more weight than energy to diets, thereby lowering ED 
disproportionately. Furthermore, energy from drinks has only transient effects on 
satiation and does not influence habitual energy intake29. Also, beverage intake is 
highly variable and difficult to be estimated by any habitual diet assessment method. 
Previous studies indicated that including drinks into the ED calculation would dilute 
the associations of ED with both energy intake and changes of weight and waist 
circumference.16, 30 When comparing the mean ED of our study population with that 
of other populations calculated using a similar method, the average ED in the current 
study lies between the population average of Japan (1.4 kcal/g) and the US (1.9 kcal/g 
in men and 1.8 kcal/g in women).6, 28  
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The relationships of ED with energy, food and nutrient intake found in the 
current study are in agreement with previous findings.1, 13, 31, 32 This may imply a high 
quality profile of diets with a lower ED because diets lower in glycemic index and 
glycemic load, containing higher amounts of fruits, vegetables and fiber and lower 
amounts of sugar and fats, especially saturated fatty acids, are generally believed to 
be favorable for promoting human health.4, 33-35 It also provides a way for reducing 
ED, by consuming more fruits and vegetables and reducing sugar and fat 
consumption.  
The mechanism linking higher ED diet consumption and large gain in weight 
and waist circumference was speculated through increasing total energy intake. 
Therefore, we did not adjusted for total energy in our main analyses. However, 
when energy intake was added in the models in additional analyses, the association 
of ED with weight and waist circumference change was not essentially changed. This 
indicates that other aspects than lowering energy intake, such as reducing fat storage, 
is responsible for the observed effects. Furthermore, additional adjustment for 
individual nutrient factor such as total fat, saturated fatty acids, fiber, glycemic index 
or glycemic load did not alter the associations either. This may suggest that lower ED 
reflects a healthy dietary pattern rather than any individual dietary component.  
The absence of an association between ED and weight change in our current 
study are at variance with other prospective cohort studies that observed a positive 
association between ED and weight change. For example, in a longitudinal study of 
186 women in the US, women with higher ED gained more weight than women with 
lower ED (6.4 kg vs. 2.5 kg over 6 years).10 In two prospective studies among British 
children, a positive association between ED and body fat mass gain has been 
observed.13, 30 In the Nurses’ Health Study II, women who increased their dietary ED 
during follow-up the most (5th quintile) had a significantly greater weight gain than 
did those who decreased their dietary ED (1st quintile) (6.42 kg vs. 4.57 kg over 8 
years). However, weight gain was not different between women who maintained a 
lower ED and women who maintained a higher ED during follow-up.11 This latter 
non-significant finding was in accordance with the finding in the MONICA study12 
and our current study. As explained by the authors, participants with a constantly 
higher ED might compensate for the energy intake from higher ED diet. The weight 
gain for those participants may have already reached a steady state after long-term 
consumption of a higher ED diet.11 However, since the habitual diets of participants 
have only been measured once at baseline, it impossible to clarify this issue in the 
current study. Another difference between the current study and the previous 
studies is the wide age range of participants (20-78 years at baseline). Despite the fact 
that no interaction with age was found, it is possible that the speed of weight gain 
slowed down in older participants.  
This prospective cohort study showed a positive overall association between ED 
and waist circumference change, which was not addressed in the abovementioned 
studies.10-13 Although the association was rather weak, a waist circumference change 
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of 0.09 cm/year represents approximately 12% of the mean waist circumference 
change in this study population. Abdominal obesity, measured by waist 
circumference, is a more accurate predictor of cardio-metabolic risk than general 
obesity measured by BMI, probably because it more closely reflects body fatness.36 
The large variation in the annual waist circumference change (SD = 1.26 cm/year) 
may be partly responsible for the small magnitude observed. Because of the small 
average waist circumference change (0.76 cm/year) as compared to the large 
variation, it is impossible to detect a stronger association.37 The weak association 
between ED and waist circumference, and the absence of an association between ED 
and weight change, could also be due to selective underreporting, which means 
underreporting of unhealthy foods and over-reporting of healthy ones.38 This is a 
common problem in epidemiological studies and compromises the accuracy of 
habitual dietary intake data, especially among overweight or obese individuals.39 
This is in line with our findings that the ED was in the direction of positively 
associated with weight change in those participants with a healthy BMI at baseline, 
whereas was inversely in overweight or obese participants. Furthermore, there is 
evidence that underreporting is less waist-related than weight-related,40 which may 
be due to the higher awareness of the importance of a healthy BMI than a healthy 
waist circumference. Therefore the association between ED and waist circumference 
change may be less biased by the under-reporting.  
The high amount of heterogeneity observed in the current study, especially the 
unexpected inverse association between ED and changes in weight and waist 
circumference in UK-Nor and NL-Doe where the follow-up anthropometrics were 
measured, may also be related to underreporting. That is because we observed a 
smaller heterogeneity across study centers in those participants who had a healthy 
baseline BMI than in those participants who were overweight or obese at baseline. 
More importantly, the inverse associations between ED and changes in weight and 
waist circumference in UK-Nor and NL-Doe became less inverse or positive in 
participants who were not overweight at baseline. The heterogeneity could also be 
due to the differences in source population between study centers. For example, in 
IT-Flo, participants include a sample of the general population and women 
participating in a breast cancer screening program. The UK-Nor cohort comes from 
general practitioners in the Norfolk region.41 In NL-Doe, respondents from a pre-
existing cardiovascular disease risk factor monitoring project were invited.42 
Although in general there is no reason to assume a priori that these cohorts are 
different with respect to the association under study, subtle differences in 
underreporting of dietary intake, possibility of altering eating habits during follow-
up, and health conscious among sub-groups may exist. 
In conclusion, the findings of the current study suggests that diets with a lower 
ED, characterized by higher intake of fruits and vegetables and lower intake of sugar 
and fat, are not associated with weight gain but may have a beneficial, albeit weak, 
effect on the prevention of abdominal obesity.  
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Abstract 
Background: Dietary fiber may play a role in obesity prevention. So far, the role of 
fiber from different sources in weight change has rarely been studied.  
Objective: To investigate the association of total dietary fiber, cereal fiber, and fruit 
and vegetable fiber with changes of weight and waist circumference. 
Design: We conducted a prospective cohort study with 89,432 European participants, 
aged 20-78 years, free of cancer, CVD and diabetes at baseline, and followed for an 
average of 6.5 years. Dietary information was collected using validated country 
specific food frequency questionnaires. Multiple linear regression analysis was 
performed in each center and estimates were combined using random effect meta-
analyses. Adjustments were made for baseline anthropometric, demographic and 
lifestyle factors, follow-up duration and other dietary variables.  
Results: Total fiber was inversely associated with subsequent weight and waist 
change. For a 10 g/day higher total fiber intake, the pooled estimate was -39 g/year 
[95% confidence interval (CI): -71, -7] for weight change and -0.08 cm/year [95% CI: -
0.11, -0.05] for waist change. A 10 g/day higher fiber intake from cereals was 
associated with -77 g/year [95% CI: -127, -26] weight change and -0.10 cm/year [95% 
CI: -0.18, -0.02] waist change. Fruit and vegetable fiber was not associated with 
weight change, but had a similar association with waist change as compared to total 
dietary fiber and cereal fiber intake. 
Conclusion: Our results may support a beneficial role of higher intake of dietary 
fiber, especially cereal fiber, on preventing body weight and waist circumference 
gain. 
Fiber intake in relation to 
subsequent changes of 
weight and waist 
circumference in European 
men and women 
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Introduction 
Dietary fiber is defined as the edible parts of plant foods that are resistant to 
digestion and absorption in the human small intestine with complete or partial 
fermentation in the large intestine. It could facilitate body weight control through 
different physiological mechanisms.1 Firstly, fiber rich foods tend to be more 
satiating due to their relatively low energy density and palatability as compared to 
low fiber foods. Secondly, dietary fiber, especially soluble fiber, could increase the 
viscosity of diets and slow down the digestion, thus stimulate the release of gut 
hormones, such as cholecystokinin and glucagon-like peptide-1, and promote satiety. 
In addition, dietary fiber could provide a mechanical barrier to the enzymatic 
digestion of other macronutrients such as fat and starch in the small intestine. 
Moreover, the slower digestion and absorption rate of carbohydrates would lead to a  
reduced postprandial blood glucose response, which over a long term could improve 
insulin sensitivity and influence fuel partitioning to favor fat oxidation.1 Although 
not completely consistent, findings from well controlled intervention studies and 
large cohort studies support the beneficial role of dietary fiber on body weight 
regulation. For example, in a 24-week intervention study,  the addition of dietary 
fiber to a low-calorie diet has significantly increased weight loss.2 In the Nurses’ 
Health Study, women with higher increase in fiber intake have gained less body 
weight over 12 years.3  In the CARDIA study, high fiber intake has been associated 
with lower weight gain in 10 years.4  
However, fiber is not a homogeneous entity and its physiological effects depend 
on several factors including its origin or sources. For example, in the Health 
Professionals Follow-up Study, it has been observed that cereal fiber is more strongly 
inversely associated with the risk of myocardial infarction than fruit and vegetable 
fiber.5 In a meta-analysis of nine cohort studies, a high intake of cereal fiber, but not 
fruit and vegetable fiber, was significantly associated with a reduced risk of type 2 
diabetes.6 However, only one epidemiological study has compared the associations 
of fiber from different sources in relation to obesity so far, showing that increased 
intakes of fruit fiber and cereal fiber, but not vegetable fiber, were associated with 
less weight gain.7 
To investigate whether the intake of dietary fiber, in total and by food sources, is 
associated with long-term weight and waist circumference change, we conducted the 
current study in a population-based prospective cohort of Europeans. With the data 
from five different countries, this study provides a large range in dietary exposures. 
 
Participants and Methods 
Participants 
This study is a part of the DiOGenes project (acronym for “Diet, Obesity and 
Genes”), a multi-disciplinary European project targeting on obesity. Participants 
came from eight cities or counties within five European countries: Florence (Italy), 
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Norfolk (UK), Amsterdam, Maastricht and Doetinchem (The Netherlands), Potsdam 
(Germany), and Copenhagen and Aarhus (Denmark), taking part in the pre-existing 
European Prospective Investigation into Cancer and Nutrition (EPIC). EPIC study 
has been approved by local review board of all participating institutions. Written 
informed consent has been obtained from all participants before joining EPIC study. 
Detailed information on the study population and data collection has been described 
elsewhere.8 Of the 146,543 men and women who took part in the baseline 
examination during 1992-1998, 102,346 (69.8%) participated in the follow-up 
examination during 1998-2005. For the present study, the following exclusion criteria 
were applied: pregnancy at baseline or follow-up (n = 133), missing information on 
diet, anthropometrics or follow-up duration (n = 2,135), the ratio of energy intake (EI) 
to estimated basal metabolic rate (BMR) was in the top or bottom 1% of the entire 
EPIC population (n = 1,803), having unrealistic anthropometric measurements (n = 
331) and having chronic diseases including cancer, diabetes and CVD at baseline (n = 
8,512). In total, 89,432 participants, 42% men and 58% women, were included in the 
data analyses.  
 
Dietary assessments 
Country-specific validated food frequency questionnaires (FFQs) were self-
administered at baseline. Energy and nutrient intakes were calculated using country-
specific food composition tables.8 Regarding these food composition tables, the 
enzymatic-Gravimetric method adopted by the AOAC (Association of the Official 
Analytical Chemists) was used to define dietary fiber in countries except the UK, 
where dietary fiber was defined as non-starch polysaccharides (NSP) and was 
measured using the Englyst method.9, 10 For potatoes, legumes, cereals, cakes and 
biscuits, the AOAC value was re-calculated from the NSP value by multiplying 1.28 
and subtracting 0.02. For vegetables, fruits and fruit- and vegetable-based products, 
the AOAC and NSP values were assumed comparable due to the low amount of 
lignin and the absence of resistant starch.  
Total dietary fiber was the fiber intake from all foods and beverages. Validity of 
questionnaires on total fiber intake assessments has been documented previously. In 
short, the FFQs been validated against either 12 24-hour diet recalls (Italy, Germany 
and The Netherlands), 16 days weighted records (UK), or two times seven days of 
weighed diet records (Denmark). The validity coefficients ranged from 0.39 to 0.74.11-
13 Cereal fiber was calculated by summing the fiber intake from cereals and cereal 
products, which include rice, pasta, breads, biscuits, crackers, breakfast cereals and 
other products made of flour. Fruit and vegetable fiber was calculated as the sum of 
fiber intake from leafy vegetables, fruiting vegetables, root vegetables (excluding 
potatoes), cabbages, mushrooms, grain and pod vegetables, onion, garlic, stalk 
vegetables, sprouts, fruits, and olives. Contributions of individual food groups to the 
intake of cereal fiber and fruit and vegetable fiber by study center are presented in a 
supplementary table (S-Table 7-1). 
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Dietary glycemic index (GI) was calculated as the weighted average of GI values 
(based on the EPIC GI database14) of carbohydrate-containing foods consumed daily 
and dietary glycemic load (GL) was calculated by multiplying the GI by the amount 
of total carbohydrate intake divided by 100.  
To improve the comparability of dietary data collected using different FFQs and 
to adjust for measurement errors, a linear calibration was performed using a single 
24-hour dietary recall from a stratified random sample (n = 6,790) of the total EPIC 
participants as reference.15 These 24-hour dietary recall data were collected using a 
software program (EPIC-SOFT) specifically designed to standardize the dietary 
measurements across European populations. Nutrient intake from these 24-hour 
recall data were standardized using the European Nutrient Database (ENDB) 
developed within the EPIC study.  
Under-reporting of EI was estimated by EI:BMR < 1.1,16 where BMR was 
estimated using the Harris-Benedict equation.8  
 
Anthropometric measurements 
Information on body weight and waist circumference was collected at baseline 
and at the end of follow-up. Details of the methods used at baseline have been 
described previously.17 In short, all participants were measured by trained 
technicians for weight, height and waist circumference using standard study 
protocols. At follow-up, body weight and waist circumference of participants in 
Doetinchem (NL) and Norfolk (UK) were measured by trained technicians according 
to the same protocols as at baseline, while others provided self-reported weight and 
waist circumference. Annual changes in weight (g/year) and waist circumference 
(cm/year) were calculated by follow-up value minus baseline value, divided by the 
total years of follow-up. Due to differences in methods used to collect 
anthropometric information at follow-up and the length of follow-up time, 
participants from Doetinchem were treated separately from those from Amsterdam 
and Maastricht, while participants from Copenhagen and Aarhus were combined 
because no such differences between these two groups existed. Thus, six study 
centers were identified, namely Florence (IT-Flo, n = 8,266), Norfolk (UK-Nor, n = 
12,031), Amsterdam and Maastricht (NL-AmMa, n = 6,226), Doetinchem (NL-Doe, n 
= 3,964), Potsdam (GER-Pot, n = 14,746), and Copenhagen and Aarhus (DK-CopAa, n 
= 33,804). 
 
Other covariates  
Information on lifestyle was collected via self-administered questionnaires. 
Questions covered age, gender, education level, physical activity, smoking, 
menopausal status, and use of hormone replace therapy (HRT). Information on 
health status, including CVD, cancer and type 2 diabetes, was collected using either 
questionnaires or disease registries. Physical activity level was based on occupational 
and recreational activities and participants were classified as either inactive, 
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moderately inactive, moderately active, active, or unknown. Education level was 
indicated as the highest level of school achieved and participants were classified into 
primary school or less, technical-professional school, secondary school, university, or 
unknown. Using the information on smoking status at baseline and at follow-up, we 
classified participants into one of the following five categories: stable smoking, start 
smoking, quit smoking, not smoking, or unknown. 
 
Statistical methods 
The associations between fiber intake and changes in weight and waist 
circumference were examined using multivariable linear regression analyses. Center-
specific analyses were conducted, after which random effect meta-analyses were 
performed to detect heterogeneity among study centers (I2) and to calculate pooled 
estimates. This has the advantages of allowing for heterogeneity not only in the effect 
of the exposure but also the influence of the confounders,18 and also explicitly 
estimates the extent of heterogeneity and leads to a natural presentation of the 
results on a forest plot. Covariates included baseline age (years), gender, weight (kg), 
height (cm) and waist circumference (cm, for waist circumference change analyses 
only), smoking, physical activity, education level, follow-up duration (years), alcohol 
intake (non drinker, 0.1 - 4.9 g/day, 4.9 - 15 g/day, 15 - 30 g/day, 30 - 60 g/day, > 60 
g/day), GI, and the intake of protein, fat and carbohydrates. Additionally, for women, 
analyses were also adjusted for menopausal status (postmenopausal yes/no) and 
hormone use (yes/no or unknown). Analyses of cereal fiber were also adjusted for 
fruit and vegetable fiber and fiber from other sources, such as potatoes, legumes and 
nuts. As fruit fiber and vegetable fiber had similar associations with weight and 
waist circumference change, they were combined into fruit and vegetable fiber. 
Analyses of fruit and vegetable fiber were also adjusted for cereal fiber and fiber 
from other sources. All dietary variables included in the analyses were calibrated 
and were adjusted for total energy intake using the residual method.  
Interaction of fiber intake with age, gender, baseline BMI, smoking, duration of 
follow-up, and EI: BMR was investigated by introducing product terms into the 
model. A two-sided P < 0.05 was considered statistically significant in the analyses of 
main effects, whereas P < 0.01 in at least three, out of the six, study centers was 
considered statistically significant when testing for interaction.  
Sensitivity analyses were performed for the main analyses, including using un-
calibrated dietary variables, using anthropometrics correcting for clothing and self-
report, and excluding those participants who developed cancer, type 2 diabetes or 
CVD during follow-up. Except for the random effect meta-analyses, which were 
conducted using STATA 8.2 (StataCorp, Texas, USA), all other statistical analyses 
were performed using SAS 9.1 (SAS, Institute, Cary, NC). 
 
Results 
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Table 7-1. Description of study population (n = 89,432). 
Total fiber intake  
(g/day) 
Cereal fiber intake  
(g/day) 
Fruit and vegetable fiber 
(g/day) 
Study 
Center 
Men Women Men Women Men Women 
IT-Flo 27.1 ± 5.5 20.7 ± 3.0 10.4 ± 2.2 6.6 ± 1.1 11.7 ± 2.6 10.2 ± 2.0 
UK-Nor 20.5 ± 2.9 17.2 ± 2.0 8.4 ± 1.6 7.0 ± 1.3 5.6 ± 1.9 5.6 ± 1.0 
NL-AmMa    25.6 ± 6.3 20.6 ± 4.4 11.7 ± 3.9 8.0 ± 2.7 6.1 ± 1.6 6.5 ± 2.2 
NL-Doe 27.0 ± 5.9 21.0 ± 5.1 11.0 ± 3.8 7.9 ± 2.6 7.2 ± 2.4 6.9 ± 2.7 
GER-Pot 23.9 ± 3.9 21.0 ± 3.2 9.1 ± 2.2 7.0 ± 1.3 8.1 ± 1.9 8.8 ± 2.2 
DK-CopAa      26.3 ± 5.3 23.1 ± 4.8 15.7 ± 3.8 12.5 ± 2.8 6.4 ± 2.7 7.4 ± 2.8 
Overall 25.0 ± 5.4 21.3 ± 4.4 12.6 ± 4.6 9.3 ± 3.5 6.9 ± 2.8 7.7 ± 2.7 
Baseline BMI 
(kg/m2) 
Baseline waist 
circumference (cm) 
Baseline age  
(years) 
 
Men Women Men Women Men Women 
IT-Flo 26.1 ± 3.2 25.0 ± 3.9 90 ± 8.9 77 ± 9.5 51 ± 7.2 52 ± 7.7 
UK-Nor 26.3 ± 3.1 25.8 ± 4.0 95 ± 9.3 81 ± 10.1 59 ± 8.9 58 ± 8.9 
NL-AmMa 25.5 ± 3.4 24.4 ± 3.8 91 ± 10.4 78 ± 9.7 43 ± 10.4 42 ± 10.6 
NL-Doe 26.0 ± 3.0 25.4 ± 4.0 95 ± 9.0 86 ± 10.7 46 ± 9.7 46 ± 9.8 
GER-Pot 26.7 ± 3.4 25.5 ± 4.4 94 ± 9.6 80 ± 10.9 52 ± 7.8 49 ± 9.2 
DK-CopAa 26.3 ± 3.4 25.4 ± 4.2 95 ± 9.4 81 ± 10.7 56 ± 4.3 56 ± 4.4 
Overall 26.3 ± 3.3 25.3 ± 4.1 94 ± 9.6 80 ± 10.6 54 ± 8.2 53 ± 8.8 
Weight change 
(g/year) 
Waist circumference 
change (cm/year) 
Follow-up duration 
(years) 
 
Men Women Men Women Men Women 
IT-Flo 128 ± 554 174 ± 546 0.75 ± 0.7 0.87 ± 0.8 9.4 ± 1.1 9.4 ± 1.1 
UK-Nor 362 ± 1017 383 ± 1095 0.22 ± 1.5 0.22 ± 1.6 3.7 ± 0.7 3.7 ± 0.7 
NL-AmMa 146 ± 599 177 ± 624 0.56 ± 0.8 0.69 ± 0.8 10.0 ± 1.4 9.9 ± 1.5 
NL-Doe 433 ± 833 447 ± 939 0.59 ± 1.0 0.56 ± 1.4 5.0 ± 0.2 5.0 ± 0.2 
GER-Pot 146 ± 613 205 ± 648 0.64 ± 0.7 0.84 ± 0.8 8.7 ± 0.8 8.6 ± 0.8 
DK-CopAa -25 ± 832 -72 ± 841 0.51 ± 1.2 1.33 ± 1.5 5.4 ± 0.3 5.4 ± 0.3 
Overall 109 ± 817 119 ± 823 0.51 ± 1.1 0.94 ± 1.3 6.2 ± 2.2 6.6 ± 2.3 
Values presented are mean ± standard deviation. 
 
Participants had a mean age of 53 years (range: 20-78 years) at baseline and were 
followed for an average of 6.5 years (range: 1.9-12.5 years). Fiber consumption varied 
across study centers and between genders (Table 7-1). Total dietary fiber intake was 
the lowest in UK-Nor (20.5 g/day and 17.2 g/day for men and women respectively). 
Danish participants had the highest cereal fiber consumption (15.7 g/day for men 
and 12.5 g/day for women), while Italian participants had the highest fruit and 
vegetable fiber intake (11.7 g/day for men and 10.2 g/day for women). Annual weight 
change was higher in NL-Doe (433 g/day for men and 447 g/year for women) and 
UK-Nor (362 g/year for men and 383 g/year for women) than in other centers. 
Annual waist circumference change was the lowest in UK-Nor (0.22 cm/year) and 
highest in men from IT-Flo (0.75 cm/year) and women from DK-CopAa (1.33 
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cm/year). Baseline BMI was similar except in NL-AmMa, where participants’ BMI 
was about 1 kg/m2 lower.  
 
Table 7-2. Characteristics by quintiles of cereal fiber and fruit and vegetable fiber intake  
(n = 89,432)*. 
By cereal fiber By fruit & vegetable 
fiber  
 
Overall 
Q1 Q3 Q5 Q1 Q3 Q5 
Total fiber intake, g/d 22.8 ± 5.2 18.4 22.2 28.9 19.9 22.8 26.6 
Cereal fiber intake, g/d 10.7 ± 4.3 5.9 9.9 17.5 11.5 10.8 10.2 
Fruit & vegetable fiber intake, g/d   7.4 ± 2.8 7.9 7.2 7.0 4.0 7.0 11.6 
Baseline age, yrs 53 ± 8.6 52 53 55 53 53 53 
Gender, % men 42 13 44 71 55 42 32 
Follow-up duration, yrs  6.5 ± 2.2 7.5 6.5 5.6 5.4 6.5 7.6 
Baseline weight, kg  73.4±13.5 69.0 73.9 77.6 75.2 73.7 71.9 
Baseline BMI, kg/m2  25.7 ± 3.8 26.1 25.7 25.5 25.9 25.6 25.7 
Overweight†, % 41 41 41 41‡ 43 40 40 
Obesity§, % 12 15 12 10 13 12 12 
Baseline waist, cm 86.2 ± 12.3 82.6 86.6 89.8 88.8 86.3 84.1 
Total energy intake, kcal/day 2200±460 1828 2211 2594 2234 2217 2196 
Fat, en %  35.6 ± 3.6 34.6 35.5 37.0 35.9 36.1 34.7 
Protein, en%  15.1 ± 1.4 15.7 15.1 14.5 15.1 14.9 15.3 
Carbohydrates, en %  43.1 ± 4.4 44.9 42.6 41.6 40.8 42.7 45.6 
Glycemic index║ 57 ± 2.6 55 57 59 59 57 55 
Glycemic load║ 134 ± 29 113 134 158 133 134 139 
Smoking status, % nonsmokers  71 74 71 66 60 73 77 
Education, % university  23 19 24 26 16 26 25 
Physical activity, % active 26 15 26 40 27 25 28‡ 
Post-menopausal women¶, %  57 34 59 74 52 56 62 
Hormone-use women¶, % 21 13 21 28 21 22 20 
* Values presented are mean ± standard deviation, mean or percentages. P for trend was tested using generalized 
linear regression (continuous variables) or logistic regression (categorical variables)  
† 25 kg/m2 ≤ BMI < 30 kg/m2   ‡ P for trend > 0.05, all others P < 0.05   § BMI ≥ 30 kg/m2 
║ Glycemic index of glucose = 100 ¶  Number of women = 52,307 
 
Participants in the higher quintile of cereal fiber intake had higher total fiber 
intake and lower fruit and vegetable fiber intake (Table 7-2). Likewise, with 
increasing intake of fruit and vegetable fiber, total fiber intake increased but cereal 
fiber intake decreased. Participants with higher cereal fiber intake were more often 
men, more often smokers, more physically active and had a higher level of education. 
Participants with higher fruit and vegetable fiber intake were more often women, 
often non-smokers and also had a higher education level. Dietary GI increased with 
the increase of cereal fiber, but decreased with the increase of fruit and vegetable 
fiber. 
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None of the potential effect modifiers investigated, including gender, age, 
baseline BMI, smoking, duration of follow-up, and EI:BMR, altered the association 
between fiber and annual changes of weight and waist circumference. Therefore, 
men and women were combined in the subsequent analyses. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7-1a.      I2 = 67%, P for heterogeneity = 0.01 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7-1b.      I2 = 35%, P for heterogeneity = 0.2 
* Values presented are regression coefficients (95% CI) of a 10 g/day total fiber intake with weight (7-1a) and 
waist circumference (7-1b) change. 
Analyses were adjusted for baseline age, weight and height, gender, smoking, education, physical activity, 
follow-up duration, alcohol consumption, the intake of fat, carbohydrates, protein, glycemic index, and, for 
women, menopausal status and use of hormone replacement therapy. For waist circumference change analyses, 
baseline waist circumference was also adjusted for. Overall estimates were based on random effect models. 
Figure 7-1. Associations between total fiber intake and changes in weight and waist circumference*. 
 
After the adjustment for potential confounders, total dietary fiber intake was 
inversely associated with annual weight change in four out of six study centers. 
When the effects in six study centers were combined, 10 g/day of total dietary fiber 
0-144 144
Study center Weight change (g/year) (95% CI)
IT-Flo 10 (-34, 54)
UK-Nor -35 (-144, 75)
NL-AmMa -45 (-83, -7)
NL-Doe 14 (-54, 83)
GER-Pot -74 (-114, -34)
DK-CopAa -73 (-98, -48)
Overall -39 (-71, -7)
0-0.37 0.37
Study center Waist change (cm/year) (95% CI)
IT-Flo -0.06 (-0.12, -0.00)
UK-Nor -0.22 (-0.37, -0.07)
NL-AmMa -0.06 (-0.11, -0.02)
NL-Doe -0.03 (-0.12, 0.06)
GER-Pot -0.11 (-0.15, -0.06)
DK-CopAa -0.10 (-0.14, -0.06)
Overall -0.08 (-0.11, -0.05)
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intake was associated with an annual weight change of -39 g/year [95% confidence 
interval (CI): -71, -7] (Figure 7-1a). This amount of weight change corresponds to a 
BMI change of about 0.013 kg/m2 in our study population (mean height = 1.69 meter).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7-2a.      I2 = 67%, P for heterogeneity = 0.01 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7-2b.      I2 = 80%, P for heterogeneity < 0.001 
* Values presented are regression coefficients (95% CI) of a 10 g/day cereal fiber intake with weight (7-2a) and 
waist circumference (7-2b) change. 
Analyses were adjusted for baseline age, weight and height, gender, smoking, education, physical activity, 
follow-up duration, alcohol consumption, the intake of fat, carbohydrates, protein, glycemic index, fruit and 
vegetable fiber, fiber from other sources, and, for women, menopausal status and use of hormone replacement 
therapy. For waist circumference change analyses, baseline waist circumference was also adjusted for.  
Overall estimates were based on random effect models. 
Figure 7-2. Associations between cereal fiber intake and changes in weight and waist circumference*. 
 
A significant amount of heterogeneity was observed (I2 = 67%, P for heterogeneity = 
0.01). In addition, total dietary fiber intake was inversely associated with waist 
circumference change in all study centers. For 10 g/day of total dietary fiber, the 
-239 0 239
Study center Weight change (g/year) (95% CI)
IT-Flo 60 (-37, 156)
UK-Nor -86 (-239, 68)
NL-AmMa -119 (-175, -62)
NL-Doe -17 (-123, 89)
GER-Pot -145 (-207, -84)
DK-CopAa -90 (-123, -56)
Overall -77 (-127, -26)
-0.48 0 0.48
Study center Waist change (cm/year) (95% CI)
IT-Flo 0.06 (-0.06, 0.19)
UK-Nor -0.27 (-0.48, -0.07)
NL-AmMa -0.15 (-0.21, -0.08)
NL-Doe -0.14 (-0.28, -0.01)
GER-Pot -0.16 (-0.23, -0.08)
DK-CopAa -0.00 (-0.06, 0.05)
Overall -0.10 (-0.18, -0.02)
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annual waist circumference change was -0.08 cm/year [95% CI: -0.11, -0.05]. The 
heterogeneity across study centers was not significant (I2 = 35%, P for heterogeneity = 
0.2) (Figure 7-1b). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7-3a.      I2 = 55%, P for heterogeneity = 0.05 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7-3b.      I2 = 70%, P for heterogeneity = 0.005 
* Values presented are regression coefficients (95% CI) for a 10 g/day of fruit and vegetable fiber intake with 
weight (7-3a) and waist circumference (7-3b) change. 
Analyses were adjusted for baseline age, weight and height, gender, smoking, education, physical activity, 
follow-up duration, alcohol consumption, the intake of fat, carbohydrates, protein, glycemic index, cereal fiber, 
fiber from other sources and, for women, menopausal status and use of hormone replacement therapy. For waist 
circumference change analyses, baseline waist circumference was also adjusted for.  
Overall estimates were based on random effect models. 
Figure 7-3. Associations of fruit and vegetable fiber intake with changes in weight and waist 
circumference*. 
 
After adjusting for fruit and vegetable fiber and fiber from other sources in 
addition to the other confounding factors, cereal fiber intake was inversely 
-234 0 234
Study center Weight change (g/year) (95% CI)
IT-Flo 23 (-36, 82)
UK-Nor 38 (-115, 191)
NL-AmMa 27 (-55, 110)
NL-Doe 117 (-0.1, 234)
GER-Pot -31 (-82, 20)
DK-CopAa -47 (-84, -10)
Overall 2 (-40, 44)
-0.27 0 0.27
Study center Waist change (cm/year) (95% CI)
IT-Flo -0.10 (-0.18, -0.02)
UK-Nor -0.06 (-0.27, 0.14)
NL-AmMa -0.07 (-0.17, 0.03)
NL-Doe 0.12 (-0.03, 0.27)
GER-Pot -0.09 (-0.15, -0.03)
DK-CopAa -0.18 (-0.24, -0.12)
Overall -0.08 (-0.15, -0.01)
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associated with weight and waist circumference change except in IT-Flo. On average, 
a 10 g/day cereal fiber was associated with an annual weight change of -77 g/year 
[95% CI: -127, -26] (I2 = 38%, P for heterogeneity = 0.01) (Figure 7-2a) and an annual 
waist circumference of -0.10 cm/year [95% CI: -0.18, -0.02] (I2 = 80%, P for 
heterogeneity < 0.001) (Figure 7-2b). 
Fruit and vegetable fiber intake was positively associated with weight change in 
four study centers, and inversely associated with waist change in five centers. The 
pooled estimate of association between 10 g/day of fruit and vegetable fiber and 
weight change was 2 g/year [95% CI: -40, 44] (I2 = 55%, P for heterogeneity = 0.05) 
(Figure 7-3a) and for waist circumference change -0.08 cm/year [95% CI: -0.15, -0.01] 
(I2 = 70%, P for heterogeneity = 0.005) (Figure 7-3b). 
Sensitivity analyses, including use of un-calibrated dietary variables, use of 
anthropometric data corrected for clothing and self-report, and exclusion of 
participants with incident cancer, type 2 diabetes or CVD during follow-up, did not 
essentially alter the results. Fiber from potatoes, nuts and legumes were not 
significantly associated with subsequent changes of weight or waist circumference. 
Including potato fiber into the fruit and vegetable fiber did not essentially change the 
results (data not shown). 
 
Discussion 
In this prospective cohort study, we observed an inverse association of total 
dietary fiber and cereal fiber intake with subsequent weight and waist circumference 
change. The intake of fruit and vegetable fiber was not appreciably associated with 
weight change, but had a similar inverse association with waist circumference 
change as compared to total dietary fiber and cereal fiber. 
The main strengths of the current study are the large sample size and the large 
variation of fiber intake among participants from five different European countries. 
Utmost care has been made to standardize the measurements across all EPIC centers, 
for example by using calibrated dietary variables based on 24-hour dietary recall 
data collected using a uniform system, the related standardized nutrient database, 
and the standardized potential confounding variables such as education level and 
physical activity. A limitation of the study is the difference in methodologies used to 
collect anthropometric data at follow-up, as weight and waist circumference 
measurements at follow-up were self-reported instead of measured in four out of six 
study centers. We tried to overcome this by correcting for clothing differences and 
self-report using previously developed methods in the EPIC study.19 However, the 
results remained unchanged. We therefore used the uncorrected data and took the 
methodological differences into account by using random effect meta-analyses. 
Dietary information was collected only once at baseline, which excluded the 
possibility to investigate the concurrent association between changes in fiber intake 
and changes in weight and waist circumference. 
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Findings from several observational and intervention studies support a beneficial 
role of total dietary fiber intake on maintaining a healthy body weight,20 promoting 
weight loss,2, 21 and preventing weight gain.3, 4 Postulated physiological mechanisms 
by which dietary fiber helps in weight and waist circumference management have 
been summarized by Pereira and Ludwig previously.1 In brief, high fiber diets are 
more satiating, could lead to a reduced energy intake; fiber could limit the access of 
other nutrients to digestive enzymes; increasing fiber intake could improve insulin 
sensitivity and stimulate fat oxidation. All these aspects benefit weight control. Our 
finding on the protective role of higher total and cereal fiber intake in preventing 
long-term weight and waist circumference gain was in line with these previous 
findings,3, 4, 7 although randomized controlled trials on weight loss so far yield less 
consistent results.22 Although we observed a small effect when judged on the 
individual level, the effect of fiber on weight change observed in our study may be of 
public health relevance. A weight change of 39 g/year (for 10 g/day of fiber intake) 
represents approximately 34% of the mean weight change in this study population 
(115 g/year). Assuming the average absolute real annual weight gain is 400 g (≈ the 
mean in UK-Nor and NL-Doe), 10 g/day higher total dietary fiber intake would 
prevent about 10% of weight gain. As the daily fiber intake was only about 23 g/day 
among participants of the current study, a 10 g/day increment would increase the 
average intake close to the recommended level of 35 g/day. 
We observed moderate to large amount of heterogeneity across study centers 
and the reason for this is not completely known. Changes in weight and waist 
circumference were measured differently in some study centers. However, using 
available methods correcting these differences did not eliminate or reduce the 
heterogeneity. Despite the study is population-based in general, sources of study 
populations were slightly different between study centers.8 In general, we have no 
reasons to assume a priori that the relation between fiber intake and weight and 
waist circumference gain should be substantially different in the populations. 
However, subtle differences in misreporting of dietary intake and health 
consciousness among cohorts may exist. We therefore applied the current meta-
analytical approach to analyze the associations first in each study center and then to 
obtain the pooled estimates using random effect models. The pooled estimates across 
study center represent the average level of effects. 
Distinguishing the effects of fiber from different sources on weight and waist 
circumference gain is potentially important for formulating public health guidelines. 
At present, the benefits of increased fiber intake in the prevention and treatment of 
obesity and associate diseases such as CVD and type 2 diabetes mainly focuses on 
soluble fiber, coming mainly from fruits and vegetables. That is because the high 
viscosity of soluble fiber could facilitate the slowing down of gastric empty and the 
absorption of macronutrients.7, 23 However, epidemiological studies in contrast show 
that cereal fiber, principally insoluble fiber, appear to offer protection from CVD and 
diabetes.5, 6, 24 Only one prospective cohort study has previously compared the effects 
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of cereal fiber, fruit fiber and vegetable fiber on subsequent weight change.7 Among 
27,082 male US health professionals aged 40-75 years, significant inverse associations 
of weight change with concurrent change in intake of total dietary fiber, cereal fiber, 
and fruit fiber, but not for vegetable fiber, were observed.7 This agrees with our 
findings on total and cereal fiber. However, the fruit and vegetable fiber in our study 
was not significantly associated with weight change. We combined the fiber from 
fruits and vegetables (not potatoes) because their associations with weight and waist 
circumference change were similar. This seems in conflict with the findings from an 
earlier analysis of the same data25 and other previous studies26, 27 showing a benefits 
of fruit and vegetable intake in body weight control. However, our findings do not 
exclude the possibility that fruits and vegetables protect against weight gain through 
other nutrients, such as reduced energy density of the diet, a decreased dietary GI, 
reduced total fat intake, or all these non-fiber aspects combined. 
We found a more pronounced protective effect of cereal fiber, which is mainly 
insoluble, on weight gain as compared to fruit and vegetable fiber, which is more 
soluble. Several explanations could be responsible for this finding. First, it could be 
due to misreporting. Fruits and vegetables are considered as healthy, therefore are 
prone to being over reported by study participants, especially among those who had 
lower intake or who were obese. Because misreporting may be more weight-related 
than waist circumference-related,28 the association of fruit and vegetable 
consumption with weight change is more likely to be biased than the association 
with waist circumference change. Secondly, cereal fiber is likely to be a marker of 
whole-grain foods,6 which have been shown to be associated with a lower BMI and 
central obesity in a meta-analysis including 15 cross-sectional or cohort studies.29 As 
compared to fruits and vegetables, whole grains contain more resistant starch, 
phytoestrogens and antioxidants including vitamins and trace minerals, such as 
calcium, potassium and magnesium, which all may have an effect on body weight.6, 
29, 30 Furthermore, the main components of cereal fiber are cellulose and hemi-
cellulose, which may have distinct effects on weight regulation. For example, in a 
randomized trial comparing the effects of pectin, cellulose and lignin on stool 
characteristics, only cellulose significantly decreased mean stool transit time and 
increased mean wet stool weight.31 The role of fiber fermentation, especially of 
soluble fiber, and its products short chain fatty acids (SCFA) in body weight 
regulation also deserves consideration and further exploration. SCFA could 
stimulate satiety and improve insulin sensitivity, thus exert a beneficial role on body 
weight regulation.1 On the other hand, part of the SCFA could be absorbed into the 
bloodstream and used as an energy source.32 
Overall, we found a small but statistically significant inverse association of total 
and cereal fiber with changes in both weight and waist circumference and of fruit 
and vegetable fiber with changes in waist circumference, but not weight. These 
findings may support that a higher intake of fiber, especially of cereal fiber, is 
beneficial for preventing (abdominal) obesity. 
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S-Table 7-1. Relative contribution of food groups to intake of cereal fiber and fruit & vegetable fiber*.  
Food groups IT-Flo UK-Nor NL-AmMa NL-Doe GER-Pot DK-CopAa 
Men                                                                                          Cereal fiber 
Flour and starches - 0.2% - - 0.1% 1.6% 
Pasta, rice, and other grains 28.5% 7.8% 5.9% 5.0% 2.5% 2.6% 
Breads 67.7% 60.2% 86.6% 87.8% 95.6% 86.5% 
Breakfast cereals - 24.7% 2.6% 2.5% 0.6% 8.6% 
Biscuits and cracker 0.4% 6.6% 3.4% 3.5% 0.6% 0.7% 
Dough and pastry 3.5% 0.3% 1.5% 1.2% 0.6% - 
Fruit and vegetable fiber 
Leafy vegetables  7.1% 1.3% 10.9% 12.3% 3.0% 0.8% 
Fruiting vegetables 14.0% 7.4% 16.5% 14.5% 16.2% 9.2% 
Root vegetables 4.2% 12.0% 7.2% 8.2% 7.3% 7.0% 
Cabbages 1.3% 15.6% 9.8% 8.8% 9.8% 6.9% 
Mushrooms 1.3% 2.0% 1.3% 0.8% 1.6% 5.8% 
Grain and pod vegetables 6.5% 18.4% 5.8% 6.1% 5.1% 3.6% 
Onion and garlic 1.4% 5.3% 1.1% 0.8% 1.5% 8.8% 
Stalk vegetables, sprouts 2.7% 3.0% 4.2% 3.2% 2.2% 3.1% 
Salad and mixed vegetables 1.0% - - - 4.9% 13.2% 
Fruits 57.2% 33.4% 43.2% 45.4% 47.1% 41.5% 
Mixed fruits 3.3% 1.6% - - 1.4% - 
Olives - - 0.1% 0.05% - - 
Women                                                                                     Cereal fiber 
Flour and starches - 0.2% - - 0.1% 1.6% 
Pasta, rice, and other grains 20.9% 9.3% 6.0% 5.1% 2.9% 2.3% 
Breads 73.7% 58.3% 84.5% 86.1% 94.7% 86.3% 
Breakfast cereals - 26.9% 3.4% 2.9% 1.0% 9.1% 
Biscuits and cracker 0.7% 4.8% 4.4% 4.6% 0.6% 0.7% 
Dough and pastry 4.6% 0.4% 1.8% 1.3% 0.6% - 
                                    Fruit and vegetable fiber 
Leafy vegetables  6.8% 1.5% 10.1% 11.6% 3.3% 0.5% 
Fruiting vegetables 14.4% 7.4% 15.6% 13.2% 16.1% 8.4% 
Root vegetables 4.7% 11.6% 7.4% 8.1% 7.5% 9.5% 
Cabbages 1.4% 15.2% 9.5% 8.5% 8.8% 5.8% 
Mushrooms 1.1% 1.9% 1.2% 0.8% 1.3% 3.8% 
Grain and pod vegetables 6.0% 15.2% 4.2% 4.3% 3.7% 2.9% 
Onion and garlic 1.4% 5.1% 1.1% 0.8% 1.0% 7.0% 
Stalk vegetables, sprouts 3.2% 3.2% 4.5% 3.5% 2.1% 2.3% 
Salad and mixed vegetables 0.7% - - - 4.1% 12.4% 
Fruits 57.4% 37.7% 46.5% 49.1% 51.1% 47.5% 
Mixed fruits 2.8% 1.1% - - 0.9% - 
Olives - - 0.1% 0.04% - - 
* Sums may not be 100% due to rounding errors. Missing means those food groups were not asked in those countries. 
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Abstract 
Background: Regulation of energy intake plays a critical role in obesity development. 
However, little is known about whether single nucleotide polymorphisms (SNPs) in 
this pathway are associated with weight and waist change, and whether dietary 
factors could modify their impacts.  
Objective: To investigate the associations of SNPs in or near 15 candidate genes 
involved in the hypothalamus pathway with subsequent changes in weight and 
waist circumference, and to explore potential interactions of these SNPs with the 
dietary glycemic index (GI).  
Design: Case-cohort study with participants from five European countries. 
Methods: Cases (n = 6,000) were selected from the total eligible cohort (n = 50,293) as 
those with the greatest unexplained annual weight gain during follow-up. A random 
sample (n = 7,061) was drawn with the intention to obtain an equal number of cases 
and non cases. Using the Illumina® platform, 134 SNPs were genotyped to capture 
the complete genetic variation across candidate genes, of which 123 were 
successfully genotyped. Logistic regression analyses were conducted to determine 
the additive effects of the minor alleles of each SNP on the case-non case status. 
Among the random sample, linear regression analyses were performed to evaluate 
the associations between the minor alleles and changes in weight (g/year) and waist 
circumference (cm/year) assuming additive genetic models. Interactions between 
SNPs and dietary GI were tested by including the cross product terms in the 
regression models. The false discovery rate method was used to adjust for multiple 
testing. 
Results: None of the SNPs under investigation showed a significant main effect on 
weight or waist change after correction for multiple comparisons. However, in the 
linear regression analyses, for both weight and waist change the rs7180849 SNP, a 
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variant near the neuromedin β gene, showed a significant interaction with dietary GI 
(P = 3×10-5 and 5×10-5, Q = 0.004 and 0.006 respectively). 
Conclusion: None of the SNPs in or near the 15 candidate genes involved in the 
hypothalamic regulation of energy intake had a direct association with weight and 
waist change. Individuals carrying the minor allele of the rs7180849 SNP seemed to 
have gained more weight and waist circumference when consuming a high GI diet 
than non-carriers. When confirmed, following a low GI diet might be particularly 
important for these people to prevent (abdominal) obesity. 
 
* Co-authors in alphabetic order:  
D. L. van der A (National Institute for Public Health and the Environment 
(RIVM), The Netherlands) 
L. Ängquist   (Institute of Preventive Medicine, Copenhagen University 
Hospital, Centre for Health and Society, Denmark) 
H. Boeing (Department of Epidemiology, German Institute of Human 
Nutrition, Germany) 
E.J.M. Feskens  (Division of Human Nutrition, Wageningen University, The 
Netherlands) 
C. Holst   (Institute of Preventive Medicine, Copenhagen University 
Hospital, Centre for Health and Society, Denmark) 
R.J.F. Loos  (MRC Epidemiology Unit, Institute of Medical Science, UK) 
K. Overvad (Department of Cardiology and Clinical Epidemiology, Aarhus 
University Hospital, Denmark) 
D. Palli (Molecular and Nutritional Epidemiology Unit, Cancer Research 
and Prevention Institute (ISPO), Italy) 
V. Santhanakrishnan (MRC Epidemiology Unit, Institute of Medical Science, UK) 
W. H.M. Saris  (Department of Human Biology, Nutrition and Toxicology 
Research Institute of Maastricht (NUTRIM), The Netherlands) 
T. I. A. Sørensen   (Institute of Preventive Medicine, Copenhagen University 
Hospital, Centre for Health and Society, Denmark) 
A. Tjønneland  (Danish Cancer Society, Institute of Cancer Epidemiology, 
Copenhagen, Denmark) 
N. Wareham (MRC Epidemiology Unit, Institute of Medical Science, UK) 
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Introduction 
The prevalence of obesity is rising worldwide. This epidemic is likely to be a 
consequence of modernization, which yields palatable and easily available high-
caloric foods and promotes a sedentary lifestyle. During the past decades, a myriad 
of dietary factors have been investigated for their potential association with weight 
change or obesity, such as dietary glycemic index (GI), which is an indicator 
classifying carbohydrate containing foods based on the blood glucose response after 
consumption.1 Although not completely consistent, findings from clinical 
intervention studies and epidemiological studies in general suggest that diets low in 
GI are beneficial in obesity prevention and weight control.1-4 One of the most 
plausible mechanisms seems to be that low GI diets could enhance satiation and 
satiety, leading to a decreased energy intake, thus prevent weight gain and promote 
weight loss.4, 5 Consistent with this, previous work within the DiOGenes study has 
shown that a higher dietary GI is associated with greater enlargement in waist 
circumference.6  
Dietary factors, however, can not fully explain the susceptibility to obesity. 
Evidence from family, twin and adoption studies has indicated a heritable 
component of obesity ranging from 40% to 70%.7 The 2005 update of the human 
obesity gene map has revealed 127 genes associated with human obesity.8, 9 Some of 
these obesity genes are involved in the hypothalamic signaling network, consist of 
gastrointestinal, adiposity, and hypothalamic signals, which plays a critical role in 
the regulation of food intake.8-10 For example, many studies have reported an 
association of common variants in the leptin and leptin receptor gene with BMI or 
obesity status.9 In a large group of Caucasian families, common polymorphisms 
within the ghrelin receptor gene region have been associated with obesity and this 
finding has been replicated in a general population.11 A number of studies, including 
a recent genome-wide association study, have associated melanocortin-4 receptor 
(MC4R) gene variants with obesity9, 12 In contrast to the large number of studies 
investigating the genetic influence of BMI or obesity status, few attempts have been 
made at identifying genetic variants for changes of weight and waist circumference 
in adults.9, 13  
The aim of the current case-cohort study was to investigate whether SNPs within 
or near genes involved in food intake regulation are associated with subsequent 
weight and waist gain and to examine their potential interaction with dietary GI. The 
results will be of relevance for both understanding the etiology of weight (waist) 
gain and tailoring dietary prevention interventions on obesity.  
 
Methods 
Participants 
Participants came from eight cities or counties within five European countries 
participating in the European Prospective Investigation into Cancer and Nutrition 
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(EPIC) study, which are Florence (Italy), Norfolk (UK), Amsterdam, Maastricht and 
Doetinchem (The Netherlands), Potsdam (Germany), Copenhagen and Aarhus 
(Denmark).14 We selected those who were younger than 60 years at baseline and 
younger than 65 years at follow-up, who had a blood sample available and had 
baseline information on diet, weight and height, and follow-up information on 
weight, who had stable smoking habits, had no previous diagnosis of cancer, 
cardiovascular diseases (CVD), and diabetes at baseline and during follow-up, and 
had an annual weight change not higher than 5 kg/year. In total 50,293 men and 
women were included in the eligible cohort.  
Cases were defined as those individuals who had experienced the greatest 
degree of unexplained weight gain. They were identified by using the residuals from 
a regression model of annual weight change on baseline values of age, weight and 
height, smoking status (current/former/never smokers), and follow-up time. 
Regression models were run separately for each country and were stratified for men 
and women. In each of the five countries except Italy, 600 male and 600 female cases 
were selected. The Italian cohort consisted of a general population-based sample and 
of women participating in a population-based breast cancer screening program. Thus, 
male participants were underrepresented (27%). To follow the same gender 
distribution as in the original cohort, 300 male and 900 female cases were selected for 
the present study. The sub-cohort sample comprised a random sample of the total 
eligible cohort which was drawn in such a way that the total number of non cases in 
each center equaled the number of cases (n = 1,200). Therefore, in all centers except 
Denmark, where overlap between cases and sub-cohort was negligible (n = 79), over 
sampling of the random samples was performed. In total, 11,921 participants were 
included in the present genetic association study: 6,000 cases and a sub-cohort of 
7,061 individuals including 5,921 non cases. 
 
Dietary, anthropometric, and other measurements 
Validated country-specific food frequency questionnaires (FFQs) were used to 
collect dietary information at baseline.14 Energy and nutrient intake of FFQ data were 
calculated using country-specific food composition tables and subsequently 
calibrated using 24-hour recall data collected from a random sample of the total EPIC 
cohort using a software program specifically designed to standardize the dietary 
measurements across European populations.15 Energy and nutrient intake from 24-
hour recalls were calculated based on the standardized European Nutrient 
DataBase.16 A specially developed GI database was used to calculate dietary GI and 
the methodologies of calculation have been described in detail elsewhere.17, 18  
Details of the anthropometric measurements have been described previously.6 In 
brief, at baseline all participants were measured for weight, height and waist 
circumference using standard study protocols.19 At follow-up, participants in 
Norfolk (UK) and Doetinchem (NL) were measured by trained technicians, while the 
remaining participants measured their weight and waist circumference at home 
SNPs and Changes of Weight and Waist Circumference 
 - 121 - 
according to the guidance provided. Due to these differences in methods used to 
collect anthropometric information at follow-up and the difference in length of 
follow-up, participants from Doetinchem (NL) were treated separately from the 
other Dutch participants in Amsterdam and Maastricht (NL). Participants from 
Copenhagen and Aarhus (DK) were combined because no such differences between 
these two groups existed. This resulted in six different study centers, namely 
Florence (IT-Flo), Norfolk (UK-Nor), Amsterdam-Maastricht (NL-AmMa), 
Doetinchem (NL-Doe), Potsdam (GER-Pot) and Copenhagen-Aarhus (DK-CopAa).  
Information on lifestyle was collected via self-administered questionnaires at 
baseline. Questions covered age, gender, physical activity, education level, smoking, 
menopausal status, and use of hormone replace therapy (HRT). Physical activity 
level was indexed into five categories (inactive, moderately inactive, moderately 
active, active, or unknown) based on occupational and recreational activities.14 
Education level was inquired as the highest level of school achieved and participants 
were classified into either primary school and less, technical-professional school, 
secondary school, university degree, or unknown. Smoking information was also 
available at follow-up. Information on health status (cancer, CVD, and diabetes) was 
collected using either questionnaires or disease registries.  
 
Selection of candidate genes and SNPs  
We selected 15 candidate genes encoding signals involved in the function of the 
hypothalamic signaling network, including the genes for cholecystokinin (CCK), 
CCK receptor, leptin, leptin receptor, ghrelin, glucagon-like peptide-1 (GLP-1), 
peptide YY3-36 (PYY), MC4R, interleukin-6 (IL-6), neuropeptide Y (NPY), pro-
opiomelanocortin (POMC), nucleobindin 2 (NUCB2), mammalian target of 
rapamycin (mTOR), neuromedin β (NMB), and serotonin receptor. CCK, PYY, and 
GLP-1 are known as satiety hormones. They are released from the gastrointestinal 
tract and can reduce appetite and food intake. Ghrelin, on the other hand, is a 
hunger hormone that could increase food intake.20 Leptin is the major adiposity 
signal that monitors nutritional status and prevents excess weight gain.21 IL-6 may 
have a similar function as leptin.22 NPY, NUCB2 and POMC are hypothalamic 
signals with either orexigenic (NPY)23 or anorexigenic (NUCB2 and POMC)24, 25 effect. 
mTOR is an important mediator between the adiposity signals and hypothalamic 
peptides.10 NMB is a member of the bombesin-like peptides family and has been 
associated with eating behavior and adiposity changes.26, 27 Serotonin could suppress 
food intake and may mediate the anorexigenic effects of leptin.28 
Based on the International HapMap data for the European ancestry (CEU), we 
selected SNPs to ensure full coverage of the complete common genetic variations in 
the candidate genes (including 5kb upstream and downstream of the gene). For 
those SNPs in complete linkage disequilibrium (LD) i.e. where the linkage measures 
D’ = 1 and r2 = 1, only one SNP was genotyped. In total, 134 SNPs were selected. A 
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complete list of the selected SNPs, including the candidate genes, is shown in a 
supplementary table (S-Table 8-1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8-1. Flow diagram of participant selection. 
 
DNA extraction and genotyping 
For all participants except those from the UK, genomic DNA was extracted from 
the buffy coats with a salting out method.29 For participants from the UK, whole-
genome amplified DNA was used. Genomic and amplified DNA samples were 
quality-checked, quantified and normalized to approximately 100ng/ml and 2.0 µg 
before genotyping. High throughput SNP genotyping was carried out using the 
Illumina® Beadstation Genotyping System at IntegraGen, France. Researchers and 
laboratory personnel were blinded to the case status and phenotypic data of the 
samples. The pre-defined criteria for successful genotyping were: the discordance 
rate between duplicates ≤ 3%; ≥ 90% of SNPs per sample should be genotyped and ≥ 
95% of samples per SNP should be genotyped. To optimize the number of SNPs for 
subsequent data analyses, we applied these criteria within each country.  
After merging the genotype and phenotype data in the Data Hub, genotype 
distributions were tested for accordance with Hardy-Weinberg equilibrium (HWE) 
in the randomly selected sub-cohort. Only those SNPs whose distributions did not 
Eligible cohort 
(n= 50,293)
Those cohort members with the greatest 
amount of unexplained weight gain during 
follow-up 
(n= 6,000 in total, 1,200 per country) 
Randomly drawn, stratified by study center 
and gender; To obtain in total 6,000 non-cases, 
over sampling was performed in all centers 
except Denmark, where overlap between 
cases and sub-cohort was negligible (n=79).  
In total 7,061 participants were included in the 
randomly chosen sub-cohort, of which 5,921 
were non-cases. 
Genotype data of 5,584 (93.0%) cases passed 
quality control and were included in the 
subsequent analyses. 
Cases  Sub-cohort 
Genotype data of 6,566 (93.0%) cohort 
members passed quality control. Among 
them, 5,507 were non-cases. 
Participants from five EPIC countries participating 
in the baseline examination  
(n= 146,543) 
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significantly deviate from HWE (P > 0.01) were retained in the subsequent analyses. 
In total, 123 SNPs were successfully genotyped for 11,091 participants. The case 
group included 5,584 participants and the sub-cohort included 6,566 participants of 
whom 5,507 were non cases.  
The flow chart of participant selection is shown in Figure 8-1. 
 
Statistical methods 
Power calculations were performed using QUANTO software, Version 1.2.4 
(May 2009).30 The lowest detectable effects in case-non case analyses (odds ratio, OR) 
at 80% of power ranged from 1.4 for minor allele frequency (MAF) 5% to 1.09 for 
MAF 50%. Except for the descriptive analyses, which were conducted using SAS 9.1 
for Windows (SAS Institute, Cary, NC), all statistical analyses were conducted using 
STATA 9.2 for Windows (StataCorp LP, Texas, USA). 
Data were analyzed using two statistical models, a logistic regression model to 
analyze the effect of each individual SNP on the risk of gaining a greater amount of 
weight during follow-up (case-non case analysis) and a generalized linear regression 
model to examine the effect of each SNP on subsequent changes of weight (g/year) 
and waist circumference (cm/year) among participants included in the sub-cohort 
(sub-cohort analysis). An additive genetic model was assumed. The analyses of the 
SNP main effects were not adjusted. However, in the sub-cohort analysis, adjustment 
was made for those variables used to define the case status, namely baseline values 
of age, weight and height, gender, smoking status, and follow-up time, to reduce the 
variation.  
For SNP-GI interaction analyses, besides SNP, GI, the cross product of SNP × GI 
were included in the models as independent variables, the logistic regression 
analyses were adjusted for physical activity, education level, alcohol intake, fat, 
protein, carbohydrates, fiber, and for women menopausal status and the use of 
hormone replace therapy. The linear regression analyses were additionally adjusted 
for the previously mentioned variables used for defining the case status. For waist 
change analyses, baseline waist circumference was also adjusted for. 
All these analyses were first conducted separately for each study center and then 
random-effect meta-analyses were performed, in order to take into account the 
possible heterogeneity across study centers and to pool the estimates into an overall 
(weighted) estimate. The significance (P value) of heterogeneity was tested using the 
Cochran Q-test.31 
Multiple comparisons were corrected for using the commonly used false 
discovery rate (FDR) method and FDR-adjusted P values (Q) < 0.1 were considered 
significant.  
 
Results 
Besides the significant difference in annual weight changes between cases and 
non cases (1,428 vs. 30 g/year) (Table 8-1), cases also included more overweight (43 
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vs. 39%) and obese (17 vs. 9%) participants, had higher baseline values of body 
weight (76.3 vs. 72.6 kg), BMI (26.4 vs. 25.2 kg/m2), and waist circumference (87.5 vs. 
84.4 cm), had higher BMI (29.4 vs. 25.3 kg/m2) and waist circumference (98.5 vs. 88.4 
cm) at follow-up, and gained more annual waist circumference (1.66 vs. 0.51 cm/year) 
(P < 0.0001 for all). Differences in GI and total energy intake were not significant. 
Although statistically significant, the differences in GL and dietary fiber were small 
in terms of average daily intake.  
 
Table 8-1. Characteristics of participants. 
 Cases 
(n = 5,584) 
Non cases 
(n = 5,507) 
P values* Sub-cohort 
(n = 6,566) 
Age, yrs 47.6 ± 7.5 48.0 ± 7.3 0.003 47.9 ± 7.3 
Gender, %men 45 45 matched 46 
Overweight, % 43 39 < 0.0001 39 
Obesity, % 17 9 < 0.0001 10 
Baseline weight, kg 76.3± 14.3 72.6± 13.4 < 0.0001 73.2 ± 13.6 
Baseline BMI, kg/m2 26.4 ± 4.2 25.2 ± 3.6 < 0.0001 25.4 ± 3.7 
Annual weight change, g/yr 1,428± 684 30 ± 622 < 0.0001 245 ± 801 
BMI at follow-up, kg/m2 29.4 ± 4.4 25.3 ± 3.5 < 0.0001 25.9 ± 3.9 
Baseline waist circumference, cm 87.5± 12.7 84.4± 12.0 < 0.0001 84.9 ± 12.1 
Annual waist change, cm/yr 1.66± 1.29 0.51± 1.13 < 0.0001 0.67 ± 1.18 
Waist circumference at follow-up, cm 98.5± 13.1 88.4± 11.7 < 0.0001 89.9 ± 12.4 
Follow-up time, yrs 6.8 ± 2.5 6.8 ± 2.5 0.08 6.9 ± 2.5 
Glycemic index (GI)† 56.5 ± 2.6 56.5 ± 2.5 0.8 56.5 ± 2.5 
Glycemic load (GL) † 139.7±33.8 141.1±32.3 0.02 141.3±32.5 
Total energy intake†, kcal/day 2,263± 522 2,268± 494 0.6 2,271± 501 
Dietary fiber†, g/day 22.1 ± 5.4 22.5 ± 5.7 0.0004 22.4 ± 5.7 
Values presented are mean ± standard deviation or otherwise indicated. 
* P values for the difference between cases and non cases, tested by student t-test (for continuous variables) or 
Cochran-Armitage trend test (categorical variables). 
† Calibrated using 24-hour dietary recall data as the reference. 
 
Case-non case analyses 
Among the 123 SNPs, two had significant (P < 0.05) direct associations with the 
risk of weight gain, which were rs1859223 in PYY (OR = 0.91 per copy of the minor 
allele, P = 0.009) and rs11571842 in CCK (OR = 1.06 per copy of the minor allele, P = 
0.03) (Table 8-2). However, these associations were not statistically significant after 
adjustment for multiple testing (Q > 0.9).  
Three SNPs showed a significant positive interaction with GI on weight gain risk, 
including rs7180849 near NMB (P = 0.003), rs2292462 in NMB (P = 0.007), and 
rs9311317 near CCK (P = 0.04). However, these associations attenuated to non-
significant after correction for multiple testing (Q > 0.4). 
 
Sub-cohort analyses 
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Weight change 
Two SNPs were inversely associated with weight change, which were rs1058046 
in PYY, (β = -27 g/year) and rs10493380 in the leptin receptor gene (LEPR), (β = -31 
g/year). One SNP, rs26802 in the ghrelin gene (GHRL), was positively associated with 
weight change (β = 25 g/year) (Table 8-3). However, after adjustment for multiple 
testing, these effects were no longer statistically significant (Q > 0.9).  
 
Table 8-2. SNPs and SNP × GI interactions significantly (P < 0.05) associated with the risk of weight 
gain in case-non case analyses. 
SNP Nearest 
gene 
No. of 
participants 
Major allele / 
Minor allele 
MAF Odds ratio 
(95% CI) 
P  
value 
Q 
value 
Main effects 
rs1859223 PYY 11,091 G / C 0.16  0.91 (0.85;0.98) 0.01 > 0.9 
rs11571842 CCK 11,091 G / A 0.49  1.06 (1.01;1.12) 0.03 > 0.9 
SNP × GI interaction* 
rs7180849 NMB 8,759 G / A 0.17  1.10 (1.03;1.18) 0.003 0.4 
rs2292462 NMB 11,091 A / C 0.47  1.05 (1.01;1.08) 0.007 0.4 
rs9311317 CCK 11,091 A / G 0.25  1.04 (1.01;1.08) 0.04 0.9 
SNP: Single nucleotide polymorphism; GI: Glycemic index; MAF: Minor allele frequency; 95% CI: 95% confidence 
interval. 
* The models included SNP, GI, SNP×GI, physical activity, education level, alcohol intake, energy-adjusted 
residuals of fat, protein, carbohydrates, and fiber, and for women, menopausal status and the use of hormone 
replace therapy. 
 
Table 8-3. SNPs and SNP × GI interactions significantly (P < 0.05) associated with subsequent weight 
change in sub-cohort analyses. 
SNP Nearest 
gene 
No. of 
participants
Major allele / 
Minor allele 
MAF β (g/year) 
(95% CI) 
P 
value 
Q 
value 
Main effects* 
rs1058046 PYY 6,566 G / C 0.33  - 27 (-51;-3) 0.03 > 0.9 
rs10493380 LEPR 6,566 A / C 0.19  - 31 (-60;-2) 0.04 > 0.9 
rs26802 GHRL 6,566 A / C 0.33  25 (1-49) 0.04 > 0.9 
SNP × GI interaction† 
rs7180849 NMB 3,723 G / A 0.17  47 (25;69) 3×10-5 0.004 
rs214075 NUCB2 6,566 C / A 0.41  16 (0.9-30) 0.04 > 0.9 
rs6719226 POMC 6,566 G / C 0.04  - 40 (-78;-1.8) 0.04 > 0.9 
rs1137101 LEPR 1,313 A / G 0.46  -26 (-52;-1.0) 0.04 > 0.9 
rs2292462 NMB 6,566 A / C 0.47  16 (0.5;31) 0.04 > 0.9 
SNP: Single nucleotide polymorphism; GI: Glycemic index; MAF: Minor allele frequency; β: Regression 
coefficient; 95% CI: 95% confidence interval. 
* The models were adjusted for baseline age, weight, and height, gender, follow-up time, and smoking. 
† The model additionally included SNP, GI, SNP×GI, physical activity, education level, alcohol intake, energy-
adjusted residuals of fat, protein, carbohydrates and fiber, and for women, menopausal status and the use of 
hormone replace therapy.  
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Figure 8-2. The regression of weight change on GI and by genotypes of the rs7180849 SNP. 
 
Five SNPs showed a significant interaction with GI, including rs7180849 (near 
NMB; P = 3×10-5), rs214075 (in NUCB2; P = 0.04), rs2292462 (in NMB; P = 0.04), 
rs6719226 (near POMC; P = 0.04) and rs1137101 (in LEPR; P = 0.04). After adjustment 
for multiple testing, only the interaction between rs7180849 and GI remained 
significant (Q = 0.004). The association between GI and weight change by genotypes 
of rs7180849 is illustrated in Figure 8-2. As compared to major allele (G) carriers, 
minor allele (A) carriers appeared to be more sensitive to a difference in dietary GI. 
When GI increased from the lowest to the highest quintile, the annual weight change 
increased from -195 g/year to 526 g/year for the participants with the AA genotype 
and from -20g/year to 344g/year for those with the GA genotype, while the annual 
weight change hardly changed for those with the GG genotype (154 g/year to 161 
g/year).  
 
Waist change 
Eight SNPs were significantly, although weakly, associated with changes in 
waist circumference. These included rs1074078 (near mTOR; β = -0.05 cm/year and P 
= 0.007), rs10766383 (in NUCB2; β = 0.05 cm/year and P = 0.01), rs10493380 (in LEPR; 
β = -0.05 cm/year and P = 0.02), rs7628795 (near CCK; β = -0.04 cm/year and P = 0.03), 
rs11129949 (in CCK; β = 0.05 cm/year and P = 0.03), rs10832763 (in NUCB2; β = 0.06 
cm/year and P = 0.03), rs12145690 (near LEPR; β = 0.03 cm/year and P = 0.04), and 
rs12700386 (near IL-6; β = 0.04 cm/year and P = 0.04). However, none of these 
associations remained significant after adjustment for multiple testing (Q = 0.7 for all) 
(Table 8-4).  
Three SNPs showed a significant interaction with GI: rs7180849 (near NMB; P = 
5×10-5), rs2025805 (in LEPR; P = 0.04), and rs9436746 (in LEPR; P = 0.04). After 
adjustment for multiple testing, only the interaction between rs7180849 and GI 
A allele is minor allele 
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remained significant (Q = 0.006). The association between GI and waist change by 
genotypes of rs7180849 is illustrated in Figure 8-3. Minor allele (A) carriers were 
more sensitive to the GI difference as compared to major allele (G) carriers. In other 
words, annual waist gain of participants carrying A allele was smaller at low level of 
dietary GI and larger at high level of dietary GI as compared to the waist gain in 
those carrying G allele. 
 
Table 8-4. SNPs and SNP × GI interactions significantly (P < 0.05) associated with subsequent waist 
circumference change in sub-cohort analyses.  
SNP Nearest 
gene 
No. of 
participants 
Major allele / 
Minor allele 
MAF β (cm/year) 
(95% CI) 
P 
value 
Q 
value 
Main effects* 
rs1074078 mTOR 6,566 G / A 0.33 -0.05 (-0.08;-0.01) 0.007 0.7 
rs10766383 NUCB2 6,566 C / A 0.28 0.05 (0.01;0.09) 0.01 0.7 
rs10493380 LEPR 6,566 A / C 0.19 -0.05 (-0.09;-0.01) 0.02 0.7 
rs7628795 CCK 6,566 G / A 0.41 -0.04 (-0.07;-0.004) 0.03 0.7 
rs11129949 CCK 6,566 A / C 0.12 0.05 (0.01;0.10) 0.03 0.7 
rs10832763 NUCB2 3,723 A / G 0.36 0.06 (0.01;0.12) 0.03 0.7 
rs12145690 LEPR 6,566 A / C 0.45 0.03 (0.001;0.07) 0.04 0.7 
rs12700386 IL-6 6,566 G / C 0.19 0.04 (0.0001;0.07) 0.04 0.7 
SNP × GI interaction† 
rs7180849 NMB 3,723 G / A 0.17 0.06 (0.03;0.09) 5×10-5 0.006 
rs2025805 LEPR 6,566 G / A 0.47 -0.02 (-0.05;-0.004) 0.02 > 0.9 
rs9436746 LEPR 6,566 C / A 0.40 0.02 (0.0003;0.04) 0.04 > 0.9 
SNP: Single nucleotide polymorphism; GI: Glycemic index; MAF: Minor allele frequency; β: Regression 
coefficient; 95% CI: 95% Confidence interval. 
* The models were adjusted for baseline age, weight and height, gender, follow-up time and smoking. 
† The model additionally included SNP, GI, SNP×GI, baseline waist circumference, physical activity, education 
level, alcohol intake, energy-adjusted residuals of fat, protein, carbohydrates and fiber, and for women, 
menopausal status and the use of hormone replace therapy.  
 
No significant heterogeneity was observed for all the above mentioned 
associations (P > 0.16 for all). 
 
Discussion 
In this large case-cohort study among Europeans from five countries, we studied 
the associations of SNPs in or near genes involved in food intake regulation of the 
hypothalamic signaling network with subsequent changes of weight and waist 
circumference. After adjustment for multiple testing, none of the SNPs under 
investigation showed a significant main effect on weight or waist circumference 
change. However, a significant interaction between the SNP rs7180849 (near NMB) 
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and GI on both weight and waist circumference change was observed, suggesting a 
synergistic effect in promoting weight and waist gain.  
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Figure 8-3. The regression of waist circumference change on GI by genotypes of the rs7180849 SNP. 
 
The main strength of the current study includes its large scale, multi-center and 
prospective design. In addition, we selected SNPs to ensure full coverage of the 
genetic variation in candidate genes and standardized the nutritional and covariate 
variables to minimize the influences caused by various collecting methods used in 
different countries. The main weakness of the current study is the self-reported 
information on weight and waist circumference at follow-up in four out of six study 
centers.6 It has been observed in our previous studies using this data that correction 
for under-reporting using the available methods did not change the main findings.6 
Although we have adjusted our analyses for many covariates, this may not be 
complete in terms of other potential confounders and changes in covariates such as 
physical activity levels and menopausal status. 
The GI was introduced to replace the traditional classification of simple vs. 
complex carbohydrates based on the blood glucose response after consumption. 
Compared with high GI foods, low GI foods are absorbed more slowly, cause higher 
satiation and satiety thus reduce energy intake.5 Moreover, the lower postprandial 
glucose and insulin fluctuation could affect nutrient partitioning in a way that 
prohibits body fat storage.1, 32 Findings from several clinical intervention studies and 
long term cohort studies have indicated a beneficial role of reducing dietary GI on 
promoting weight loss33, 34 and preventing weight and waist gain,35, 36 including our 
own studies.6 However, findings are not completely consistent. We suspect that the 
discrepancy among studies and the heterogeneity observed in our own analyses 
might be partially attributed to the effects of genetic factors on adiposity gain in 
different populations.  
A allele is minor allele 
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The critical role of energy intake regulation and the hypothalamic signaling 
network in weight change and obesity has long been recognized.20 A number of 
studies observed associations between genetic variations in this pathway and 
obesity-related phenotypes.9, 11, 12, 37, 38 However, in the present large European case-
cohort study, we did not observe significant main effects with weight and waist 
change for the SNPs under investigation. Previous studies suggest that the level of 
BMI and weight change might be influenced by different genetic variants.13, 39 In 
contrast to the well-established heritability of obesity, the genetic influence of weight 
change in adults is less well characterized.40 For example, although the impacts of 
genes such as FTO and MC4R on body fat and BMI have been well identified, their 
role in weight change regulation has yet to be assessed. A relatively low statistical 
power for those SNPs with low minor allele frequencies might also partly explain the 
null finding. In addition, our results might be too conservative since we used a 
random effects meta-analytical approach to analyze our data.31 Similarly, in the 
genome-wide associations studies conducted so far, only a limited number of SNPs 
have been identified as being obesity-associated. Together they explain only a small 
proportion of the variation in BMI,41 despite the fact that a heritability of obesity of 
40-70% has been established. This “heritability gap” also exists for many traits and 
other chronic diseases,42, 43 and might be due to the fact that many markers have to be 
discovered, some of which may locate in chromosome regions devoid of genes; or 
because in a polygenic condition like obesity, a single genetic polymorphism has 
only a small or null effect on the phenotype whereas the cumulative effects of genetic 
variants and complex interactions involve multiple genetic variants and multiple 
environmental factors need to be explored in a systematic way.37, 44 Also, 
understanding the impacts of rare SNPs (population prevalence rate < 1%), other 
types of variants, such as copy number variation, and epigenetics or DNA 
methylation patterns on the development of obesity or weight change is of 
importance.41 
In our sub-cohort analyses, a significant interaction between GI and SNP 
rs7180849 (near NMB) was observed. This interaction was marginally significant in 
case-non case analyses (P = 0.003, Q = 0.4). However, no significant main effect of this 
SNP on weight or waist circumference change was observed. As previously 
illustrated by Perusse and Bouchard, it is possible that gene-environment 
interactions exist while there is no direct genetic effect on disease risks.45  A similar 
situation has been observed in other studies as well, for example in the Nurses’ 
Health Study, Pro12Ala polymorphism in the peroxisome proliferator-activated 
receptor gamma (PPARγ) gene was not directly associated with BMI but this variant 
modified the relationship between total fat intake and BMI.46 The observed 
associations between GI, rs7180849 near the NMB, and subsequent changes of weight 
and waist circumference, yet to be replicated by other studies, may indicate that this 
SNP per se does not cause weight and waist gain directly, but can exacerbate the 
deleterious effects of high GI diets.  
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NMB is a decapeptide that belongs to the bombesin-like peptide family and is 
widely distributed in the human central nervous system (CNS), pancreas, adrenals, 
gastrointestinal tract and adipose tissue.26 Evidence shows that NMB, released in the 
gastrointestinal tract in response to food intake, represents a mediator between the 
gut and the brain and serves as a satiation signal to terminate meals.26 NMB is also 
expressed in adipose tissue and can act as an adiposity signal reflecting nutritional 
status and regulating food intake over a longer term.26, 27 Intravenous infusion of 
NMB has been shown to reduce meal size and meal duration in rats.47 A missense 
mutation p.P73T in the NMB has been associated with eating behaviors associated 
with obesity, including disinhibition (the tendency to overeat in response to different 
stimuli) and susceptibility to hunger (the perceived need for foods), and the amount 
of body fat gain during a 6-year follow-up in Quebec Family Study.38 In German 
children and adolescents, the silent polymorphism g.G401A in the NMB has been 
significantly associated with body weight.48 SNP rs7180849 is located at ~3kb 
upstream of the NMB (S-Figure 8-1) and is in absolute LD (r2 = 1.0, D’ = 1.0 in CEU 
Hapmap) with SNP rs3809508 which is positioned in the intron region of the NMB. 
There is no identified function of either rs7180849 or rs3809508 on NMB expression 
or obesity development so far. However, given the potential preventing role of NMB 
on obesity and the observed positive interaction between rs7180849 and GI on 
weight and waist gain observed in our current study, we speculate that rs7180849, or 
rs3809508, is associated with lower NMB expression. However, this hypothesis needs 
to be verified in experimental studies.  
The current study reports for the first time that high GI diets may modify the 
effects of a genetic polymorphism on weight and waist change. Gathering more 
insight in interactions between genetic and dietary factors is critical for dietary 
counseling and interventions to be properly designed and targeted. However, during 
the last several decades, despite the identified obesity-associated genetic 
polymorphisms,49 interactions between these polymorphisms and dietary factors in 
the modulation of appetite, energy intake, and body weight and body composition 
change have been scarcely studied. Genome wide studies have their advantage in 
identifying genetic factors associated with complex diseases such as obesity, given 
the hypothesis free approach and full coverage of the entire genome. However, due 
to statistical and computational difficulties, testing gene-diet interactions has not yet 
been widely applied on a whole-genome scale.  
To conclude, among this European population from five countries, none of the 
123 SNPs in or near 15 candidate genes involved in the hypothalamic regulation 
pathway of food intake had a significant independent effect on the risk of weight and 
waist circumference gain. A SNP near the NMB (rs7180849) showed a significant 
interaction with dietary GI on subsequent weight and waist change. This finding 
may implicate that this polymorphism amplifies the impact of high GI diets on 
weight and waist circumference change, thus lowering dietary GI seems more 
important and effective for individuals with this genotype. However, given that the 
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present study is the first to report this interaction, further studies are needed to 
verify this finding. 
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S-Table 8-1. List of the genes (n = 15) and SNPs (n = 134) selected for genotyping. 
Gene (chromosome) SNPs N* Position Major allele/Minor allele MAF 
CCK (chr 3) rs9311317 6 42270809 A / G 0.25 
 rs10460960 6 42283738 A / G 0.11 
 rs10865918 6 42278314 A / C 0.38 
 rs11571842 6 42281449 G / A 0.49 
 rs11129949 6 42277811 A / C 0.12 
 rs747455 6 42280967 G / A 0.24 
 rs8192472 6 42274873 G / A 0.38 
 rs7628795 6 42270197 G / A 0.41 
 rs11129947 0   Failed 
CCKAR (chr 4) rs2000978 6 26097086 A / G 0.17 
 rs7665027 6 26096006 A / G 0.15 
 rs1573596 6 26090086 G / A 0.47 
 rs915889 6 26095291 G / A 0.07 
 rs2854030 6 26091118 G / A 0.29 
 rs1800855 0   Failed 
GHRL (chr 3) rs171336 6 10300749 C / A 0.36 
 rs35683 6 10303249 C / A 0.48 
 rs11718213 6 10300949 A / C 0.10 
 rs35684 c 5 10301685 A / G 0.28 
 rs26802 6 10307364 A / C 0.33 
 rs1617161 6 10311852 G / A 0.11 
 rs27647 6 10307467 A / G 0.40 
 rs17032621 6 10300637 A / G 0.14 
 rs1629816 d 2 10311290 G / A 0.38 
 rs10490815 6 10310144 A / G 0.29 
 rs3755777 6 10308363 G / C 0.25 
 rs2619507 6 10310785 A / G 0.16 
 rs4684677 0   Failed 
GLP-1 (chr 2) rs3761656 6 162719480 A / C 0.08 
 rs13416088 6 162705904 G / A 0.21 
 rs1990761 0   Failed 
5-HT1A (chr 5) rs1423691 6 63287417 A / G 0.50 
IL-6 (chr 7) rs2069827 e 2 22731980 C / A 0.09 
 rs2069840 6 22735096 G / C 0.34 
 rs12700386 6 22729533 G / C 0.19 
 rs10242595 6 22740755 G / A 0.32 
 rs2069861 6 22738178 G / A 0.09 
 rs1800795 6 22733169 C / G 0.41 
 rs2069837 6 22734551 A / G 0.08 
LEP (chr 7) rs11763517 6 127677297 A / G 0.49 
 rs3828942 f 3 127681540 G / A 0.45 
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 rs2071045 6 127680215 A / G 0.24 
 rs2278815 6 127669086 A / G 0.43 
 rs11760956 6 127678322 G / A 0.37 
 rs7788818 6 127681119 G / A 0.06 
LEPR (chr 1) rs1137101 g 2 65831100 A / G 0.46 
 rs1022981 6 65772621 A / G 0.25 
 rs1137100 6 65809028 A / G 0.24 
 rs7516341 6 65860730 A / G 0.37 
 rs1892534 6 65878531 G / A 0.38 
 rs1892535 6 65869768 G / A 0.18 
 rs3790426 6 65815606 C / A 0.24 
 rs9436746 6 65681060 C / A 0.40 
 rs970467 6 65679349 G / A 0.11 
 rs1045895 6 65670568 G / A 0.40 
 rs10493380 6 65818704 A / C 0.19 
 rs6588147 6 65708081 A / G 0.32 
 rs2025805 6 65722465 G / A 0.47 
 rs3790433 6 65666929 G / A 0.26 
 rs1171279 6 65761080 G / A 0.27 
 rs1171267 h 4 65776441 C / A 0.34 
 rs11208659 6 65751867 A / G 0.10 
 rs6704167 i 5 65710467 A / T 0.45 
 rs1171278 j 3 65760733 G / A 0.18 
 rs12409877 6 65716459 G / A 0.39 
 rs8179183 6 65848539 G / C 0.18 
 rs6662904 6 65770327 G / A 0.48 
 rs3806318 c 5 65657944 A / G 0.28 
 rs4655537 6 65831388 G / A 0.36 
 rs9436301 6 65668514 A / G 0.24 
 rs4655802 6 65660818 A / G 0.41 
 rs12145690 6 65659600 A / C 0.45 
 rs1887285 6 65670334 A / G 0.09 
 rs9436740 6 65664488 T / A 0.28 
 rs11585329 6 65846401 C / A 0.15 
 rs3762274 k 5 65836700 A / G 0.39 
 rs6673324 6 65803650 A / G 0.49 
 rs10158579 6 65722643 A / G 0.13 
 rs9436297 6 65661441 A / G 0.14 
 rs6672331 6 65748434 G / C 0.03 
 rs9436302 0   Failed 
MC4R (chr 18) rs11872992 6 56191566 G / A 0.13 
 rs8093815 6 56187482 G / A 0.31 
 rs1943226 6 56186183 A / C 0.10 
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 rs1943220 0   Failed 
 rs17066846 0   Failed 
mTOR (chr 1) rs1770345 a 2 11137166 A / C 0.47 
 rs1074078 6 11249374 G / A 0.33 
 rs12732063 6 11113818 G / A 0.05 
 rs1057079 b 3 11127644 A / G 0.26 
NMB (chr 15) rs7180849 c 5 82996662 G / A 0.17 
 rs2292462 6 83001757 A / C 0.47 
 rs17598561 l 4 82999609 G / A 0.06 
 rs1051168 6 83001523 C / A 0.29 
 rs309430 0   Failed 
NPY (chr 7) rs16472 6 24300593 G / A 0.09 
 rs5574 6 24295657 G / A 0.47 
 rs9785023 6 24291533 A / G 0.50 
 rs16135 c 5 24294444 G / A 0.07 
 rs16141 c 5 24291283 A / C 0.49 
 rs3025118 6 24294201 C / A 0.04 
 rs16148 c 5 24288862 A / G 0.34 
 rs12700524 6 24287938 A / G 0.14 
 rs16142 0   Failed 
 rs2023890 0   Failed 
NUCB2 (chr 11) rs214075 6 17256992 C / A 0.41 
 rs10832763 c 5 17307778 A / G 0.36 
 rs7127347 6 17257419 A / C 0.13 
 rs2634462 6 17295702 G / A 0.27 
 rs10741725 6 17277372 C / A 0.46 
 rs214105 6 17270096 A / G 0.28 
 rs757081 6 17308258 C / G 0.32 
 rs12419530 6 17262798 A / G 0.04 
 rs214086 6 17255041 G / C 0.42 
 rs214082 6 17255965 G / A 0.41 
 rs10766383 6 17286373 C / A 0.28 
 rs1330 6 17272604 G / A 0.33 
POMC (chr 2) rs6713532 6 25238336 A / G 0.23 
 rs934778 6 25242727 A / G 0.30 
 rs1866146 6 25234076 A / G 0.34 
 rs6545975 6 25238988 A / G 0.39 
 rs3769671 6 25243656 A / C 0.03 
 rs6719226 6 25249515 G / C 0.04 
 rs7565877 6 25239567 A / G 0.11 
 rs7565427 6 25239141 G / A 0.13 
 rs6734859 6 25233411 G / A 0.13 
PYY (chr 17) rs3744419 6 39438166 G / A 0.20 
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 rs1859223 6 39435090 G / C 0.16 
 rs8079623 6 39382855 G / C 0.11 
 rs1058046 6 39386056 G / C 0.33 
 rs1662754 6 39381050 A / T 0.44 
 rs9907468 6 39407614 G / A 0.10 
 rs1618809 6 39421450 G / A 0.37 
 rs1642598 0   Failed 
5-HT1A: Serotonin receptor gene; MAF: Minor allele frequency 
* Number of study centers for which the SNP information was available, 0 means either genotyping failed or the 
SNP did not pass the predefined quality control. 
a. Available in Italy and the UK. b. Available in Italy, Germany and Denmark. c. Available in 5 center in 4 countries 
except for the UK. d. Available in Italy and Germany. e. Available in Italy and Denmark. f. Available in The 
Netherlands (2 centers) and Germany. g. Available in the 2 center in The Netherlands. h. Available in Italy, The 
Netherlands (2 centers) and Denmark. i. Available in 5 center in 4 countries except for Germany. j. Available in Italy, 
UK and Germany. k. Available in 5 center in 4 countries except for Denmark. l. Available in 4 countries except for 
The Netherlands.  
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* Derived using HAPLOVIEW. Pairwise LD statistics are the R2 values (in percentages). 
rs 3809508 was not genotyped in our study because it is in absolute LD with rs7180849 (D’=1 and R2=100%).  
S-Figure 8-1. Linkage disequilibrium (LD) plot of the neuromedin β (NMB) gene*. 
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The main aim of the research described in this thesis was to investigate the 
impact of diets with different glycemic indices (GI), glycemic loads (GL), fiber 
contents, fiber sources, and energy density (ED) on the subsequent changes of weight 
and waist circumference in a large sample of European populations followed for an 
average of 6.5 years. In addition, the evidence and underlying mechanisms of the 
potential health effects of low GI diets were reviewed, and the ability to assess 
dietary GI and GL using a food frequency questionnaire (FFQ) was evaluated. In this 
last chapter, the main findings and interpretations will be reviewed, methodological 
issues and possible public health messages will be discussed, and recommendations 
for future nutrition research, especially epidemiological research, in the area of 
obesity will be given. 
 
Main Findings and Interpretations 
GI is a relative measure of dietary carbohydrates’ potential to raise blood glucose 
after consumption. It is a rather new concept introduced in the early 1980s, but the 
boom in etiological research started since late 1990s.1 To better understand this 
concept and the physiological mechanisms underlying the potential health effects of 
diets with different GI values, and to give an update on the evidence for the 
beneficial impact of low GI diets on chronic diseases, a detailed literature review was 
performed. As concluded in chapter 2, it is plausible that low GI diets favorably 
influence the management and prevention of type 2 diabetes, obesity, cardiovascular 
diseases and certain types of cancer. However, findings are yet far from consistent.2  
As stated earlier, the main aim of this thesis work was to investigate the impact 
of dietary factors, assessed by food frequency questionnaires (FFQs), on subsequent 
weight and waist change in a large sample of Europeans from five countries 
participating in the EPIC study (European Prospective Investigation into Cancer and 
Nutrition). These dietary factors include GI as well as GL, which is a measure of the 
entire glycemic burden of a food or a diet and combines the quality (GI) and quantity 
of carbohydrates.3 However, the FFQs used in the EPIC study were not specially 
designed to measure dietary GI and GL, and their validity had never been assessed 
before. Therefore, it is critical to obtain insights into the quality of the GI and GL 
measurements before associating them to weight and waist change. Two studies 
were conducted to address this issue.  
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Firstly, in a cross-sectional analysis of 974 participants from two ongoing Dutch 
cohort studies (the CoDAM study and the Hoorn study), we investigated the 
association of GI, GL with blood concentrations of metabolic risk factors (Chapter 3). 
We chose these two cohorts because they used the same FFQ to estimate habitual 
diets as the Dutch arms of the EPIC study. We observed a significant association of 
GI with fasting insulin, HOMA-IR, HDL cholesterol, total/HDL cholesterol ratio, and 
C-reactive protein (CRP). However, no significant association was observed between 
GL and any of the metabolic factors under investigation.4 Our findings support the 
beneficial role of low GI diets in preventing metabolic syndrome, insulin resistance, 
type 2 diabetes, and cardiovascular diseases. More importantly, they may also 
suggest a good validity of GI measured by this FFQ.5  
Secondly, using the original data used to validate the Dutch EPIC FFQ,6, 7 we 
examined the reproducibility and relative validity of GI and GL (Chapter 4). The 
interclass correlation coefficients between the three repeated FFQ measurements of 
GI and GL were 0.78 and 0.74 respectively, indicating a good reproducibility. 
Correlation coefficients between the FFQ measurements and the weighted averages 
of twelve 24-hour dietary recalls were 0.63 for both GI and GL, which indicates a 
satisfactory relative validity.8  
 
Table 9-1. Associations of dietary variables with subsequent changes in weight (g/year) and waist 
circumference (cm/year) among 89,432 Europeans. 
Ch. Dietary exposures β on annual weight change 
(95% CI) 
β on annual waist circumference 
change (95% CI) 
Glycemic index (GI)* 34 (-47, 115) 0.19 (0.11, 0.27) 5 
Glycemic load (GL)† 10 (-65, 85) 0.06 (-0.01, 0.13) 
6 Energy density (ED) ‡ -42 (-112, 28) 0.09 (0.01, 0.18) 
Total dietary fiber║ - 39 (-71, -7) -0.08 (-0.11, -0.05) 
Cereal fiber║ -77 (-127, -26) -0.10 (-0.18, -0.02) 7 
Fruit & vegetable fiber║ 2 (-40, 44) -0.08 (-0.15, -0.01) 
β: Regression coefficient; CI: Confidence interval. 
* The effects were for 10 units of GI; † The effects were for 50 units of GL; ‡ The effects were for 1 kcal/g of ED. ║ 
The effects were for 10 g/day of fiber. 
Heterogeneity among study centers was significant for all except for total dietary fiber on waist circumference 
change. 
 
Chapter 5, 6 and 7 present the results on the main effects of the dietary factors on 
subsequent changes of body weight and waist circumference. As shown in Table 9-1, 
neither GI nor GL was significantly associated with weight change. GI, but not GL, 
was significantly and positively associated with annual waist circumference 
(Chapter 5).9 ED was not significantly associated with weight change either, but it 
was significantly and positively associated with the change in waist circumference 
(Chapter 6).10 Both total dietary fiber and cereal fiber were significantly and inversely 
associated with subsequent weight and waist change, while fiber from fruits and 
vegetables was only inversely associated with waist change, not weight change 
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(Chapter 7). These observed associations confirm some, but not all, earlier findings11-
14 and suggest a beneficial role of low GI, high fiber, and low ED diets in the 
prevention of excessive weight and waist gain. However, the regression coefficients 
were rather small especially when viewed from the individual level. This may be 
partly due to the under-reporting of energy intake,15 which is more pronounced 
among obese individuals. This notion was supported by a stronger association 
between ED and waist change in non-obese (BMI < 25 kg/m2) compared to the 
association in overweight or obese participants (0.17 cm/year vs. 0.04 cm/year for 1 
kcal/g ED) (Chapter 6).10  
In Chapter 8, we examined the impact of several single nucleotide 
polymorphisms (SNPs) on subsequent weight and waist change. We focused on 
SNPs in or near genes involved in the hypothalamic signaling network, which plays 
a critical role in the regulation of satiation and satiety and thus energy intake. The 
potential interaction between these SNPs and GI was also investigated. None of the 
SNPs under investigation was directly associated with weight or waist change. A 
significant interaction between GI and rs7180849, a SNP near the neuromedin β 
(NMB) gene, on both weight and waist change was observed. Minor allele carriers 
seemed to be more sensitive to the impact of dietary GI on weight and waist change 
than no carriers. This finding implicates that following a low GI diet might be of 
special importance for people carrying minor allele of this SNP. However, further 
studies are needed to verify this finding. 
 
Methodological Considerations 
In this paragraph we discuss several general methodological issues, from study 
design and study populations to exposure and outcome assessments and statistical 
methods. This discussion will further elaborate the strengths and weaknesses of our 
studies and will provide a general interpretation of the associations between dietary 
factors and body weight and waist circumference change observed in this thesis. 
 
Study design 
Observational study  
Mainly due to the limitations of observational studies, such as uncontrolled 
confounding, findings from randomized controlled trials (RCTs) are generally 
believed to provide the highest level of evidence.16 However, conducting large-scale, 
long-term, well-controlled RCTs examining the effects of dietary factors on weight 
change is extremely difficult, sometimes even impossible, due to the obstacles in 
costs, logistics, and ethical issues.16  
Conducting RCTs on weight gain prevention is even more difficult, given the 
chronic process of weight gain and the long-term nature of such trials leading to 
difficulties in compliance. In addition, weight gain in a certain time period may be 
small and with a large inter-individual variation. Also, many factors can contribute 
to weight gain (see Chapter 1) and the impact of any individual factor (the 
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intervention) would be small. These two aspects necessitate a very large sample size 
for sufficient statistical power of detecting a significant effect. Therefore, most of the 
RCTs focused on diet-induced weight loss instead of weight gain. However, not all 
diets promoting weight loss among obese individuals are appropriate for a long-
term use to prevent weight gain, such as the well-known very-low-carbohydrate 
diet.17-19 Some of the RCTs, for instance the one within the DiOGenes project,20 
investigated the role of dietary interventions in preventing weight regain after a 
period of quick weight loss, which might be considered as a proxy of weight gain. 
However, evidence from both animal and human studies has shown that strict 
energy restriction and quick weight loss are usually accompanied by several 
metabolic, behavior and psychological adaptations, for example a decreased leptin 
level and an increased cortisol level, leading to a reduced energy expenditure and an 
increased appetite (hyperphagia),21, 22 an enhanced preference for highly palatable 
high fat energy dense foods,22-24 and prioritized carbohydrate oxidation leading to a 
retention of fat for the formation of the visceral adipose tissue.25 Therefore, strategies 
for weight regain prevention may not be exactly the same as those for preventing 
weight gain. 
In spite of the weaknesses, observational studies have specific strengths, such as 
a large sample size thus an enhanced statistical power and a longer follow-up time, 
in the case of cohort studies, which enables researchers to investigate the long-term 
effects of multiple dietary factors independently and interactively. The results of 
population-based observational studies could be easily generalized as they are based 
on the natural development of a trait in a real-life situation. 
 
Prospective study 
Associations observed in cross-sectional studies can be affected by reverse 
causality, which means some participants may change their exposure status due to 
the presence of outcome. For example, in studies of diet and adiposity associations, 
participants may have switched their dietary behavior due to obesity. This 
phenomenon limits our capability to interpret the research findings. Moreover, 
underreporting of energy, in particular fat and sugar,26, 27 intake is clearly related to 
the degree of obesity and could distort the diet – body weight association under 
investigation.28 As we have mentioned in previous chapters, the prospective design 
is one of the main strengths of our studies, besides the large sample size. However, 
we could not rule out the possibility that what we were investigating is only the tail 
of the real association. Weight (and also waist) gain is a chronic process and the 
largest rate among adults occurs during early adulthood. Body weight tends to level 
off or even decline during the later years of life (60+ years).29 In our study, mean 
baseline age of the participants is around 55 years, which means that most of the 
participants have already put on a considerable amount of body fat during the first 
half of their lives. This might partly explain the small effects we have observed.  
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Heterogeneous study population 
Our study participants came from five different European countries. Multi-
centre studies have been considered of special strength through enlarged inter-
individual differences in both exposures and outcomes, thereby creating a larger 
statistical power. In addition, conclusions drawn from studies with heterogeneous 
populations generally have a larger generalizibility.20 However, there can also be 
inherited limitations, such as the different methodologies used to collect habitual 
diets. Using country-specific food frequency questionnaires (FFQs) to assess diets is 
necessary, due to the differences in eating patterns, nutrient composition and 
availabilities of foods, language, and so on. However, different FFQs may have 
considerably distinct reproducibility and validity.30 In addition, different food 
composition tables also induce measurement errors when different methods are used 
to analyze the nutrient values. In the EPIC study, extensive efforts have been made 
to improve the comparability of the dietary variables as well as other important 
lifestyle factors, such as physical activity. For example, foods consumed in different 
countries were classified into the same food groups; nutrient values, i.e. fiber intake, 
analyzed using different methods were standardized; a linear regression calibration 
was performed to reduce the country-specific measurement errors and to further 
improve the comparability of dietary variables. For the latter, we regressed the 
intake of foods and nutrients measured by the FFQs on the 24-hour recall data 
collected using the standardized EPIC-SOFT program.31, 32 Nutrient intake in the 24-
hour recall data was calculated using a standardized nutrient database.33 The 
downside of this calibration practice is the potential of bias caused by the fact that 
the reference 24-hour recall data was collected only once. This may cause bias in 
terms of representing long-term habitual diets, and the errors in the 24-hour recall 
and the FFQs can be correlated. However, Kaaks et al in a methodological review 
have concluded that: “ … a calibration study based on only a single day's food intake 
record (but generally on a larger number of subjects) can provide sufficient reference 
information to correct relative risk estimates for biases due to measurement error”; 
“A major advantage of calibration studies based on this single-day-per-subject 
design is that they can be conducted on a representative sample of cohort 
participants more easily than validity studies in which reference measurements are 
repeated”.34 I our studies, we have taken the uncertainty in calibrated data into 
account by performing sensitivity analyses with un-calibrated dietary variables 
(Chapter 5, 6 and 7). 
 
Measurement errors in exposures and outcomes 
As has been discussed in the individual chapters (Chapter 5, 6, and 7), 
measurement errors likely to occur in both dietary and anthropometric variables. 
The error in self-measured anthropometrics might be relatively easy to prevent, 
whereas the measurement error in dietary variables at present is a great concern in 
nutritional research. In most of the epidemiological studies, energy, particularly fat 
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and sugar, intake is underreported.26, 27 This underreporting is usually not random 
and is significantly greater among those with higher BMI. Other factors such as 
gender and weight-consciousness are also related to energy under-reporting.35, 36 In 
our study, dietary variables including total energy, food and nutrient intake 
estimated using FFQs have been validated against a reference method, such as 
multiple 24-hour recalls, weighted food records and biomarkers.4, 8, 30 However, given 
the fact that most of the dietary variables were only validated against a reference 
method which may have related measurement errors with the FFQs, the validity 
estimates might be overestimated.  
Differential underreporting may distort the association between energy intake 
and body weight. Given the prospective design of our current study, underreporting 
of total energy in our study might not be directly related to weight change, since the 
dietary information was collected prior to the occurrence of weight change. However, 
it is likely that an indirect effect through baseline weight is present. Therefore, it is 
critical to adjust for measurement error in data analyses,15 for which multiple 
strategies have been applied. Firstly, energy-adjusted residuals of dietary variables 
(both the exposure and confounding variables) have been used. This method has 
been recognized as the major analytical technique in nutritional epidemiology to 
correct for measurement errors in dietary variables of interest.36, 37 Secondly, a linear 
regression calibration has been performed. In addition, we have adjusted our 
analyses for baseline weight, height, and gender and explored the effect modification 
by baseline BMI and the ratio of energy intake to estimated basal metabolic rate. The 
application of these methods enhanced the reliability of our findings. 
 
Statistical methods 
In our study, we applied a random-effect meta-analytical approach for our data 
analysis. This is a two-stage process including separate analyses in each study center 
and pooling the center-specific estimates using random-effect models.37 This 
approach was chosen because of the heterogeneity across study centers observed in 
our study. Some may argue that we should use a combined analysis with an 
adjustment for center, since this study (the EPIC study) was designed and conducted 
as a single study carried out on different locations, and many efforts have been made 
to standardize the data. In addition, aggregated analyses could take a better 
advantage of the variations in exposures across whole study participants.37 However, 
the high amount of heterogeneity observed indicates the existence of significant 
differences with respect to the effects of dietary factors on weight and waist 
circumference change in participants from different study centers. Presenting a 
pooled estimate without mentioning the differences between centers is therefore 
inappropriate. With the meta-analytical approach, the regression models were run in 
each participating cohort separately, which allows exposure and covariates to be 
differently associated with the outcome in each center. Using the random-effects 
model to pool the results, we took heterogeneity into account through a larger 
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standard error and a wider confidence interval. The estimates reported in our papers 
are therefore the most conservative ones in terms of both the magnitude of estimates 
and their significance. The unexplained heterogeneity observed in our findings may 
indicate that there are some factors, currently unknown to us, driving the differences 
and inviting further examination.  
 
Genetic Epidemiology 
Twin, adoption and family studies have indicated that common obesity has a 
genetic component as high as 40-70%.38 The DiOGenes project, under which the 
studies presented in this thesis were conducted, applied a hypothesis driven 
candidate gene approach to study the impact of genes on obesity. This approach 
involves the selection of genes that are a priori suspected to be involved in the 
development of obesity or weight change based on previous knowledge. With the 
completion of the International Human HapMap Project and the advances in high-
throughput genotyping technologies, genome-wide association studies on chronic 
diseases including obesity have been increasingly conducted.39, 40 As compared to 
this hypothesis free approach, the most valuable aspect of the candidate gene 
approach lies in the opportunity of detailed analyses on the gene-gene and gene-
environment interactions.41  
In our study on SNPs (Chapter 8), we investigated the effect of individual SNPs 
and their interactions with dietary GI on weight and waist change, without taking 
into account the cumulative effects of several SNPs or the SNP-SNP interactions. 
This is because our ultimate research objective was to understand the function of 
individual genes and genetic variants in obesity prevention, for the purpose of better 
targeting the obesity treatment and prevention interventions later. Common obesity 
is a polygenic trait, to which a single genetic polymorphism may have only a small, if 
not null, contribution, while the complex gene-gene and gene-environment 
interactions may play an important role.42, 43 Analytical techniques investigating the 
genetic effects on weight change while at the same time taking into account the 
complex interactions, such as the random forest approach, might be of great 
importance in determining the genetic pool of obesity in future.44  
 
Public Health Relevance 
The continually increasing obesity prevalence has spurred many international 
and national public health agencies, such as the WHO, to provide public 
recommendations for halting this epidemic. Public recommendations should be 
evidence-based and findings from all types of studies, i.e. observational, mechanistic 
and randomized intervention studies, are needed.17 One of the strengths of our 
present prospective cohort studies is its population-based design, which means 
findings have higher generalizability. Several aspects should however be considered.  
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Small effect sizes may have significant public health relevance. The effects of 
dietary factors on subsequent weight and waist circumference observed in the 
current thesis were generally small (Table 9-1). From an individual perspective, 
these effects are definitely of no relevance. However, results from epidemiological 
studies should be interpreted at population level instead of individual level.45 Some 
small effects size may have large public health consequences if the risk factors have 
high prevalence and the disease presents an important public health concern. From 
this point of view, our findings are of public health relevance because obesity is 
currently an important public health issue and western diets are usually energy 
dense, high in GI, and low in fiber. Furthermore, we have adjusted our analyses for a 
number of potential confounders to obtain independent effects of the main exposure. 
In real life, several dietary factors may be changed simultaneously. For example, 
when fiber intake is increased through switching from refined cereals to wholegrain 
cereals, dietary GI may also be decreased, and therefore the effects could be additive. 
More importantly, the mean annual weight and waist circumference change in our 
study population were 115 g/year and 0.76 cm/year respectively, and thus the effects 
of 39-77 g/year and 0.08-0.19 cm/year (Table 9-1) represent 34%-67% of the mean 
weight change and 11%-25% of the mean waist circumference change. Therefore, the 
effects observed in the present study are of public health relevance and best be 
considered at proportional instead of absolute scale when translated into the impact 
at the individual level.  
 
Low glycemic index does not necessarily mean healthy. The debates on the GI 
concept have not yet come to a halt.46 Whether recommending a low GI diet could 
mislead consumers to follow a high fat - low carbohydrate diet is the main concern. 
There is no doubt that GI alone will not label a food as “healthy” or “unhealthy”. For 
example, a chocolate bar can have a GI lower than 40 while a watermelon can have a 
GI around 80.47 The GI value of fructose (~20) is much lower than the GI value of 
glucose (~100), but this does not exclude the possibility that high fructose 
consumption could lead to a reduction in insulin sensitivity and increase in visceral 
adiposity and blood lipids.48 The public health messages regarding GI must be that 
the application of the GI should be in the context of the overall composition of the 
diet, focusing on the quality of starchy foods in particular, while other dietary factors, 
such as energy density and contents of fiber should also be taken into account. Low 
GI is not equal to healthy.  
 
A high fiber, low glycemic index and low energy dense dietary pattern probably is 
beneficial in terms of prevention of weight and waist gain. Intake of foods and 
nutrients tend to be highly correlated in free-living people. This is not only the case 
for macronutrients (e.g. a low- or no-carbohydrate diet must be necessarily high in 
fat or protein), but also for other dietary factors, such as vitamin C and fruit fiber. 
Although it is possible to calculate the independent impact of single dietary factors 
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on disease outcome in statistical analyses, it is hardly possible to change only one or 
few nutrients in real life through the variation in meals. For example, choosing an 
apple instead of a candy bar as a snack may simultaneously increase the fiber content 
and decrease GI and ED of the diet. In addition, other valuable changes could also be 
achieved, such as increased vitamin and decreased fat intake. On the other hand, 
dietary recommendations should be based on dietary patterns rather than individual 
dietary factors. A cola drink (ED = 40 kcal/ 240g = 0.17) can be low energy dense as 
compared to a banana (ED = 80 kcal/100g = 0.8) which contains much more fiber and 
vitamins than the former. A balanced diet is critically important for a long-term 
weight control and a general health. Although we have observed only small effects 
for dietary fiber, ED and GI on weight and waist change, our findings suggest that a 
dietary pattern rich in fiber and low in GI and ED will be beneficial for preventing 
body weight and waist gain. Further studies investigating the association of this 
dietary pattern with weight and waist change as well as other obesity-related chronic 
conditions such as type 2 diabetes, cardiovascular diseases, certain cancers and 
mortality are of interest. To be able to achieve this dietary pattern, people should 
increase their consumption of whole-grain based cereal, pasta and bread especially 
focusing on the low GI variants such as rye breads, consume more legumes, fruits, 
and vegetables, and limit total fat intake.  
The glycemic load (GL) deserves some further discussion. As a concept 
introduced to capture the total glycemic burden of foods or diets by combining both 
the quality (GI) and quantity of carbohydrates, GL has more physiological meaning 
than GI. However, in epidemiological studies like ours, GL is often highly correlated 
with total carbohydrate intake, which makes it difficult to distinguish the impact of 
these two variables. In real life setting, understanding what GL means could guide 
us to choose a low GI diet. For example, for foods rich in carbohydrates (e.g. rice and 
breads), more attention should be paid on their GI values, since even a small bite will 
contribute substantially to the overall dietary GI and GL. On the other hand, if a food 
contains a limited amount of carbohydrates (i.e. water melon), its contribution to the 
overall dietary GI and GL will be minimal, even though it is of high GI. 
 
A calorie is a calorie?! Although a significant beneficial effect of a low GI diet on 
waist circumference change was observed, as described in chapter 5, the effect of GL 
was not statistically significant, which means, as compared to low fat diets, low GL 
diets do not seem to be beneficial for preventing weight and waist circumference 
gain in an iso-caloric situation. This finding is in line with the proposition “a calorie 
is a calorie” in terms of weight change.49 Several recent intervention studies also 
draw a similar conclusion: weight loss and maintenance relies on calorie restriction 
and is independent of the macronutrient composition of the diet.50, 51 However, in an 
earlier meta-regression of 87 studies, diets lower in carbohydrates have been 
associated with a larger weight loss regardless of total energy intake.52 In the 
Women’s Health Initiative Dietary Modification Trial, a long term intervention trial 
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on the prevention of cancer and cardiovascular diseases in postmenopausal women, 
weight loss was more pronounced among women who had the greatest decrease in 
percentage of energy from fat.29 In a meta-analysis of 16 trials comparing ad libitum 
low-fat diets with a control group, the low-fat intervention group lost on average 3.2 
kg more than the control group during the 2-12 months intervention periods.17 
Although there is still room for debate about whether a calorie is indeed a calorie 
with respect to weight control,53-55 in any case moderate caloric restriction is 
beneficial in terms of preventing weight gain.  
 
Personalized nutrition: an attractive perspective but it may prove problematic. In 
this thesis we observed that GI and a variant near neuromedin β (NMB) gene 
interactively associated with both weight and waist circumference change (Chapter 
8). This finding needs to be replicated and verified in future studies. In general, the 
exploration of how genetic polymorphisms interact with different dietary factors on 
weight change will help to understand the etiology of obesity and to fine-tune the 
targets of nutritional prevention and treatment. Personalized nutrition is a 
conceptual analogue of personalized medicine, meaning adapting diets to individual 
needs based on people’s genotype or gene expression profile. This is a very attractive 
option for nutrition scientists as well as the general public. But, it should be a 
personal choice at best and may prove problematic if given as a public 
recommendation. First, our knowledge on gene-diet interactions still needs to be 
improved. The interactions may be proven too complex to be prescribed with simple 
understandable dietary advices as they may involve multiple genetic and dietary 
factors. Furthermore, there is a big knowledge-behavior gap in health promotion. 
Information on genetic predisposition may be of some use in motivating predisposed 
people to change their diets, but it can also counteract the effects of public health 
messages, by misleading the public that only those carrying “risk genes” need to care 
about their diets. Last but not the least, personalized nutrition may bring numerous 
ethical problems, such as discrimination and stigma, if it would become routine in 
practice.56  
 
Other determinants of obesity should also be taken into account. As a common 
complex disorder, obesity or weight gain is associated with many factors,43 some of 
which are briefly mentioned in the General Introduction of this thesis. Although the 
main cause for becoming heavier might be different among individuals, preventing a 
positive energy balance through an increased physical activity and a decreased 
calorie intake probably is the core of obesity prevention for everybody. These 
behavior changes of individuals need a supportive environment to be able to sustain. 
For this the development of public policies that address obesity issues is very 
important. For example, some countries have already taken a lead in legislation on 
approaches to combat obesity, such as sugar-sweetened beverages have been taxed 
more than other commodities57 and banned from school vending machines.58 
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Currently, more investigation on the effectiveness these legislation strategies is 
needed. 
 
Future Research  
No results of epidemiological studies can be considered final. Future studies are 
definitely necessary to confirm or deny the findings in this thesis. With respect to 
large prospective cohort studies, more efforts should be paid to the detailed 
collection of information on body fatness, dietary exposures, genetic variants and 
other behavioral variables such as physical activity to be able to precisely address the 
issue of energy balance, which is the core of the obesity problem.  
With regard to total body fat measurements, technologies such as computerized 
tomography (CT) and magnetic resonance imaging (MRI) might be of help when the 
financial and practical barriers could be overcome.59, 60 These imaging techniques are 
especially useful for quantifying the distribution of abdominal adipose tissue as 
subcutaneous abdominal fat or visceral fat, which is helpful for the estimation of the 
risk of insulin resistance, type 2 diabetes and cardiovascular diseases.61, 62 As a valid, 
simple and inexpensive approach to assess body fat status, especially in large 
populations, anthropometric measurements, such as waist circumference, waist-hip-
ratio and sagittal diameter,63 need to be standardized in aspects such as clothing and 
fasting status of subjects and the sites of the measurements.64 Because it does not 
distinguish lean and fat body mass, BMI may not be a good indicator of adiposity at 
individual level. However, on a group basis, the BMI has been shown to be 
reasonably correlated with body fat content.65  
Progress in the quality of dietary assessments will not only benefit obesity 
research, but also other areas of nutritional epidemiology, thus contributing to a 
better understanding and practicing of a 'healthy diet'.66 For example, improving the 
definition and determination methods for dietary fiber is definitely important from 
both scientific and public health perspectives.67 Enhancing the ability of dietary 
assessment tools to measure habitual GI and GL is necessary for comparing and 
translating the study findings and to solve the discussion on their utilities. For this, 
more foods should be tested for their GI values using a standard protocol.68 Specific 
dietary assessment tools should be designed focusing on carbohydrate-rich foods 
and collecting information on the nature of mono-, di- and polysaccharides, brands 
of products, fiber contents, preparation methods, how long the food is cooked, at 
what temperature it is consumed and with what foods together, and whether the 
breads contain intact kernels, etcerera.2 Accurately measuring dietary intake may 
become reality in the future, perhaps as a result of technological breakthroughs, 
improved statistical methods or robust biomarkers.69  
Despite the large heritability of obesity established by family, adoption and twin 
studies, a very limited number of common variants have thus far been identified as 
obesity phenotype-associated. Further increasing the sample sizes or performing 
meta-analyses of human genetic studies, increasing the precision of phenotype 
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measures, focusing on fat mass instead of BMI, studying fat distribution together 
with the total amount of fat tissue, obtaining more insights on the complex gene-
gene and gene-environment interactions,44 and developing tools which allow us to 
identify rare variants (population frequency < 1%), and other types of variants, such 
as copy number variation, should be the direction of future research. Further 
research is also needed to investigate the impact of epigenetics or DNA methylation 
patterns on the development of obesity or weight change.70 In addition, detailed 
information on genetic variants influencing gene expression and protein function 
need to be collected. Furthermore, genetic etiology of BMI or obesity may vary across 
the lifespan.71 Therefore, lifelong follow-up studies on birth cohorts are of special 
interests for investigating the environmental, genetic, genetic and epigenetic 
influences on the development of obesity.  
Improved knowledge and understanding the dietary and genetic determinants 
of obesity is only the first step of tackling the obesity problem. As mentioned earlier, 
there is still a large gap between knowledge and behavior changes. Research in 
finding effective methods, such as societal and environmental changes,72 to stimulate 
adaptations in dietary habits is vital for the translation of improved knowledge into 
healthy behaviors.  
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Obesity is defined as a condition of excessive fat accumulation in adipose tissue, 
to the extent that health may be impaired. It has become a worldwide epidemic, 
leading to a substantial health and economic burden. Investigating what are the 
optimal strategies to prevent or treat obesity has become of utmost importance. 
Many dietary factors have been associated with change of adiposity, but findings are 
in general inconsistent (Chapter 1). The main aim of this thesis was to investigate to 
what extent dietary factors related to satiation and satiety, including dietary 
glycemic index (GI), glycemic load (GL), energy density (ED) and fiber intake, are 
associated with subsequent changes in body weight and waist circumference, a 
marker of abdominal obesity. The study was performed as part of the DiOGenes 
project (acronym for “Diet Obesity and Genes”). We used data from a large 
population-based prospective cohort study with participants from five countries 
participating in the European Prospective Investigation into Cancer and Nutrition 
(EPIC study).  
GI is a quantitative indicator of the glycemic quality of carbohydrate-containing 
foods. It is measured as the incremental area under the blood glucose response curve 
(IAUC) of a test food as a percentage of the IAUC caused by a reference food, which 
is either glucose or white bread. Both test and reference foods should contain an 
equal amount of available carbohydrates. Usually, this is 50 gram or, in case of low-
carbohydrate foods, 25 gram. GI is a rather new concept proposed in the early 1980s, 
but much of the etiological research did not start until the late 1990’s when GL, a 
measure of the entire glycemic burden of a food by combining both the quality and 
quantity of carbohydrates, was introduced. To better understand the GI concept, a 
comprehensive literature review on its physiological mechanisms and observed 
health impacts was performed (Chapter 2). Our main conclusion from this review is 
that it is plausible that low GI foods favorably influence the management and 
prevention of type 2 diabetes, obesity, cardiovascular diseases, and certain cancers. 
However, findings are far from consistent.  
In the EPIC study, habitual diets were assessed by using food frequency 
questionnaires (FFQs), which were not specially designed to measure dietary GI and 
GL and the reproducibility and validity of these measurements had never been 
assessed before. It is important to obtain insight into the quality of the GI and GL 
measurements before examining their association with disease endpoints, in our case 
the subsequent changes in body weight and waist circumference. Therefore, two 
studies were conducted to address this issue.  
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Firstly, using data from two ongoing Dutch cohort studies (the CoDAM study and 
the Hoorn study), in which habitual diet was estimated by the same FFQ as in the 
Dutch arms of the EPIC study, we investigated the association of GI and GL with 
blood concentrations of metabolic risk factors (Chapter 3). We observed that a 10 
unit lower GI was associated with a 7% higher HDL-cholesterol, 23% lower fasting 
insulin, 23% lower HOMA-IR, 10% lower total/HDL cholesterol ratio, and 29% lower 
CRP. However, no significant association was observed between GL and any of the 
metabolic factors under investigation. This might be due to the strong correlation 
between GL and total carbohydrate intake (r = 0.97), meaning that the two variables 
were measuring the same property of the diet. It was therefore difficult to detect any 
extra effect of GL on top of the impact of total carbohydrates. These findings support 
the hypothesis of a beneficial role of low GI diets in preventing the metabolic 
syndrome, insulin resistance, type 2 diabetes and cardiovascular diseases. More 
importantly, they may also suggest a good validity of GI measured by this FFQ.  
Secondly, with the original data used to validate the Dutch EPIC FFQ in terms of the 
intake of total energy, food groups (i.e. breads, cereals, and potatoes) and nutrients 
(i.e. total carbohydrates and dietary fiber), we examined the reproducibility and 
relative validity of GI and GL (Chapter 4). The interclass correlation coefficients 
between the three repeated FFQ measurements of GI and GL were 0.78 and 0.74 
respectively, which indicated a good reproducibility. Correlation coefficients 
between the FFQ measurements and the weighted averages of twelve 24-hour 
dietary recalls were 0.63 for both GI and GL, indicating a satisfactory relative validity.  
Studies presented in chapter 5, 6 and 7 were conducted among 89,432 men and 
women. They came from six study centers in five European countries. On average, 
participants were 53 years old at baseline and were followed for 6.5 years. Chapter 5 
is about the main effects of dietary GI and GL on subsequent changes in body weight 
and waist circumference. Our hypothesis was that there would be a positive 
association between GI, GL and subsequent gain in body weight and waist 
circumference. This was based on the literature showing that low GI foods are slowly 
digested and absorbed, thus can stimulate a higher satiation and satiety leading to a 
decreased total energy intake and promoting a healthy weight. Overall, in our study, 
weight change was not significantly associated with either GI or GL. However, the 
positive association between GI, not GL, and annual waist circumference change was 
statistically significant. Participants with higher GI of 10 units gained on average 0.19 
cm/year more in their waist circumference than those with lower GI. The lack of 
association between GI and weight change may be due to the under-reporting of 
energy intake, which might be more weight-related than waist circumference-related. 
The lack of association of GL with both weight and waist circumference change may 
be, as above-mentioned, due to the close correlation between GL and total 
carbohydrate intake (r = 0.98). 
Chapter 6 focuses on dietary ED in relation to subsequent changes of body 
weight and waist circumference. Dietary ED is defined as the energy content per unit 
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weight of food (kcal/g). Because people tend to eat a similar volume of food to reach 
satiation and satiety, energy dense foods could cause passive over-consumption in 
terms of energy intake. However, there is a lack of conclusive evidence from long-
term cohort studies on the beneficial role of low ED in the prevention of subsequent 
weight and waist circumference gain. This might be due to variations in the 
methodology used to calculate dietary ED. We calculated ED as the energy provided 
by foods divided by the total weight of foods. Beverages were not included in the 
calculation based on evidence showing that 1) beverages lower ED 
disproportionately; 2) energy from drinks has only transient effects on satiation and 
does not influence habitual energy intake; 3) beverage intake is highly variable and 
difficult to be estimated by any habitual diet assessment method. Overall, we did not 
observe a significant association between ED and weight change, although 1 kcal/g 
ED was positively and significantly associated with 0.09 cm/year of waist 
circumference change. Like for GI, the lack of association between ED and weight 
change may be due to the under-reporting of total energy intake.  
Although a beneficial role of high fiber intake in the prevention of weight and 
waist circumference gain has been generally accepted, limited data is available on 
whether the impact of fiber varies according to its food sources. Therefore, in chapter 
7, we analyzed the associations of total fiber, cereal fiber and fruit and vegetable fiber 
with subsequent changes of body weight and waist circumference. We found that 
total fiber and cereal fiber were inversely associated with weight change (-39 and -77 
g/year respectively for 10 g fiber), but not fruit and vegetable fiber (2 g/year for 10 g 
fiber). However, all these three types of fiber were inversely associated with changes 
in waist circumference with a similar magnitude (-0.08, -0.10, and -0.08 cm/year 
respectively for 10 g fiber). The protective effect of cereal fiber on weight gain was 
more pronounced as compared to fruit and vegetable fiber. Several explanations 
could be responsible for this, including misreporting of fruits and vegetables, 
especially among those who had lower intake or who were obese; extra protective 
effects of whole-grain, which is the main source of cereal fiber and includes other 
components such as resistant starch, phytoestrogens, polyphenols, and antioxidants; 
and the unique influences of specific cereal fiber components such as cellulose.  
All these observed associations confirm some, but not all, of the previous 
findings in the literature and suggest a beneficial role of low GI, high fiber, low ED 
diets in the prevention of excessive weight and waist gain. The small effect sizes 
observed may, at least partly, be due to the under-reporting of dietary intake, which 
is more pronounced among obese individuals. This notion was supported by the 
(trend of) stronger positive associations between ED and changes of weight and 
waist circumference in participants with a healthy BMI than in overweight or obese 
participants (1 kcal/g ED was associated with 29 vs. -103 g/year of weight change and 
0.17 vs. 0.04 cm/year of waist circumference change) (Chapter 6). Heterogeneity 
across study centers was significant in most of the associations under investigation. 
The exact cause is unknown but many potential factors such as different 
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methodologies used to collect dietary exposures and anthropometrics, under-
reporting of energy intake, and different sources of study population in different 
centers may partially explain the heterogeneity across study centers. (Chapter 5, 6 
and 7) 
In chapter 8, we performed a case-cohort study exploring the associations of 
candidate gene variants (single nucleotide polymorphisms; SNPs) in the 
hypothalamic pathway with subsequent changes of body weight and waist 
circumference. We focused on the hypothalamic pathway because of its critical role 
in the regulation of satiation, satiety and thus energy intake. The potential 
interactions between these SNPs and GI were also investigated, given the possible 
impacts of dietary GI on satiation and satiety. Overall, none of the 123 SNPs in 15 
candidate genes had a significant main effect on changes in weight or waist 
circumference. However, the interaction between GI and SNP rs7180849, near the 
neuromedin β gene (NMB) reached statistical significance (P = 3×10-5 and 5×10-5). The 
associations between GI and subsequent changes of body weight and waist 
circumference were stronger in participants carrying the minor allele. This finding, 
when confirmed, implies that consuming low GI diets might be of special 
importance for minor allele carriers of this SNP.  
In chapter 9, the main findings of this thesis are summarized and their 
interpretation, methodological issues and public health relevance are discussed. In 
addition, recommendations for future research are addressed. Overall, the findings 
presented in this thesis support the current recommendation of consuming low ED 
and high fiber foods to prevent obesity. Based on our own findings on GI, as well as 
those from the literature, we think that it may be appropriate to recommend a low GI 
diet for the prevention of (abdominal) obesity. However, more research is needed to 
investigate the association of GI, and also GL, with obesity and obesity-related 
chronic diseases, as well as their interactions with genetic variants.  
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Obesitas is een chronische ziekte waarbij een overmatige vetstapeling in het 
lichaam aanleiding geeft tot gezondheidsrisico’s. Inmiddels is obesitas een 
wereldwijde epidemie geworden, die leidt tot een aanzienlijke last voor de 
gezondheid en een toename in de kosten van zorg. De beste strategiën voor het 
voorkómen of behandelen van obesitas zijn daarom op dit moment belangrijke 
onderwerpen voor onderzoek. Specifieke voedingsfactoren zouden in principe 
kunnen bijdragen aan het voorkómen van obesitas, maar de resultaten zijn tot nu toe 
over het algemeen inconsistent. De belangrijkste doelstelling van dit proefschrift was 
om te onderzoeken in hoeverre voedingsfactoren die betrokken zijn bij de 
verzadiging tijdens en tussen de maaltijden, gerelateerd zijn aan veranderingen in 
lichaamsgewicht en middelomtrek (als maat voor abdominale obesitas). Om deze 
relaties te bestuderen hebben we gebruik gemaakt van gegevens uit de “European 
Prospective Investigation into Cancer and Nutrition” (EPIC) studie, een groot 
prospectief cohortonderzoek onder mannen en vrouwen uit vijf Europese landen. 
Het onderzoek zoals beschreven in dit proefschrift werd uitgevoerd als onderdeel 
van het DiOGenes project (een acroniem voor “Diet, Obesity and Genes”). 
Voedingsfactoren die betrokken zijn bij de verzadiging tijdens en tussen de 
maaltijden zijn onder andere glycemische index (GI), glycemische belasting (GL), 
energiedichtheid (ED) en voedingsvezel. GI is een kwantitatieve maat voor de 
snelheid waarmee het bloedglucose stijgt na consumptie van koolhydraatbevattende 
voedingsmiddelen. De GI wordt gedefinieerd als de toename in de oppervlakte 
onder de bloedsuikercurve na consumptie van een voedingsmiddel, uitgedrukt als 
percentage van de oppervlakte onder de bloedsuikercurve van een referentie 
voedingsmiddel. Het is hierbij van belang dat het te onderzoeken voedingsmiddel en 
het referentie voedingsmiddel een gelijke hoeveelheid koolhydraten bevat (meestal 
50g of 25g). De GI is een relatief nieuw concept dat begin jaren ‘80 werd 
geïntroduceerd. Pas na de invoering van GL, een maat voor de totale glycemische 
belasting van een voedingsmiddel waarin rekening wordt gehouden met zowel de 
kwaliteit als de hoeveelheid koolhydraten, is er belangstelling ontstaan voor het 
bestuderen van de relaties tussen GI, GL en chronische ziekten zoals obesitas en 
hart- en vaatziekten. Om het concept GI beter te begrijpen is een uitgebreide 
literatuurstudie uitgevoerd naar de fysiologische mechanismen en de geobserveerde 
gezondheidseffecten (Hoofdstuk 2). Op basis van de literatuur concluderen we dat 
het aannemelijk is dat voedingsmiddelen met een lage GI een positieve invloed 
hebben op de behandeling en de preventie van type 2 diabetes, obesitas, hart- en 
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vaatziekten en verschillende typen kanker. Desondanks zijn de resultaten verre van 
consistent.  
In de EPIC studie werd de gebruikelijke voeding nagevraagd met een 
voedselfrequentievragenlijst (FFQ). Deze vragenlijsten zijn niet specifiek ontwikkeld 
om de GI en GL van de dagelijkse voeding vast te stellen. Voordat de relatie met 
veranderingen in lichaamsgewicht en middelomtrek kan worden onderzocht, is 
inzicht in de validiteit en reproduceerbaarheid van de GI en GL metingen 
noodzakelijk. Er werden twee studies uitgevoerd om deze aspecten te bestuderen. 
Ten eerste onderzochten we het verband tussen GI en GL en concentraties in het 
bloed van cardio-metabole risicofactoren (Hoofdstuk 3). Hiervoor hebben we 
gebruik gemaakt van twee lopende Nederlandse onderzoeken (de CoDAM studie en 
de Hoorn studie) waarin de gebruikelijke voeding werd nagevraagd met dezelfde 
FFQ die gebruikt was in het Nederlandse deel van de EPIC studie. We vonden dat 
een daling van de GI met 10 eenheden gerelateerd was aan een 7% hogere HDL-
cholesterol waarde, een 23% lagere nuchter insulineconcentratie, een 23% lagere 
HOMA-IR, een 10% lager totaal/HDL cholesterol ratio, en een 29% lagere CRP-
waarde in het bloed. We vonden echter geen significant verband tussen deze 
risicofactoren en GL. Dit zou veroorzaakt kunnen zijn door de sterke correlatie van 
GL met de totale inneming van koolhydraten (r=0,97), wat betekent dat de twee 
variabelen dezelfde eigenschap van de voeding meten. Het is daarom moeilijk om 
een extra effect van GL te onderscheiden. Deze resultaten ondersteunen de 
hypothese dat een voeding met een lage GI kan bijdragen aan de preventie van het 
metabool syndroom, insuline resistentie, type 2 diabetes en hart- en vaatziekten. Nog 
belangrijker is dat deze resultaten ook suggereren dat de validiteit van deze FFQ om 
GI te meten goed was. In een tweede onderzoek werd met de oorspronkelijke 
gegevens die gebruikt waren om de Nederlandse EPIC FFQ te valideren in termen 
van energie en bepaalde macro- en micronutriënten, de reproduceerbaarheid en 
relatieve validiteit van GI en GL onderzocht (Hoofdstuk 4). De interclass-
correlatiecoëfficiënten tussen drie herhaalde FFQ metingen van GI en GL waren 
respectievelijk 0,78 en 0,74, wat duidt op een goede reproduceerbaarheid. 
Correlatiecoëfficiënten tussen de metingen van de FFQ en de gewogen gemiddelden 
van twaalf 24-uurs navragen van de voeding waren 0,63 voor zowel GI als GL, wat 
aangeeft dat de relatieve validiteit voldoende is.  
De studies die worden gepresenteerd in hoofdstuk 5, 6 en 7 zijn uitgevoerd bij 
89.432 mannen en vrouwen. Zij kwamen uit 6 studiecentra in 5 verschillende 
Europese landen. Gemiddeld waren de deelnemers 53 jaar oud aan het begin van de 
studie en werden ze 6,5 jaar gevolgd. Een belangrijke hypothese van het onderzoek 
was dat er een positief verband bestaat tussen GI en GL enerzijds en 
gewichtsveranderingen anderzijds. Daarom voerden we een studie uit naar de 
effecten van GI en GL op de veranderingen in lichaamsgewicht en middelomtrek 
(Hoofdstuk 5). Er werd geen significant verband gevonden tussen GI en 
gewichtsverandering, maar wel tussen GI en de jaarlijkse verandering in 
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middelomtrek. Deelnemers waarbij de GI met 10 eenheden toenam, namen 
gemiddeld 0,19 cm/jaar meer in middelomtrek toe. Voor GL werd geen significant 
verband gevonden met veranderingen in gewicht of middelomtrek.  
De energiedichtheid van een voedingsmiddel is gedefinieerd als de hoeveelheid 
beschikbare energie per gewicht van het voedingsmiddel (kcal/g). Omdat personen 
vaak geneigd zijn om een gelijke hoeveelheid gewicht of volume van een 
voedingsmiddel te eten om verzadigd te raken, kunnen energierijke 
voedingsmiddelen leiden tot passieve overconsumptie van de totale energie-
inneming. Er is echter gebrek aan overtuigend bewijs van langdurige 
cohortonderzoeken die de positieve rol van voedingsmiddelen met een lage 
energiedichtheid in de preventie van een toename in gewicht en middelomtrek 
kunnen bevestigen. Dit zou verklaard kunnen worden door de verschillen in 
methodiek waarmee de energiedichtheid van een voedingsmiddel wordt berekend. 
Wij berekenden de energiedichtheid als de energie van een voedingsmiddel gedeeld 
door het totale gewicht van het voedingsmiddel. Dranken werden niet in de 
berekening opgenomen, en wel om de volgende redenen: 1) dranken verlagen de 
energiedichtheid onevenredig; 2) de energie van dranken geeft alleen een 
kortdurend effect op de verzadiging tijdens een maaltijd en heeft geen effect op de 
gebruikelijke energie-inneming; en 3) de inneming van dranken is erg variabel en 
moeilijk te meten door elke methode om de gebruikelijke voeding te meten. De 
resultaten lieten geen significant verband zien tussen energiedichtheid en 
gewichtsverandering, hoewel een toename in energiedichtheid van 1 kcal/g 
significant was geassocieerd met een 0,09 cm toename in middelomtrek. Net als bij 
GI, zou ook hier onderrapportage van de energie-inneming de afwezigheid van een 
verband tussen energiedichtheid en gewichtsverandering kunnen verklaren.  
Ondanks dat het algemeen geaccepteerd is dat een hoge vezel inname een 
gunstige rol speelt bij de preventie van overgewicht, is maar weinig bekend of vezel 
afkomstig uit verschillende voedingsbronnen ook verschillende effecten laten zien. 
Om die reden werd in hoofdstuk 7 het verband tussen totaal vezel, vezel uit 
graanproducten en vezel uit groente en fruit met veranderingen in lichaamsgewicht 
en middelomtrek bestudeerd. We vonden dat totaal voedingsvezel en vezel uit 
graanproducten negatief geassocieerd waren met gewichtsverandering (-39 en -77 
g/jaar voor 10 g vezel), maar niet met vezel uit groente of fruit (2 g/jaar voor 10 g 
vezel). Totaal vezel, vezel uit graanproducten en vezel uit groente en fruit waren 
allemaal negatief gerelateerd aan veranderingen in middelomtrek (respectievelijk -
0,08, -0,10 en -0,08 cm per jaar voor 10 g vezel). Verschillende verklaringen kunnen 
ten grondslag liggen aan de afwezigheid van een verband tussen vezel uit groente en 
fruit en gewichtsverandering, waaronder selectieve onderrapportage van de groente 
en fruit inneming, die mogelijk sterker gerelateerd zou kunnen zijn aan gewicht dan 
aan middelomtrek; een additioneel beschermend effect van volkorenprodukten, de 
belangrijkste bron van graanvezel die ook andere mogelijk relevant componenten 
bevat, zoals niet-fermenteerbare voedingsvezels, phyto-oestrogenen, polyfenolen en 
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anti-oxidanten; en de unieke effecten van specifieke componenten in vezels uit 
graanproducten zoals cellulose.  
Alle geobserveerde verbanden bevestigen sommige, maar niet alle, eerdere 
bevindingen in de literatuur, en duiden op een positieve rol van een voeding met een 
lage GI, hoge vezel en lage energiedichtheid in de preventie van overmatige toename 
in gewicht en middelomtrek. De kleine effecten die zijn geobserveerd zouden, op 
zijn minst gedeeltelijk, kunnen worden toegeschreven aan de onderrapportage van 
de inneming van de voeding, die sterker is in deelnemers met obesitas. Deze 
veronderstelling wordt ondersteund door de verschillen in resultaat tussen 
deelnemers met en zonder overgewicht bij aanvang van de studie zoals beschreven 
in Hoofdstuk 6. Het verband tussen energiedichtheid en veranderingen in gewicht 
en middelomtrek was sterker bij deelnemers zonder overgewicht dan in deelnemers 
met overgewicht. Een toename in energiedichtheid van 1 kcal/g was geassocieerd 
met 29 g/jaar in gewicht en 0,17 cm/jaar in middelomtrek in de eerstgenoemde groep 
vs. -103 g/jaar en 0,04 cm/jaar bij de deelnemers met overgewicht. 
In hoofdstuk 8 voerden we een case-cohort onderzoek uit om de associaties van 
polymorfismen in kandidaat genen (single nucleotide polymorfismen; SNPs) in de 
signaalroute van de hypothalamus te onderzoek in relatie tot veranderingen in 
gewicht en middelomtrek. We richtten ons op de signaalroute van de hypothalamus, 
omdat deze een belangrijke rol speelt bij de regulatie van verzadiging en dus ook bij 
energie-inneming. De mogelijke interacties tussen deze SNPs en GI werden ook 
onderzocht, gegeven de mogelijke effecten van GI op verzadiging en energie-
inneming. Geconcludeerd werd dat geen van de 123 SNP’s in de 15 genen die 
onderzocht werden een significant effect hadden op veranderingen in gewicht en 
middelomtrek. Echter, de interactie tussen GI en SNP rs7180849, nabij het 
neuromedin β gen (NMB), was statistisch significant ook na correctie voor 
meervoudig testen (False Discovery Rate) (P = 3×10-5 and 5×10-5). De verbanden 
tussen GI en veranderingen in lichaamsgewicht en middelomtrek waren sterker in 
deelnemers die vaker het minst voorkomend (‘minor’) allel (A) bezaten. Wanneer 
deze bevinding wordt bevestigd betekent dat dat de consumptie van een voeding 
met een lage GI belangrijk zou kunnen zijn voor dragers bij het minor allel van deze 
SNP.  
In hoofdstuk 9 worden de belangrijkste conclusies van dit proefschrift 
samengevat en worden de interpretatie, methodologische aspecten en de relevantie 
voor de volksgezondheid bediscussieerd. Daarnaast worden ook aanbevelingen voor 
toekomstig onderzoek gedaan. Geconcludeerd kan worden dat de bevindingen 
beschreven in dit proefschrift, de huidige aanbeveling om een voeding met een lage 
energiedichtheid en met een hoog vezelgehalte te consumeren, ondersteunen. 
Gebaseerd op onze eigen conclusies, alsmede op de conclusies uit de literatuur, 
denken wij ook dat het mogelijk is om een voeding met een lage GI aan te bevelen 
voor de preventie van (abdominale) obesitas. Echter, meer onderzoek is nodig om  
ook de associatie van GL met obesitas, en chronische ziekten die gerelateerd zijn aan 
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obesitas, goed naar waarde te kunnen schatten. Interacties met genetische aanleg 
zouden hier ook nadrukkelijk bij betrokken moeten worden. 
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肥胖是指过多的脂肪组织在体内堆积，它是一种全球范围内的流行
病，对人类健康造成严重的危害，给社会带来沉重的经济负担。也正是
因为这样,大力研究找到有效的预防或治疗肥胖的方法已经变得迫在眉
睫。多年的研究显示，诸多膳食因素与肥胖有关，但是总的来说这些研
究结果并不一致, 因此很难从中得出确凿的结论（第 1 章）。本论文的
主要目的是研究与饱食感/饱食度有关的膳食因素与体重及腰围(腰围是
一个常用的反映中心性肥胖的指标)变化的关系。这些膳食因素包括了膳
食的生糖指数（GI），生糖负荷（GL）和能量密度（ED）以及膳食纤
维摄入量。本研究是 DiOGenes（膳食、肥胖和基因）项目的一部分，
数据来源于欧洲癌症和营养学前瞻性队列研究（EPIC 研究）中的 5 个
国家。 
生糖指数（GI）是一个反映食物中碳水化合物生糖特征的指标。某
种待测食物的生糖指数是由该食物所引起的血糖反应曲线下面积与参考
食物所引起的相应面积的比值所决定。待测食物和参考食物（葡萄糖或
白面包）应包含等量的可利用的碳水化合物 (生糖碳水化合物)。通常情
况下应该是50克，但是如果食物的碳水化合物含量过低，则采用25克。
生糖指数是在20世纪80年代初期提出的概念，但是直到90年代末生糖负
荷（GL）的概念被提出之后，大量的病因学方面的研究才逐步开展起
来。生糖负荷是一个结合食物碳水化合物的质和量，测量食物对机体血
糖反应的总体负荷。为了更好的理解什么是生糖指数，生糖指数各异的
食物是通过怎样的生理学机制来影响人们的身体健康，以及可能影响哪
些健康指标，我们首先进行了一个系统全面的叙述性文献综述（第2
章）。通过该综述我们得出了如下的主要结论：选择生糖指数低的食物
有益于预防和控制II型糖尿病、肥胖、心血管疾病以及某些癌症。但是, 
并不是所有的研究结果都支持该结论。 
在EPIC研究中，研究参与者的膳食习惯是由食物频率表（FFQs）来
评价的。但是，这些食物频率表并不是为测定膳食的生糖指数和生糖负
荷而专门设计的，之前也从未对这些食物频率表的再现性和有效性进行
评价。在研究生糖指数和生糖负荷与体重和腰围变化的关系之前了解它
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们经由食物频率表所测得的值的质量非常重要。因此，我们做了如下两
个研究： 
首先，我们分析了生糖指数和生糖负荷与代谢有关风险因素的血浓
度的关系（第3章）。我们采用的数据来源于荷兰的两个正在进行中的
前瞻性队列研究（CoDAM 研究和Hoorn研究）。之所以采用这两个研
究是因为它们使用了荷兰EPIC研究中心所用的食物频率表来调查膳食习
惯。数据分析的结果显示，与较高膳食生糖指数者比，膳食生糖指数低
10个单位的研究参与者有较高的高密度脂蛋白胆固醇（7%）和较低的空
腹胰岛素（23%）、胰岛素抵抗指数（HOMA-IR，23%）、总胆固醇/
高密度脂蛋白胆固醇比（10%）及C反应蛋白（29%）。然而，我们并
没有发现生糖负荷与我们所研究的任何代谢风险因素之间存在统计学上
显著的关联性。这也许是因为生糖负荷与总碳水化合物摄入量之间存在
异常紧密的相关性（r = 0.97)。这意味着这两个变量其实反映相同的
膳食特征，因此很难想像和发现生糖负荷具有总碳水化合物所不具有的
作用。总之，我们的有关生糖指数的研究结果支持以前的一些研究发现, 
即低生糖指数膳食可能对预防代谢综合征、胰岛素抵抗、II型糖尿病和心
血管疾病有益。更重要的是，这些研究结果也间接地说明了这个食物频
率表所测定的膳食生糖指数具有良好的有效性（第3章）。 
其次，我们检验了生糖指数和生糖负荷测定值的重复性和有效性。这
得益于荷兰EPIC研究中心所提供的验证食物频率表的原始数据，该数据
曾经被用于验证总能量、食物组（如面包、谷类和土豆）和营养素（如
总碳水化合物和膳食纤维）摄入量测定值的重复性和有效性。我们发
现，三次重复使用该食物频率表所测得的生糖指数的相关系数是0.78、
生糖负荷的相关系数是0.74。这说明了该两项指标具有较好的重复性。
食物频率表所测得的生糖指数和生糖负荷值与24小时膳食回顾法所测得
的数值的加权平均值之间的相关系数是0.63。这显示了该食物频率表的
有效性也合符要求（第4章）。 
本论文中第 5、6、7 章中所涉及的研究是在 5 个欧洲国家的 6 个研究
中心的 89432 人中进行的。研究对象在基线时平均年龄 53 岁，随访 6
年半。第 5 章是研究生糖指数和生糖负荷与体重和腰围变化的关系。我
们的研究假设是：生糖指数和生糖负荷高的研究参与者体重和腰围增加
较多。这是基于以前的研究结果，显示与生糖指数高的食物相比，生糖
指数低的食物比较不容易被消化和吸收，因此会提高进食后的饱食感和
饱食度，抑制过多的能量摄入，进而有利于保持健康体重。然而，我们
的研究发现，生糖负荷与体重和腰围变化均没有显著性关系。尽管生糖
指数也与体重改变没有显著性关系，然而它与腰围变化之间的关系达到
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了统计学意义上的显著性。膳食生糖指数高 10 个单位的研究参与者，
他们每年的腰围增加值高 0.19 厘米。值得一提的是，我们发现生糖指
数与腰围变化有关但是与体重变化无关，这可能与研究参与者低估他们
的实际能量摄入有关。曾经有研究发现，与腰围相比，体重的大小更容
易影响研究参与者，尤其是肥胖者，过低估计和报告他们的能量摄入。
关于生糖负荷，它与体重和腰围变化均无显著的关系，这可能是由于它
与总碳水化合物之间的过度紧密相关所致（r = 0.98）。 
第 6 章是关于膳食的能量密度（ED）与体重和腰围变化的关系。能
力密度是指每单位重量的食物所能提供的能量（千卡/克）。因为人们
趋向于吃同样重量/体积的食物以获得饱食感和饱食度，能量密度高的
食物更容易导致能量的过度摄入。然而，长期队列研究的结果并不完全
支持低能量密度膳食在预防体重和腰围增加方面的功用，这可能与计算
膳食能量密度的方法不同有关。我们计算膳食能量密度是用所有食物所
提供的能量除以食物总重量，饮料并没有包括在内。这是因为有证据显
示 1）饮料可以不成比例地降低膳食的能量密度；2）来源于饮料的能量
对饱食感只有短暂的作用，并不影响习惯性膳食能量摄入；3）饮料摄
入的变异较大，很难用任何膳食习惯的评价方法进行准确估计。尽管我
们没能发现能量密度与体重变化之间存在显著的关系，能量密度高 1 千
卡/克的研究参与者的年平均腰围增加多 0.09 厘米，该回归系数达到了
统计学显著性。与生糖指数的情形相似，能量密度与体重变化无关但与
腰围变化有关可能是由于体重大的研究参与者过低估计他们的能力摄入
有关。 
尽管高膳食纤维摄入在预防体重和腰围增加方面的功效已被普遍接
受，关于是否不同食物来源的膳食纤维有不同的作用这方面的研究数据
还很少。因此在第7章，我们分析了总膳食纤维、谷类纤维、水果和蔬
菜纤维与体重和腰围变化的关系。我们发现，总膳食纤维与谷类纤维高
的人体重增加比较少，每增加10克膳食纤维，年体重增加分别减少39克
和77克。每增加10克水果和蔬菜纤维年体重增加增加2克，但是这个关
系没有显著性。在腰围变化方面，总膳食纤维、谷类纤维、水果和蔬菜
纤维均与之的关系相似：每增加10克膳食纤维年腰围增加分别减少
0.08、0.10和0.08厘米。这里值得说明的是，与水果和蔬菜纤维相比，
增加谷类纤维摄入似乎更有益于预防体重增加，这可能是由于食物频率
表所测得的蔬菜和水果摄入量中的误差掩盖了水果和蔬菜纤维与体重变
化的关系。因为我们知道，摄入较低者以及肥胖者更容易高估他们的蔬
菜水果摄入量，而且与腰围相比体重的大小更容易影响报告的准确性。
其次，谷类纤维主要来源于全谷类食物，其中也许包含膳食纤维以外的
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保护成份比如抗性淀粉、植物性雌激素、多酚类和抗氧化剂。还有，特
定的谷类纤维成分如纤维素也许对体重调节具有独特的影响。 
我们的研究发现证实了一部分前人的研究结果，建议低生糖指数、高
纤维、低能量密度膳食在预防超重和腰围加大方面的功效。总的说来，
我们检测到的回归系数比较小，这可能至少部分是由于膳食摄入的低报
告所造成的，这种低报告在肥胖人群中尤为明显。之所以这样推断是由
于我们在研究能量密度与体重和腰围关系时发现，正回归系数在非肥胖
人群中比在肥胖人群中大，1千卡/克能量密度分别与29克/年和-103克
/年体重变化及0.17厘米/年和0.04厘米/年腰围变化有关（第6章）。我
们的绝大部分研究结果在6个研究中心之间具有显著的差异性，其具体
的原因不是很清楚，但可能是多因素造成的结果。比如说在膳食因素和
人体测量学指标收集方法上的差异、不同的能量摄入低报告模式、以及
研究参与者来源的不同等等。 
在第8章，我们利用一个病例队列研究来探究在下丘脑路径上候选基
因的变异（单核苷酸多态，SNPs)与体重和腰围的变化的关系，以及这
些SNPs和生糖指数的潜在的交互作用。之所以关注下丘脑路径是因为
它在控制饱食感和饱食度进而能量摄入方面的关键性作用。总的来说，
在我们所研究的15个基因上的123个SNPs中，没有任何一个SNP独立影
响体重和腰围的改变。然而，生糖指数和SNP rs7180849的交互作用具
有统计意义上的显著性（体重变化的P = 3×10-5，腰围变化的P = 5×
10-5）。该SNP位于神经调节肽β（NMB）基因上游大概3Kb的位置
上。少数等位基因携带者的膳食生糖指数与体重及腰围变化的关联性更
强。这一发现如果被证实，就意味着对携带该SNP少数等位基因的人群
来说，选择生糖指数低的膳食具有特殊的重要性。 
本论文第 9 章总结和阐释了各章节的主要发现，并对方法学上问题和
对公共卫生的意义进行了讨论。另外，也对未来该领域研究的方向提出
了展望。总而言之，我们的研究结果支持当前的“低能量密度和高纤维
膳食以预防肥胖”的建议。根据我们在生糖指数方面的研究结果和文献
资料来看，我们认为推荐生糖指数低的食物以预防（中心型）肥胖也许
是适当的，尽管我们目前还需要更多的研究来理清有关生糖指数、生糖
负荷与肥胖及其相关慢性病的关系，以及他们与遗传性变异的交互作
用。 
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